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Fushi tarazu factor 1b (Ff1b) is a nuclear receptor, (NR) belonging to the NR5A 
class of transcription factors that have important roles in the endocrine function and 
development in zebrafish (Chai et al. 2000; Chai et al. 2003; Hsu et al. 2003). While 
we now understand the expression patterns, physiological roles and the downstream 
targets of the FF1 genes, the transcriptional mechanisms regulating their tissue specific 
expression remain largely unknown. In this study, we have localized the interrenal- and 
VMH (ventromedial hypothalamus)-specific enhancers to the ff1b Intron IV and Intron 
V//VII respectively. The ff1b Intron IV, with the interrenal-specific enhancer of ff1b, 
was analyzed by fragmentation and various in-silico comparative analysis. This has 
helped identify a 116 bp intronic segment that drove reporter expression to the zebrafish 
interrenal gland.  
In order to analyze the stable expression patterns induced by the ff1b Intron IV, 
a stable zebrafish transgenic line was generated with ff1b Intron IV driving reporter 
expression to the interrenal. We have also analyzed the expression patterns induced by 
the mouse Sf1 fetal adrenal enhancer in the zebrafish embryos. The observation of 
reporter expression in domains other than the interrenal gland in the developing embryo 
has opened up further avenues to study the differences in enhancer usage between 





In an effort to identify the specific transcription factors involved in regulating 
the VMH-specific expression of ff1b in the zebrafish embryos, the identified human 
VMH enhancer (VMHE) was analyzed if it could induce reporter expression in the 
zebrafish VMH. The VMHE successfully recapitulated mCherry expression in the 
zebrafish VMH indicating the use of similar transcriptional mechanisms between 
zebrafish ff1b and mammalian Sf1. The VMHE was then dissected and fragments 
analyzed for enhancer activity in zebrafish embryos in order to identify specific 
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CHAPTER 1  
INTRODUCTION 
1.1. The hypothalamic-pituitary-steroidogenic (HPS) axis 
The endocrine system works alongside of the nervous system to form the two 
main control systems of the body. The major components of the endocrine system are 
the hypothalamus, pineal gland, pituitary gland, thyroid gland, thymus, adrenal gland, 
ovary and testis. These organs are indispensable for the regulation of growth and 
development, metabolism, mood and behavior as well as sexual and reproductive 
processes. The hypothalamus is a small, yet vitally important brain region that functions 
as the central regulator enabling the interaction between the nervous system and the 
endocrine system. It co-ordinates signals from the upper cortical inputs, autonomic 
function, environmental cues and peripheral endocrine feedback and delivers precise 
signals to the body’s master gland - the pituitary through the hypophyseal portal system. 
The pituitary gland in turn, releases hormones that control the other endocrine organs in 
the body. The two organs thus form the hypothalamic-pituitary axis that directly 
influence the functions of the adrenal cortex and the gonads (testis and ovary) which 
comprise the major steroid producing tissues in the endocrine system together with the 
hypothalamus and pituitary constitute the hypothalamic-pituitary-steroidogenic (HPS) 
axis. The HPS axis can be further sub-divided into the hypothalamic-pituitary-adrenal 
(HPA) axis and the hypothalamic-pituitary-gonadal (HPG) axis. 
1.1.1.   Conserved and divergent features of the HPS axis in teleosts 
The teleosts emerged from the class of actinopterygian fishes about 300 – 350 
million years before present and comprise the largest class of vertebrates with almost 
28,000 species. Despite the large evolutionary distance, the teleosts possess a functional 
equivalent of the HPS axis with the basic components being similar in mammals. 
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However, as a result of vast adaptive radiation and a whole genome duplication event 
during the early evolution of teleosts (Ravi et al. 2008), there exists certain unique 
differences between mammals and teleosts.   
The vertebrate neuroendocrine system consists of the hypophysis or pituitary and 
the secretory neurons situated within the hypothalamic nuclei. The pituitary gland is a 
complex organ sub-divided into two regions - the anterior pituitary (adenohypophysis) 
that consists of hormone producing glandular cells and the posterior pituitary 
(neurohypophysis) that consists of axon terminals of the neurosecretory cells. The 
integration of the hypothalamus and pituitary in the HPS axis is accomplished by the 
hypophyseal artery that transports blood and the secreted hormones from the 
hypothalamus to the pituitary. The blood to the neurohypophysis is supplied by the 
inferior hypophyseal artery while the superior hypophyseal artery supplies blood to the 
adenohypophysis. The adenohypophysis in mammals can be subdivided into three 
regions: the pars distalis (PD), pars intermedia (PI), and pars tuberalis (PT). The 
mammalian neurohypophysis can be separated into two distinct domains – 1. The median 
eminence (ME) 2. The pars nervosa (PN). In mammals, the hypothalamic neurons, 
involved in the regulation of the HPS axis, send neuronal projections to the median 
eminence (ME) that causes the release of the peptides into the hypophyseal portal system 
vascularizing the adenohypophysis. The hypothalamo-hypophysial system in teleosts is 
composed of the same main components as in mammals namely the hypothalamus, 
neurohypophysis and adenohypophysis. The teleosts, however, differ in terms of the 
different components of the adenohypophysis where the teleosts lack the pars tuberalis 
(Bentley 1998). The teleostean adenohypophysis has three lobes namely the rostral PD, 
proximal PD and the PI. With no specific ME in teleosts, they lack a true hypothalamo-
hypophyseal portal system as in mammals. Hence, in order to compensate, the 
adenohypophysis is extensively innervated by finger-like projections of the 
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hypothalamic and preoptic neurons that make direct synaptic connections to the receptors 
on the pituitary cells (Norris et al. 1987; Peter et al. 1990).  
The HPA and HPG axes are highly specialized in the hormones secreted inspite 
of functioning as an integrated system (Norris 2007). Along the HPA axis, the 
paraventricular nucleus (PVN) of the hypothalamus secretes vasopressin and 
corticotropin-releasing hormone (CRH) in response to stress. The CRH regulates the 
corticotrophs in the adenohypophysis to stimulate the production of proopiomelanocortin 
(POMC) peptide that is eventually cleaved into adrenocorticotrophic hormone (ACTH) 
and β-endorphins. The ACTH, through the blood circulation, reaches the ACTH 
receptors (melanocortin 2 receptors) MC2R that are present on the surface of the 
adrenocortical cells. The hormone stimulation, through a series of signal transduction 
events involving the cyclic adenosine monophosphate (cAMP) second messenger 
system, causes the release of corticosteroid hormones in the adrenal cortex. There are 
two subcategories of corticosteroids in mammals – mineralocorticoids (aldosterone) and 
glucocorticoids (cortisol and corticosterone). The cortisol in turn acts back on the 
glucocorticoid receptors present on the hypothalamus and pituitary and regulates the 
release of CRH in a classic negative feedback loop mechanism (Dallman et al. 1987; 
Reichardt et al. 1996). In the teleost however, the primary circulating steroid is cortisol. 
Teleosts lack aldosterone and cortisol acts as a principal ligand for both glucocorticoid 
receptors (GR) and mineralocorticoid receptors (MR) (Gilmour 2005).  
The other major components of the HPS axis are the gonads that along with the 
hypothalamus and pituitary form the HPG axis. The HPG axis plays a critical role in 
development, reproduction and aging in animals. The pre-optic area (POA) and arcuate 
nuclei (ARC) of the hypothalamus secrete the gonadotropin-releasing hormone (GnRH) 
that travels via the hypophyseal portal system and binds to receptors on the secretory 
cells of the adenohypophysis. This stimulates the gondatropes in the pituitary gland to 
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secrete the two principal gonadotropins – luteinizing hormone (LH) and follicle 
stimulating hormone (FSH). The two hormones, LH and FSH, bind to G-protein coupled 
c-AMP-dependent receptors on ovaries and testes and activate the release of steroids 
(estrogen, testosterone) that are vital for reproductive development and function (Hillier 
2001; Sairam et al. 2001).  
 
Figure 1.1 Schematic representation of Hypothalamus-Pituitary-Adrenal-Gonadal 
axis in mammals. (Part of the image taken from http://bio1152.nicerweb.com) 
 
The HPG axis in teleosts is functionally similar to that of mammals. Apart from 
the direct innervation of the adenohypophysis from the neurons carrying GnRH, in 
contrast to the highly vascularized pituitary in mammals, the gonadotropes in the teleost 
pituitary are organized in specific compartments. On the other hand, the gonadotropic 
cells of the mammalian pituitary are arranged in a mosaic pattern. The localization of the 
LH and FSH receptors (LHR and FHR) are also different between mammals and teleosts. 
In mammals, LHR is expressed in the Leydig cells and the FHR in the Sertoli cells 
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(Walker et al. 2005; O'Shaughnessy et al. 2009). In teleosts, however, both LHR and 
FHR are expressed in both Sertoli and Leydig cells suggesting a dual function of LH and 
FSH in regulating spermatogenesis (Garcia-Lopez et al. 2009; Garcia-Lopez et al. 2010; 
Levavi-Sivan et al. 2010).  
Both the HPA and HPG are controlled by different signaling pathways and 
produce distinct steroid hormones. However, there still exists a very strong 
interdependence between the two axes. Studies have shown constant adrenal contribution 
to circulating androgen levels in post-menopausal ovary (Couzinet et al. 2001) and have 
also identified the presence of LH receptors in specific zones of the human adrenal cortex 
(Pabon et al. 1996). In spite of the adrenal gland primarily being responsible for the 
production of glucocorticoids and mineralocorticoids, they also express low levels of 
gonad specific G-protein coupled receptor. Apart from the basic anatomy and hormones 
secreted, another unifying aspect of the vertebrate endocrine system is the NR5A1 NR 
that is expressed in all the major organs of the HPS axis. Our study focusses on the tissue 
specific regulation of Ff1b in zebrafish that might provide a great deal of insight into the 
regulatory systems of the vertebrate endocrine system.  
1.2. Nuclear receptors NR5A: A key molecular agent in the HPS axis 
Nuclear receptors (NRs) are transcription factors (TFs) that, in response to ligand 
activation, orchestrate the transcription of their target genes by binding to specific DNA 
sequences and often engaging an array of coactivator or corepressor proteins. They 
constitute a large family of evolutionarily related TFs of which 48 members have been 
identified in human (Robinson-Rechavi et al. 2001). Nearly all the NRs share a highly 
conserved DNA binding domain (DBD) and a much less conserved ligand binding 
domain (LBD) (Kumar et al. 1999). They are involved in many physiological processes 
and play crucial roles in embryonic development, growth, metabolism, cell 
differentiation, metamorphosis, circadian rhythms and homeostasis (Mangelsdorf et al. 
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1995; Giguere 1999; Gronemeyer et al. 2004; Zhao et al. 2014). They also regulate the 
development and functioning of the HPS axis and many NRs have steroids as their 
cognate ligands. 
The NR5 subfamily of NRs, represented by the Fushi-tarazu factor 1 (Ftz-F1), 
was first identified in Drosophila as a transcriptional regulator of the pair rule 
segmentation gene fushi tarazu (ftz). It represents a class of an ancestral orphan NR with 
indispensable functions in both vertebrates and invertebrates (Ueda et al. 1990; Lavorgna 
et al. 1991; Laudet et al. 1995; Laudet 1997). Members of the NR5 receptors have been 
identified and implicated in the development and maintenance of organs along the HPS 
axis in a wide variety of animals - from nematodes and flies to fish and mammals. The 
evolutionary conservation of DBD of the FF1s indicates their critical function during 
development. Based on expression patterns and sequence similarity, the FF1 genes can 
be classified into two major groups, namely the NR5A1 (Steroidogenic factor 1/ Adrenal 
4 binding protein) (SF-1/Ad4BP) and NR5A2 (Liver receptor homologue/ α-fetoprotein 
transcription factor) (LRH/FTF). 
The NR5A family of NRs share a common structural organization composed of 
four functionally interacting domains: the Activating function 1 (AF1) domain at the N-
terminus, the highly conserved DBD that contains the two Cys2-Cys2 type zinc fingers 
that recognizes specific sequences on target genes, a flexible hinge domain, followed by 
the structurally conserved LBD with the Activation Function 2 domain (AF2) at the C 
terminus that is essential for ligand dependent transcription activation (Yussa et al. 2001; 
Li et al. 2003; Pick et al. 2006). The DBD of the NR5A family of NRs is characterized 
by the presence of a unique Ftz-F1 box that increases the DNA-binding specificity and 
distinguishes this family of NRs from the others. The Ftz-F1 box contains a bipartite 
nuclear localization signal. It is essential for nuclear localization and for interaction with 
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TFIIB and c-Jun, which is required for stimulating transcription of target genes (Wilson 
et al. 1993; Li et al. 1999; Pick et al. 2006). 
 
Figure 1.2 Structural and functional domains in NR5A nuclear receptors. The 
NR5A family of NRs have common structural and functional domains. They are 
characterized by an activating function domain (AF1) and a conserved DNA binding 
domain (DBD) at the N terminus, variable hinge domain, and a conserved ligand binding 
domain (LBD) at the C terminus 
 
The NR5A1 family of NRs have been classified as orphan NRs due to the absence 
of a known physiological ligand in activating their function. However, recent studies 
have determined the crystal structures of the LBD of human NR5A1 and have identified 
the role of phospholipids in activating the transcription of target genes by directly binding 
to the NRs (Krylova et al. 2005; Wang et al. 2005; Blind et al. 2014).   
1.2.1. NR5A1 (SF-1/Ad4BP) and NR5A2 (LRH-1/FTF) 
NR5A1, also known as Steroidogenic factor 1 (SF-1), was identified by two 
independent research teams during their search for TFs that could regulate the expression 
of steroidogenic enzymes. The presence of a conserved regulatory hexanucleotide core 
element – AGGTCA in the proximal promoter regions of the steroid hydroxylases 
indicated a common DNA binding protein involved in the regulation of the steroidogenic 
enzymes in the Y1 adrenocortical cells (Rice et al. 1991; Morohashi et al. 1992; Honda 
et al. 1993). Subsequent analysis of the cDNA sequence of the corresponding protein 
showed a striking homology to the Drosophila TF ftz-f1 and it was confirmed that SF-1 
belonged to nuclear hormone receptor family (Rice et al. 1991; Honda et al. 1993). The 
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53kDa protein was also called Adrenal 4 Binding Protein (Ad4BP) since it was first 
isolated from the bovine adrenal glands. SF-1 recognizes variations of the DNA sequence 
PyCAAGGTCA and binds to target DNA as a monomer (Rice et al. 1991; Wilson et al. 
1993). In addition to its resemblance to the Ftz-F1 family of orphan NRs, the mouse SF-
1 cDNA is also very similar to the embryonal long terminal repeat-binding protein (ELP) 
isolated from mouse embryonal carcinoma cells (Tsukiyama et al. 1992). 
Characterization of the mouse gene showed that the Sf-1 locus also encodes for three 
ELP transcripts – ELP1, ELP2 and ELP3 by alternative promoter usage and differential 
3’ splicing (Ikeda et al. 1993; Ninomiya et al. 1995). Despite the fact that ELP also 
recognizes the nucleotide sequences in the promoter of target genes as SF-1, the effect 
was much weaker and SF-1 was established to play the major role in exerting a regulatory 
effect in the HPS axis (Morohashi et al. 1994; Luo et al. 1995). 
In accordance with the role of SF-1 in the transcriptional activation of the 
steroidogenic enzymes, the major sites of SF-1 expression are the steroidogenic organs 
– adrenal cortex and the gonads (Ikeda et al. 1994; Morohashi et al. 1994). SF-1 
expression is also observed at the ventromedial hypothalamus (VMH) and the pituitary 
gonadotrope (Ingraham et al. 1994; Ikeda et al. 1995; Shinoda et al. 1995) and genetic 
ablation experiments in mice have shown the importance of SF-1 in the proper 
functioning of the HPS axis (Hammer et al. 1999). Extremely weak expression of SF-1 
was observed in the placenta, in spite of it being a major site of steroidogenesis during 
pregnancy (Ramayya et al. 1997). Interestingly, normal placental development and 
steroid production in Sf-1 knockout (KO) mice indicates that SF-1 might not be required 
for steroidogenesis in the placenta (Sadovsky et al. 1995). Later experiments have 
revealed that the α-isoform of the human activating protein-2 assumes the role of SF-1 
in the human placenta and binds to the recognition site upstream of the P450scc gene 
(Ben-Zimra et al. 2002). Apart from the major steroidogenic tissues , SF-1 expression 
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was also observed in the pancreas (Morales et al. 2006) as well as in non steroidogenic 
tissues such as spleen (Ramayya et al. 1997; Morohashi et al. 1999) and the skin (Patel 
et al. 2001). 
The other member of the NR5A subfamily of NRs, NR5A2, also known as the 
liver receptor homologue 1 (LRH-1) or α-fetoprotein transcription factor (FTF), is 
involved in the regulation of gene encoding enzymes in bile acid synthesis such as 
CYP7A and CYP8b1 (del Castillo-Olivares et al. 2000; Lu et al. 2000; del Castillo-
Olivares et al. 2004) and other genes involved in cholesterol transport in the liver and the 
intestine (Luo et al. 2001; Schoonjans et al. 2002). It was earlier assumed that SF-1 
expression was exclusive to steroidogenic organs and LRH-2 expression was limited to 
the liver and the intestine. However, recent experiments have identified high levels of 
LRH-1 transcripts in the ovary (Liu et al. 2003a) and lower levels in the adrenal and 
placenta (Wang et al. 2001c). The ability of LRH-1 to be able to bind to upstream 
promoter elements of steroidogenic enzymes such as CYP11A1, 3βHSD, CYP17 and 
StAR suggests an overlapping function LRH-1 and SF-1 (Sirianni et al. 2002; Falender 
et al. 2003). The functional redundancy is further complicated with both SF-1 and LRH-
1 binding to the same FRE with equally high affinities (Fitzpatrick et al. 1993). 
1.2.2.   NR5A subfamily members in zebrafish 
The Ftz-F1 family of orphan NRs in zebrafish is composed of four members that 
have been cloned and identified as the orthologs of mammalian SF-1 and LRH-1. The 
four Ff1s in zebrafish are namely, Ff1a (Liu et al. 1997), Ff1b (Chai et al. 2000), Ff1c 
(Xia 2003) and Ff1d (Kuo et al. 2005). The expression of Ff1a and Ff1b begins earlier in 
development than Ff1c and Ff1d. ff1a (nr5a2) has more widespread and complex 
expression as compared to ff1b and can be detected in the spinal neurons, somites, the 
hypothalamus and the trigeminal ganglia, endodermal cells in the trunk and the slow 
muscle precursor cells (von Hofsten et al. 2001; Kuo et al. 2005; Sheela et al. 2005). In 
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the adults, ff1a is expressed in the liver, mandibular arches, brain and along the gut (von 
Hofsten et al. 2001; Kuo et al. 2005; von Hofsten et al. 2005e). Comparative sequence 
and functional analysis have established that Ff1a is the homologue of LRH-1/FTF (Lin 
et al. 2000; Liu et al. 2000; von Hofsten et al. 2001).   
The other main Ftz-F1 member in zebrafish, ff1b (nr5a1a), however, has a more 
restricted expression pattern and its expression is observed mainly in the VMH, the 
interrenal gland and the gonads (Chai et al. 2000). Sequence analysis of ff1b transcripts 
and its role in the interrenal gland development and regulation of expression of 
steroidogenic enzymes have established that Ff1b is the functional homologue of SF-
1/Ad4BP (NR5A1) (Chai et al. 2003; Hsu et al. 2003). Among the few differences that 
exist between the mammalian SF-1 and zebrafish ff1b is the genomic organization and 
the distribution of the introns. While ff1b contains seven introns with an additional intron 
splitting the hinge domain, the mammalian SF-1 is characterized by only six introns with 
an intact hinge domain. This difference could be easily attributed to the large 
evolutionary distance between the two species. However, with the discovery of a fetal 
adrenal specific enhancer in Intron IV of the SF-1 gene, with no corresponding conserved 
sequence that could be detected in the zebrafish ff1b gene, the presence of an additional 
intron in ff1b is purported to have an evolutionary implication. With the focus in our lab 
primarily being Ff1b, earlier studies in our lab have managed to successfully establish a 
stable transgenic line tracing the expression of Ff1b in the developing embryo (Quek 
2009). The Ff1b led EGFP expression was observed in the VMH and the interrenal gland. 
Apart from the endogenous expression domains of Ff1b, fluorescence was also detected 
in the muscles, otic vesicle, common cardiac vein and neuromasts. Nevertheless, the 
transgenic line generated has proved very useful in our study to examine molecular 
mechanisms underlying the tissue specific expression of Ff1b in zebrafish.  
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The expression of ff1c is not observed during the embryonic stages and is not 
turned on until 4 days post-fertilization. In the adults however, ff1c transcripts are 
ubiquitous and are detected in the intestine, liver, gonads, muscles and heart (Xia 2003; 
Kuo et al. 2005; von Hofsten et al. 2005f). The last Ftz-f1 member in zebrafish, Ff1d, 
shares a 62% homology to Ff1b and is detected right from fertilization throughout all the 
stages of development. The earliest expression is detected at around 24 hours post 
fertilization in the area around the rostral diencephalon and by 30 hours post fertilization 
(hpf), coincides with the expression of ff1b in the interrenal primordium (von Hofsten et 
al. 2005a). However, while the expression of ff1d in the interrenal does not persist beyond 
48 hpf, ff1d continues to be expressed in the adult brain corresponding to the location of 
the zebrafish pituitary and hypothalamus (Kuo et al. 2005; von Hofsten et al. 2005a). 
Expression of ff1d is also observed in the testis and ovary. Unlike ff1b, ff1d expression 
in the testis is higher than that of the ovary (von Hofsten et al. 2005a; von Hofsten et al. 
2005f). The functional information on both Ff1c and Ff1d is still not available, but the 
specific expression patterns of the four Ff1 genes indicates that they might have 
overlapping and yet distinctive functions in zebrafish. 
The four zebrafish ff1 genes were studied extensively by phylogenetic analysis, 
genetic mapping and their evolutionary relationship to the tetrapod FF1s were also 
compared (Kuo et al. 2005). All the four zebrafish ff1 genes have highly conserved DBD 
and LBD and recognize the same consensus FRE in their target genes (Liu et al. 2003b). 
Phylogenetic analysis and chromosomal mapping clearly showed that ff1a is orthologous 
to NR5A2 suggesting that both zebrafish ff1a and the human NR5A2 could be derived 
from a common ancestor. However, the relationship between the zebrafish ff1b and ff1d 
with the tetrapod NR5A1 and NR5A2 is less apparent. ff1b and ff1d are shown to be gene 
duplicates on the phylogenetic tree since they located on paralogous chromosomes when 
compared to related species that have only a single NR5A1 gene (Amores et al. 1998; 
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Postlethwait et al. 1998; Taylor et al. 2003; Jaillon et al. 2004). The zebrafish ff1c, 
however, is classified as a third set of ff1 genes and probably arises from a genome 
amplification event that occurred before the divergence of the tetrapod and teleost 
(Amores et al. 1998).   
 
Figure 1.3 Stable transgenic line Tg(ff1bEx2:GFP) generated in our lab tracing the 
Ff1b expressing cells in the zebrafish embryo. The transgenic line generated was able 
to recapitulate EGFP expression in the zebrafish VMH and the interrenal. However, 
expression was also observed at the otic vesicle, common cardiac vein and muscles in 
the developing embryo. Scale bar – 100μm. Abbreviations; vh, ventromedial 
hypothalamus; ir, interrenal; ov, otic vesicle; m, muscles; ccv, common cardiac vein. 
(Quek 2009) 
 
1.3. NR5A1 and its role in the development and function of the HPS axis 
With the discovery of SF-1 as the NR essential for regulating the transcription of 
steroidogenic enzymes in the early 1990s, considerable amount of research has been 
made towards understanding the function of SF-1 in mice and its zebrafish orthologue, 
Ff1b. Studies have shown the role of SF-1 in the development and maintenance of organs 
at different levels of the HPS axis. A great deal of information into the function of SF-1 
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has been gained from knockout studies of SF-1 in mice and morpholino mediated knock 
down of ff1b in zebrafish. The role of NR5A1 in the sex determination pathway has also 
been discussed in the following sections.   
1.3.1.  Insights from knockout mice 
The critical role of SF-1 in the adrenal glands and gonads were examined by 
targeted disruption of the mouse Sf-1 gene simultaneously by three independent labs (Luo 
et al. 1994; Sadovsky et al. 1995; Shinoda et al. 1995). While the Sf-1 (KO) mice survived 
in utero, they died by postnatal day 8 due to deficiency of corticosterone. The mice also 
exhibited complete agenesis of both the adrenal glands and gonads (Luo et al. 1994; 
Shinoda et al. 1995; Bland et al. 2000). The signs of abnormal gonadal development in 
the KO mice begin to manifest precisely at the stage when the gonadal primordium 
differentiates into either the testis or the ovary. The genital ridge undergoes apoptosis 
accompanied by chromatin condensation in both the epithelium and the mesenchyme 
(Luo et al. 1994). The spleen of the Sf-1 disrupted mice also showed structural 
abnormalities combined with the non-uniform distribution of erythrocytes (Morohashi et 
al. 1999). These results show that while SF-1 is required for the development of the 
adrenal gland and the proper functioning of the steroidogenic tissues, it is also involved 
in the maintenance and differentiation of the gonads. 
The disruption of SF-1 also resulted in morphological abnormalities in the 
pituitary and VMH of the Sf-1 KO mice. Contrary to the complete absence of the adrenal 
gland and gonads in the KO mice, histological examinations of the VMH and pituitary 
showed occurrence of aplasia (Ikeda et al. 1995; Shinoda et al. 1995). The VMH was 
characterized by a large number of disseminated neurons and formed no distinct 
nucleation. The ependymal layer adjacent to the VMH exhibited thickening accompanied 
by the presence of immature neurons suggesting that Sf-1 KO affected neurogenesis, cell 
migration and organization of the functional nucleus in the VMH (Shinoda et al. 1995). 
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A more detailed examination of the VMH using immunoreactive peptides revealed that 
the normal exclusion of the γ-aminobutyric acid (GABA) from the developing VMH 
does not take place (Dellovade et al. 2000). The expression patterns of hypothalamic 
markers such as neuropeptide Y, estrogen receptor α, Islet-1 and Nkx2.1 were also 
displaced and randomly distributed as compared to the wild-type (Dellovade et al. 2000; 
Davis et al. 2004a). KO of Sf-1 in mice resulted in a drastic reduction of the gonadotropes 
in the pituitary – LH, FSH (Ingraham et al. 1994; Shinoda et al. 1995). These experiments 
collectively show the involvement of SF-1 in the establishment and maintenance of the 
HPS axis. 
1.3.2.  Insights from tissue specific knockout of SF-1 
Targeted disruption of SF-1 resulted in mice that lacked adrenal gland and gonads 
with structural abnormalities of the VMH and decreased gonadotrope expression in the 
pituitary. However, tissue specific KO of SF-1 helped to answer questions about the role 
of SF-1 in specific organs of the HPS axis. Cre-loxP recombination strategy was adopted 
to inactivate a loxP modified SF-1 locus in the anterior pituitary gland by using a Cre 
recombinase driven by the gonadotrope-specific promoter of αGSU gene (Zhao et al. 
2001b; Zhao et al. 2001a). The pituitary-specific SF1 KO mice are sexually infertile and 
did not exhibit signs of sexual development. Both the gonads were hypoplastic and while 
the testes were characterized by immature spermatogonia, primitive seminiferous tubules 
and diminished number of germ cells, the ovaries did not show the presence of follicles 
and corpora lutea. The hypoplastic Leydig cells in males and the absence of follicular 
maturation in females are the direct result of low levels of LH and FSH in pituitary 
specific SF1 KO mice. 
A similar strategy was used to KO SF-1 specifically in the gonads using an anti-
Mullerian hormone (AMH) type 2 receptor (Amhr2)-Cre that directed Cre expression to 
the Leydig and interstitial cells in the testes and the granulosa and theca cells in the 
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ovaries (Jeyasuria et al. 2004). The SF-1 KO mice had intact adrenal glands in spite of 
being smaller than the wild-type indicating that the KO was targeted specifically to the 
gonads and did not have any effect on the adrenal gland development. Both the male and 
female gonads in the SF-1 KO mice were however, sterile and indistinguishable from 
those of wild-type females. In males, the absence of SF-1 resulted in impaired 
spermatogenesis, decreased testes size and cryptorchidism that could be possibly due to 
the absence of androgens. The development of the ovaries were also affected in the KO 
mice as observed by the absence of any corpora lutea and decreased number of follicles.  
In order to define the role of SF-1 in the VMH, the Cre-loxP system was also 
used to inactivate SF-1 in the central nervous system (CNS) (Davis et al. 2004a; Zhao et 
al. 2008; Kim et al. 2009). The CNS specific knockdown of SF-1 resulted in mice with 
structural defects in the VMH combined with higher anxiety-like behavior than the wild-
type. The hypothalamus of the KO mice were also characterized by altered distribution 
of genes linked to stress and anxiety such as brain-derived neurotrophic factor (BDNF), 
type 2 receptor for CRH (Crhr2) and urocortin 3 (Ucn 3). These results indicate the role 
of SF-1 in regulating anxiety behavior, energy homeostasis, appetite regulation and 
locomotor activity. 
1.3.3.  Role of Ff1b in zebrafish  
Ff1b has been shown to be the earliest known marker of the interrenal gland in 
zebrafish. It is also observed in the VMH as early as 20 – 22 hpf (Chai et al. 2000). The 
expression of ff1b precedes steroidogenesis by almost 2 hours during the development of 
the interrenal gland indicating that Ff1b is required for the development of the interrenal 





Figure 1.4 Phenotypes induced by the microninjection of ff1bMO in zebrafish 
embryos. The effects of ff1b MO in zebrafish embryos were analyzed by in-situ 
hybridization (left panel) and were classified based on their severity from Class A to 
Class D with the arrow heads pointing to the blood island formation (Chai et al. 2003). 
The role of Ff1b in the morphogenesis of the interrenal gland was better visualized by 
injecting the ff1b MO in the transgenic line Tg(ff1bEx2:GFP) that also showed the 
disappearance of EGFP fluorescence in the interrenal as the severity progressed (Chai et 
al. 2003; Quek 2009).  
The knockdown of ff1b function in zebrafish by using antisense morpholino 
(MO) resulted in phenotype similar to the KO of SF-1 in mice. Apart from the distinct 
absence of interrenal tissue revealed by histological examinations, the ff1b morphants 
also displayed impaired osmoregulation (Chai et al. 2003). Based on the severity of the 
phenotype the morphants as a result of knockdown of ff1b can be sub-divided into four 
classes A to D. The transgenic line Tg(ff1bEx2:GFP) generated in our lab was also used 
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to study the effect of ff1b MO injection that distinctly showed the reduction in EGFP 
fluorescence at the interrenal as the morphant phenotypes progressed from Class A to 
Class D (Quek 2009). The observation of down regulation of the expression of 
steroidogenic enzymes such as cyp11a and 3β-hsd was in congruity to the role of Ff1b 
in regulating steroidogenesis. While the knockdown of dax1 also led to impaired 
osmoregulation and down regulation of steroidogenic enzymes, the knockdown of ff1b 
also led to the ablation of dax1 indicating that Dax1 functions downstream of Ff1b and 
is required for the functioning and development of the interrenal gland (Zhao et al. 2006). 
These observations were highly similar to that observed in the mouse studies indicating 
a strong conservation in the development of the adrenocortical tissues between tetrapod 
and teleosts.  
1.3.4. Role of NR5A1 in sex determination 
NR5A1 plays an important role in sex determination at all three levels of the HPG 
axis. SF-1 expressed in the VMH nucleus plays an important role in regulating the 
expression of the pituitary GnRH (Shinoda et al. 1995). SF-1 regulates the expression of 
nitric oxide synthase that in turn induces the release of gonadotropins in the pituitary 
(Wei et al. 2002). Studies have also shown that GnRH in the pituitary also regulates the 
expression of SF-1 in the pituitary (Haisenleder et al. 1996). During the development of 
the gonads in the genital ridge, the SF-1 expression is maintained along with the 
expression of SRY, located on the Y chromosome and required for the determination and 
differentiation of the testis. SF-1 has been shown to interact with SOX9, GATA-4 and 
WT1 in order to regulate the activity of the anti-Mullerian hormone (AMH) that is 
required for the regression of the mullerian duct in male gonadogenesis (de Santa Barbara 
et al. 1998; Nachtigal et al. 1998; Tremblay et al. 1999; de Santa Barbara et al. 2000). 
However, in the case of the development of the ovaries, the Dosage-sensitive sex 
reversal-adrenal hypoplasia congenita critical region on the X chromosome (DAX-1) 
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represses the expression of SF-1 indicating that SF-1 is not required for the early 
development of the ovaries (Tremblay et al. 2001b). The expression of SF-1 is turned on 
later during the development of the female gonads.  
Sex determination in zebrafish, on the other hand, is described as a complicated 
process that, apart from genetic factors, is also influenced by various environmental 
factors (Liew et al. 2014). The actual mechanisms responsible for sex determination in 
zebrafish are yet to be elucidated since no sex chromosome has been identified in 
zebrafish so far. Among the many genes that have been involved in sex determination in 
zebrafish, the Ff1 genes have been shown to play a prominent role in the differentiation 
of the gonadal tissues and their function by regulating the expression of the steroidogenic 
enzyme, Cyp19a. The aromatase (product of the cyp19 gene) is important for regulating 
the balance between androgens and estrogens in the zebrafish embryos by directing the 
conversion of testosterone into estradiol (Fenske et al. 2004; von Hofsten et al. 2005f). 
Studies have also shown that Ff1d, the paralogue of Ff1b, is expressed in the interstitial 
Leydig and Sertoli cells of the testis and is involved in regulating the expression of AMH. 
AMH is important since it inhibits the formation of the mullerian ducts and therefore, is 
required for the development of male sexual characteristics (von Hofsten et al. 2005a). 
In the ovaries, AMH is observed in the granulosa cells and where it is regulates the 
growth of the follicles in the oocyte (Salmon et al. 2004). Based on the information 
available on their mammalian orthologs, the ff1 genes could possibly have multiple 
interacting partners involved in sex determination such as sox9, wt1, gata4 and dax1. The 
underlying molecular mechanisms, however, are yet to be elucidated. 
1.4. Transcriptional regulation of NR5A1 
The studies on NR5A1 in both mammals and zebrafish have shown that the NR 
that plays an important role in the HPS axis is also subjected to tight transcriptional 
regulation. Considerable amount of research has been done towards understanding the 
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molecular mechanisms involved in the spatial and temporal expression of SF-1. Earlier 
studies were focused on identifying various promoter elements of SF-1 that module the 
activity of SF-1 in transient transfection assays. With the advent of DNA engineering 
techniques, large chromosomal segments spanning the genomic locus of SF-1 were 
cloned using yeast artificial chromosome (YAC) and bacterial artificial chromosome 
(BAC). This enabled the identification of several tissue specific enhancers on the mouse 
Sf1. In spite of this, the precise TFs and the pathways defining the tissue specific 
expression of SF-1 are still unknown.  
1.4.1. NR5A1 regulation by cis elements at 5’ proximal promoter 
With the genomic sequence of SF-1 becoming available by the mid-1990s, the 
initial studies involved the study of the 5’ proximal promoter of the SF-1 gene (Ninomiya 
et al. 1995; Wong et al. 1996). A number of cis-elements required for SF-1 expression 
were identified by transient transfection assays. Studies identified a 90 bp promoter 
fragment that contained regulatory elements – E box, CCAAT box and Sp1 binding sites 
on a 90 bp upstream promoter fragment that directed SF-1 expression in the steroidogenic 
cells of the testis and the adrenal cortex (Nomura et al. 1995; Woodson et al. 1997; 
Scherrer et al. 2002). The E and the CCAAT box were shown to bind to various 
complexes, notable among them being the Upstream Stimulatory Factor (USF) and NF-
Y proteins, in various heterologous cell lines (Woodson et al. 1997; Harris et al. 1998; 
Oba et al. 2000). Further examination of the 5’ proximal promoter revealed the presence 
of conserved binding sites of SOX and GATA proteins. While SOX9 was shown to 
upregulate the expression of SF-1 in Sertoli cells (Shen et al. 2002), GATA-4 has been 
shown to be actively involved in gonadal development by activating the expression of 




In spite of these studies that identified potential cis-elements in the promoter 
region of SF-1, subsequent studies that used various length of promoter elements in 
mouse studies failed to recapitulate the earlier results (Stallings et al. 2002; Wilhelm et 
al. 2002). A 674 bp 5’ promoter element on the mouse Sf1 was identified that contained 
binding sites of WT1 and LHX9. While this element reproduced reporter expression in 
the gonads, expression was not detected in other endogenous expression domains of SF-
1 (Wilhelm et al. 2002). Another study that used a 50 kb genomic fragment inserted in a 
BAC vector, which included a 45 kb 5’ flanking region of the mouse SF-1 and 5kb of the 
gene locus until the second exon was able to induce EGFP reporter expression in the 
adrenal cortical cells, Leydig and theca cells of the gonads and the VMH neurons 
(Stallings et al. 2002). Interestingly, however, expression was not observed in the 
pituitary gonadotropes. This indicated that the 50 kb genomic segment did not contain 
all the regulatory elements required to recapitulate the endogenous expression of SF-1. 
A transgenic mouse study conducted later that utilized a 153 kb of the entire rat SF-1 
gene locus was able to recapitulate the endogenous expression of SF-1 in all the 
expression domains (Karpova et al. 2005c). They were also able to rescue SF-1 KO mice 
using the 153 kb genomic sequence (Karpova et al. 2005a). This indicated that while the 
promoter elements are required for inducing SF-1 transcription in various tissues, the 
tissue specific regulator elements of SF-1 are located at distal locations from the start 
site.  
1.4.2. Localization of enhancers regulating tissue specific expression of SF-1 to the 
introns 
Based on the earlier transgenic mouse studies that predicted potential tissue 
specific regulatory elements at distal locations (Karpova et al. 2005a; Karpova et al. 
2005c), efforts were made towards locating distal enhancers in the mouse Sf1 gene. By 
using overlapping segments of the Sf1 gene locus inserted in a basal cosmid vector 
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accompanied with deletion analysis, a 503 bp VMH specific enhancer was localized to 
Intron VI of the Sf1 gene (Shima et al. 2005). Upon comparing the mouse VMHE to the 
human SF-1, highly conserved regions were also detected in the SF-1 gene. This study 
showed the presence of clusters of conserved nucleotides that by means of deletion and 
mutational analysis were shown to be essential for inducing VMH specific expression of 
the reporter.  
The Intron VI of the Sf1 gene was also shown to contain a 486 bp pituitary 
specific enhancer of the Sf1 gene that successfully recapitulated the endogenous 
expression of SF-1 from the fetal stage of the Rathke’s pouch to the adult pituitary (Shima 
et al. 2008). Various conserved elements were identified on the pituitary enhancer and 
among them the binding site for pituitary homeobox 2 (Pitx2) was specifically shown to 
regulate the expression of the Sf1 gene by interacting with the enhancer.  
Based on the same experimental approach, a 685 bp fetal adrenal enhancer 
(FAdE) regulating the tissue specific expression of Sf1 in the mouse fetal adrenal was 
identified in Intron IV of the Sf1 gene (Zubair et al. 2006). However, the identified 
enhancer was able to reproduce expression only in the fetal adrenal and the expression 
became considerably weak by E17.5 and the lacZ expressing cells disappeared alongside 
the regression of the X zone. This study purported an interesting theory suggesting that 
the regulation of SF-1 was controlled by different set of mechanisms in the adult and 
fetal adrenal. Closer examination of the FAdE sequence revealed the presence of binding 
sites of Pbx/Prep and Pbx/Hox TFs that could have a potential role in regulating the tissue 
specific expression of Sf1 in the fetal adrenal. 
The same research group has also identified an enhancer in the upstream region 
of the Sf1 that specifically drove reporter expression in the fetal Leydig cells of the 
developing mouse embryo (Shima et al. 2012). Closer examination of the sequence 
22 
 
revealed the significance of an Ad4BP/SF-1 and E-box binding sites, the mutation of 
which resulted in ablation of enhancer activity in the Leydig cells.  
1.4.3. Epigenetic regulation of SF-1 
Apart from the 5’ proximal promoter elements and intronic enhancers, studies 
have also established a significant relation between the DNA methylation status and the 
activity of the enhancers and basal promoter of Sf1 (Xue et al. 2007; Hoivik et al. 2008; 
Hoivik et al. 2011; Hoivik et al. 2013). The 5’ proximal promoter was shown to be 
unmethylated in the tissues where they were expressed and hypermethylated in the 
tissues where they were not expressed (Xue et al. 2007; Hoivik et al. 2008). The study 
further indicated that USF and RNA polymerase II required for activating the 
transcription of Sf1 were specifically recruited to those tissues where the promoter region 
of Sf1 are hypomethylated. Similar epigenetic modifications were observed on the tissue 
specific enhanccers of the mouse Sf1 gene. The presence of CpG islands on the intronic 
enhancers were revealed that were hypomethylated in the tissues where they were active 
and hypermethylated in the tissues where they were inactive (Hoivik et al. 2011). 
Abnormal DNA methylation has also been implicated in diseases and has been known to 
cause endometriosis due to an increased expression of steroidogenic enzymes 
(Utsunomiya et al. 2008; Bulun et al. 2009; Noel et al. 2010). By means of disulphite 
sequencing, it has been established that the promoter region is hypomethylated in patients 
suffering from endometriosis. This resulted in an increased level of SF-1 mRNA in the 
endometriotic cells.  
1.4.4. Autoregulation of SF-1 
Many studies have suggested that the Sf-1 gene autoregulates its expression by 
binding to the Ftz-F1 Response Element (FRE) located on its first intron (Nomura et al. 
1996; Oba et al. 2000). This was confirmed by mutational analysis where the mutated 
FRE resulted in a decrease in reporter activity in transient transfection assays (Nomura 
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et al. 1996). The open chromatic structure around the FRE on the Sf-1 gene locus has 
been suggested to further indicate that SF-1 is involved in auto-regulation (Ninomiya et 
al. 1996). However, other studies have also suggested that this would not be the case in 
all species since auto-regulation of SF-1 was not observed in the case of human SF-1 
(Oba et al. 2000). With the identification of the FAdE in the mouse Sf1  and the analysis 
of potential TF binding sites on it, highly conserved FREs were identified that were 
involved in an autoregulatory loop controlling the expression of SF-1 in the mouse fetal 
adrenal (Zubair et al. 2006).  
1.4.5. Insights into the regulation of SF-1 from KO mice 
Various gene KO studies have indicated the potential role of TFs in regulating 
the tissue specific expression of SF-1. Both Wt1 null mice and Lhx9 null mice 
demonstrate a failure in the development of the gonads and an accompanied loss in SF-
1 expression indicating that they have a potential role in regulating the expression of SF-
1 (Birk et al. 2000; Wilhelm et al. 2002). Another TF, the pre B-cell TF (Pbx1) was also 
shown to be linked to the regulation of Sf1 since the Pbx1 null mice have defective 
adrenal and gonads (Schnabel et al. 2003). The presence of binding sites for the Pbx1 TF 
on the FAdE of the mouse Sf1 and their involvement in regulating the expression of the 
reporter in the fetal adrenal also corroborated the earlier result (Zubair et al. 2006).  
1.5. Differences in the organogenesis between the mammalian adrenal gland and 
the interrenal gland in zebrafish 
The adrenal gland is a crucial component of the HPA axis and plays a very 
important role in mammalian stress response. Its equivalent in the teleost is called the 
interrenal gland that is markedly different in its organogenesis and its structural 
organization. In spite of that, both the adrenal gland and the interrenal gland are similar 
in their function and role in the regulation of electrolyte balance, cardiac function and 
stress response. With the main focus of our study being the TFs regulating the expression 
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of FF1b in the interrenal gland of zebrafish, it is important that we compare the interrenal 
gland with the mammalian adrenal gland to understand their various differences.  
The adrenal gland in mammals can be sub-divided into two distinct layers – the 
adrenal cortex and the adrenal medulla. The adrenal cortex secretes two major classes of 
steroids – mineralocorticoids and glucocorticoids; whose importance is very evident 
from the fatality induced by the removal of the adrenals. In mammals, the adrenal glands 
appear in pairs and are located superior to each kidney (ad-renal or supra-renal). Each 
gland is compartmentalized into two main regions based on their histological structure, 
embryonic origin and physiological function – the adrenal cortex that forms the outer 
region and is a major center for steroid production and the adrenal medulla that forms 
the inner part and is mainly involved in the release of catecholamines (adrenaline and nor 
adrenaline). 
The adrenal cortex is functionally defined and further divided into three distinct 
layers that express specific steroidogenic enzymes and have the ability to respond to 
specific peptide hormones – outer zona glomerulosa (ZG), central zona fasciculata (ZF) 
and inner zona reticularis (ZR). The ZG secretes mineralocorticoids (mainly aldosterone 
and deoxycorticosterone), regulated by the renin-angiotensin system, in response to 
increased levels of potassium or decreased blood flow to the kidneys. Aldosterone plays 
a very important role in maintaining electrolyte balance by increasing re-absorption of 
sodium and water and excretion of potassium. The ZF and ZR secrete glucocorticoids 
(cortisol in humans and corticosterone in mice) and weak dehydroepiandrosterone 
(DHEA) under the direct stimulatory influence of ACTH from the pituitary gland. 
Glucocorticoid hormones regulate numerous physiological processes such as protein and 
fat metabolism, glucose regulation and anti-inflammatory and immunosuppression. This 
takes place by the binding of a hormone bound glucocorticoid receptor (GR) dimer to a 
glucocorticoid receptor element in the regulatory regions of various target genes thereby 
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controlling their expression (Yudt et al. 2002; Schoneveld et al. 2004). Studies have also 
shown the presence of a fetal zone between the adrenal cortex and medulla in humans 
(called the X zone in mouse) that possess characteristics of a transient developmental 
zone. The fetal zone, composed of steroid secreting cells and characterized by the 
presence of lipid droplets, mitochondrial complexes and smooth endoplasmic reticulum 
(Hirokawa et al. 1974), produces dehydroepiandrosterone sulfate (DHEAS) that acts as 
the principal steroid product of the human fetal adrenal gland throughout gestation 
(Mesiano et al. 1997). 
The adrenal gland equivalent in teleosts is composed of interrenal cells 
(equivalent of adrenal cortex of mammals) and the chromaffin cells (the mammalian 
adrenomedullary counterpart) whose anatomical organization differs markedly from that 
of the vertebrates. As reviewed in (Nandi 1962) there exists no phylogenetic trend in the 
distribution of the two cell types among the different species (Figure 1.3). In teleosts, the 
adrenal homolog does not form a compact and encapsulated organ, but appears as a 
structure composed of the steroidogenic interrenal cells interspersed with non 
steroidogenic chromaffin and hematopoietic cells. The resulting interrenal gland is 
generally located anterior to the pronephros (kidney) and being embedded in the cephalic 
regions of the kidney, is commonly referred to as the head kidney. 
In (Nandi 1962), 129 teleost species were studied and examined for the 
distribution of the interrenal and chromaffin cells in the interrenal gland. The interrenal 
gland was observed to be composed of streaks, lumps or cell strands situated proximally 
to the posterior cardinal veins and its branches. In many teleosts, the interrenal gland is 
located asymmetrically to one side of the trunk (Milano et al. 1997; Rocha et al. 2001; 




Figure 1.5 Structural organization and comparison of chromaffin and 
adrenocortical cells in divergent lineages (Quek 2009). 
 
1.5.1. Organogenesis of the mammalian adrenal gland 
Extensive studies has been done to explain the development of the different zones 
in the human adrenal gland (Sucheston et al. 1972). The adrenal gland development is a 
process that begins at 3 weeks of gestation and continues well into adult life. By 
examining the histological sections of human adrenals from autopsy specimens of ages 
ranging from one month of gestation to 69 years, the study described five phases of 
adrenal development: 1) condensation of the coelomic epithelium  between 3 – 4 weeks 
of gestation 2) secondary proliferation of coelomic epithelium accompanied by migration 
of coelomic epithelial cells that occurs between 4 – 6 weeks of gestation 3) 
morphological differentiation of the cortex into two distinct zones – fetal and definitive 
zone by 8 to 10 weeks of gestation 4) the ZG, ZF and medulla begin to be delineated by 
28 – 30 weeks of gestation making the fetal cortex difficult to be differentiated from the 
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medulla leading to the gradual decline and disappearance of the fetal cortex 5) final 
establishment and stabilization of the definitive adrenal zones that is achieved by 
eleventh to fifteenth year of the adult. 
An important point to be noted here is that the adrenal cortex in mammals begins 
to be formed by proliferation of the coelomic epithelial cells between the primitive 
urogenital ridge and the dorsal mesentery. These primitive cells then migrate and 
accumulate at the cranial end of the mesenephros and form the earliest recognizable 
structure of the adrenal gland known as the “adrenal blastema”. An interesting study has 
shown that the steroidogenic cells of the adrenal and gonad differentiate from the same 
cell population of the coelomic epithelium and hence referred it to as the adreno-gonadal 
primordium. In general, the cell population medial to the mesenephros and on the dorsal 
aortal side forms the adrenal cortex and the cells ventral to the mesenephros and on the 
coelomic epithelial side forms the gonads (Hatano et al. 1996). By the eighth week of 
gestation, the migrating mass of cells differentiate into large polyhedral cells and begin 
to show structural characteristics of steroidogenic ability. These cells finally become the 
primordial fetal zone of the adrenal gland and the fetus acquires a rudimentary adrenal 
cortex that are made up of two zonal compartments – the outer definitive zone and the 
inner fetal zone. The adrenal blastema, by the ninth week of gestation, encapsulates the 
adrenal primordium and it becomes highly vascularized by a network of sinusoidal 
capillaries that persists throughout the fetal life. As development progresses, the 
definitive zone gradually accumulates some cytoplasmic lipid and resembles 
steroidogenic cells and by late gestation, the definitive zone looks similar to the adult 
ZG. Between the fetal and definitive zone, a third transitional zone was identified that 
seemed to possess intermediate characteristics with the capability to synthesize cortisol 
similar to the adult ZF. Indeed, by the 30th week of gestation, while the definitive zone 
takes on ZG, the transitional zone takes on ZF (Mesiano et al. 1997).  
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The medulla is largely absent in the fetal adrenal except for few islands of 
chromaffin cells scattered around the cortex. However, towards the 30th week of 
gestation, as the outer ZG, ZF begin to be delineated, the chromaffin cells begin to 
increase in the center making it difficult to distinguish between the fetal cortex and the 
medulla. The fetal adrenal cortex dramatically remodels after birth where the fetal zone 
undergoes apoptosis accompanied by progressive proliferation and differentiation of the 
cells derived from the definitive zone to form the three defined zones of the adrenal 
cortex – ZG, ZF and the ZR (Spencer et al. 1999). Only after the fetal zone completely 
disappears, the adrenal chromaffin cells gather around the central vein to form the adrenal 
medulla. Thus to summarize, the development of the adrenal gland involves a 
combination of complex processes such as cellular hyperplasia, hypertrophy, migration 
and senescence.  
1.5.2. Regulation of adrenocortical development in mammals 
It is important to have an understanding of the genes and molecular pathways 
implicated in the development of the adrenal cortex and so far, three main genes encoding 
TFs have been identified to play essential roles in the early stages of fetal adrenal 
development – Steroidogenic Factor 1 (SF-1), Wilms Tumor 1 (WT-1), and Dosage 
Sensitive Sex reversal Adrenal hypoplasia congenital (AHC) critical region on the X 
chromosome (DAX-1). These genes act in a coordinated manner in a common 
developmental pathway to regulate the expression of target genes for the normal 
development of both the adrenal gland and gonads since they have a common precursor 
– the adrenogonadal primordium. 
The exact mechanisms describing how SF-1 regulates adrenal development is 
unclear. However, studies suggest that SF-1 regulates the expression of genes that 
determine cell proliferation and apoptosis. In support of this theory, studies have shown 
the presence of a disorganized medulla and reduced adrenal cortex in SF-1 KO mice 
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(detailed in section 1.3.1). Expression of SF-1 can be detected in the adrenogonadal 
primordium (AGP) at a very early stage and its expression persists both in the adrenal 
and the gonads. An interesting study also showed that the dosage level of Sf1 for rescue 
affected the development of the target tissues differentially wherein lower levels of SF-
1 was able to rescue gonad formation compared to the adrenal gland (Achermann et al. 
2002; Fatchiyah et al. 2006).  
WT-1, a Kruppel-type zinc finger protein and originally identified as a tumor 
suppressor gene, has been implicated to have an important developmental role in various 
organs and tissues. WT-1 (-KTS isoform) plays a crucial role in early urogenital 
development as seen in the failure of kidney and gonad development in WT-1 mutant 
embryos (Kreidberg et al. 1993). Mouse studies have suggested the role of the Sf1 gene 
as a mediator for WT-1 function in early gonadogenesis (Wilhelm et al. 2002). Using 
biochemical experiments, they have shown that WT-1 and LHX9 function as the direct 
activators of the Sf1 gene and expression analysis of WT-1 mutant embryos showed a 
complete absence of Sf1. The introduction of a human WT-1 YAC transgene into WT-1 
null mice, that lacked the adrenals, allowed the embryos to survive past gestation in spite 
of the adrenal glands being greatly reduced in size compared to the wild type controls 
(Moore et al. 1999). Interestingly, the ectopic expression of WT-1 in the AGP seems to 
lock the adrenocortical cells into a progenitor state and WT-1 repression is required for 
adrenocortical development (Bandiera et al. 2013). While WT-1 and GATA4 are co-
expressed with SF-1 in the developing gonad, WT-1 was not detectable in a majority of 
the adrenocortical progenitors. Cre-mediated activation of WT-1 expression in 
adrenocortical steroidogenic cells resulted in highly abnormal adrenal glands of smaller 
size compared to wild type controls. Thus, to summarize, studies have established the 
crucial role of WT-1 in the AGP. However, as development progresses, while Sf1 
regulation by WT-1 is essential in gonadal development, expression of WT-1 in the 
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adrenocortical progenitors is repressed in order for steroidogenesis in the adrenals to 
occur. 
DAX-1 is another TF that is essential for the development of the adrenal gland. 
The mutation of the gene causes X-linked, cytomegalic form of adrenal hypoplasia 
congenital (AHC) in patients. The disease is largely characterized by an absent adrenal 
cortex that is accompanied by a disorganized fetal zone (Muscatelli et al. 1994; Zanaria 
et al. 1994). DAX-1, that encodes an unusual member of the NR family, begins to be 
expressed in the mouse adrenal primordium by E10.5 and studies showed that SF-1 
expression coincided with or preceded that of DAX-1 in the urogenital ridge and the 
brain (Ikeda et al. 1996). The co-localization of SF-1 and DAX-1 suggested the 
interaction between the two genes during endocrine development. However, in spite of 
the presence of SF-1 responsive element on the DAX-1 promoter (Burris et al. 1995; 
Kawabe et al. 1999), the expression of DAX-1 remained unimpaired in Sf-1 null mice. 
On the other hand, Dax-1 null mice did not show signs of adrenal hypoplasia and had 
normal definitive cortical zones. However, the fetal adrenal zone in the Dax-1 null mice 
failed to regress properly after puberty indicating the role of DAX-1 in the inititation of 
fetal adrenal degeneration (Yu et al. 1998). Interestingly, introduction of Dax-1 null 
mutation into Sf-1 heterozygotes reverses the adrenal hypoplasia and steroidogenesis 
phenotype (Babu et al. 2002).  
Pre-B-cell transcription factor 1 (Pbx1), encodes a TALE (three amino acid 
loop extension) class of homeodomain TFs, functions as a developmental regulator and 
its absence leads to embryonic lethality at a very early stage. Pbx1 was shown to be 
expressed in the presumptive mouse AGP and nephrogenic cord by E10.0 and later also 
in the epithelium of the Mullerian duct. Pbx1-/- mutant mice were characterized by 
hypoplastic adrenal glands and kidneys with histologically indistinguishable gonads 
between males and females (Schnabel et al. 2003; Lichtenauer et al. 2007). Interestingly, 
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while Pbx1 mutant embryos had continued SF-1 expression in the gonads, SF-1 
expression in the adrenocortical cells were largely reduced indicating that Pbx-1 
functions to regulate the expression of SF-1 in the adrenal cortex and thereby contributes 
in the expansion of the adrenocortical primordium during development. Cited2, another 
TF that binds to other transcription coactivators to regulate gene expression, has also 
shown to be important for adrenal development as seen in Cited2 null mice studies 
(Bamforth et al. 2001). Studies have shown that Cited2 interacts with WT-1 to stimulate 
the expression of SF-1 in the AGP at a critical point during embryogenesis in order to 
increase the expression of SF-1 above the required threshold for normal adrenal 
development (Val et al. 2007).  
WNT are glycoproteins that play a very important role in early embryonic 
development. Among the various Wnt factors, Wnt4 has a role in the development of the 
adrenal cortex. Wnt4, expressed in the AGP, has been implicated in the cell sorting 
between the adrenal cortex and gonads. Studies with Wnt-deficient mice showed the 
presence of adrenal like cells in the gonads that indicated abnormal migration of cells 
from the adrenogonadal primordium (Heikkilä et al. 2002). Wnt molecules regulate 
growth and differentiation via different pathways, one of them being β-catenin that can 
interact with the Lef/Tcf family of TFs and regulate the transcription of downstream 
genes. Using Cre-loxP strategy to conditionally inactivate β-catenin alleles in the adrenal 
cortex, studies showed complete adrenal aplasia or a depletion in the adrenocortical cells 
(Kim et al. 2008). β-catenin was also shown to synergize with SF-1 in order to regulate 
the transcription of genes required for adrenogonadal development (Gummow et al. 
2003; Jordan et al. 2003). The regulation of the adrenocortical development is a complex 
process and involves a repertoire of genes, and only few have been identified so far. 
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1.5.3. Interrenal organogenesis and regulation in zebrafish  
The interrenal gland in zebrafish is located within the head kidney that consists 
of fused bilateral lobes in the anterior part of the kidney. Not surprisingly, the 
development of the interrenal gland is tightly coupled to that of the pronephros. Both the 
pronephros and the interrenal tissues are derived from the intermediate mesoderm with 
the early interrenal tissue appearing as bilateral clusters caudal to the glomerulus and 
ventral to the notochord and third somite (Chai et al. 2003; Hsu et al. 2003). The 
interrenal primordium first appears at 20-22 hours post fertilization (hpf) (Chai et al. 
2003). By 24hpf, the interrenal primordium begins to express cyp11a1 and by 30hpf, the 
bilateral cluster of interrenal cells undergo migration towards the midline followed by 
the convergence of the bilateral interrenal primordia slightly towards the right of the 
notochord (Hsu et al. 2003).  
At 3 days post fertilization (dpf), the interrenal primordium is surrounded by a 
capsule-like structure forming a distinct organ. The electron micrographs of the interrenal 
show the presence of large number of mitochondria which contain tubulovesicular cristae 
that indicate that the cells are already steroidogenic by 3 dpf. However, even at 5 dpf, the 
interrenal does not exhibit the characteristic epithelial-like shape or arrangement and is 
not associated with any blood vessels indicating that the interrenal organogenesis is still 
incomplete at 5 dpf. 
Vascularization of the interrenal is an important requirement for endocrine 
function. Both the interrenals and pronephros, which remain in close proximity to the 
pronephros even after their separation and during their migration, depend on endothelial 
signaling for their development. Zebrafish mutant embryos with deleted endothelial cells 
demonstrate failure in the convergence of the interrenal primordia at the midline 
suggesting the requirement of endothelium in guiding the migration of the interrenal 





Figure 1.6 Morphogenetic processes involved in the development of the interrenal 
organ. Following the initial specification at 22 hpf, they undergo migration and converge 
at the midline by 24 hpf. The interrenal cells begin the production of steroids as early as 
28 hpf. By 48 hpf, the chromaffin cells invade the interrenal cells and remain dispersed 
amongst them in contrary to the layered structure of the mammalian adrenal gland (Liu 
2007).  
 
Similar to the mammalian adrenal cortex, a number of molecular factors play a 
role in the interrenal development. Zebrafish wt-1 is expressed in the intermediate 
mesoderm by 20 – 22 hpf in the prospective pronephric and interrenal primordia (Hsu et 
al. 2003) Some of the wt-1 expressing cells appear to express ff1b indicating the possible 
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interaction between Ff1b and Wt-1. However, by 24hpf, the wt-1-expressing cells 
separate from the ff1b-expressing cells as the interrenal primordium undergoes migration 
towards midline followed by fusion. The size of the interrenal primordium is 
considerably reduced with lower ff1b expression in wt-1 morphants leading to the 
indication of a possible role of Wt-1 as a determining factor for the initial ff1b expression 
and interrenal differentiation.  
Ff1b, being the earliest known marker for teleost interrenal development, is 
essential for the development of the interrenal and regulation of steroidogenesis. 
Morpholino-mediated knockdown of ff1b function disrupted interrenal development and 
leads to impaired osmoreguation. Histological analysis of ff1b morphants showed a lack 
of interrenal tissue accompanied with the absence of cyp11a and 3β-hsd expression (Chai 
et al. 2003). Analogous to the mammalian adrenal development, zebrafish Dax1 is 
required for the development of the interrenal gland. The expression of dax1 begins at 
around 26 – 28 hpf in the rostral basal forebrain and the trunk and by 31 – 32 hpf, weak 
expression of dax1 begins to co-localize with ff1b. Morpholino mediated knockdown of 
dax1 downregulates the expression of steroidogenic enzymes – cyp11a and 3β-hsd and 
it also leads to impaired osmoregulation (Zhao et al. 2006). Histological analyses did not 
show any structural abnormalities in the interrenal tissues on dax1 knockdown 
suggesting that Dax1 was not required for the formation of the interrenal gland, but for 
the functional acquisition of the steroidogenic capacity by the interrenal cells. Moreover, 
the dax1 expression begins at around 31 hpf in the interrenal cells shortly after the 
bilateral clusters fuse at the midline and before the onset of steroidogenesis. The dax1 
gene has been assumed to function downstream of ff1b during interrenal development as 
shown by the normal ff1b expression in the embryos injected with dax1 MO but reduced 
dax1 expression in embryos injected with ff1b MO. Interestingly, while mammalian 
DAX-1 functions as a corepressor for SF-1 and negatively regulates the transcriptional 
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activities of SF-1, the zebrafish Dax-1 lacks the LXXLL motifs required for corepressing 
functions and it is still unclear if Dax-1 interacts with Ff1b to regulate transcription of 
downstream genes. Unlike Dax-1, the prospero-related homeodomain protein, Prox1 has 
been shown to interact with Ff1b and functions as an Ff1b corepressor. Prox1 expression 
begins at the interrenal tissue by 28hpf, after the convergence of the bilateral clusters of 
interrenal primordium at the central midline. While Prox1 is not required for the 
specification of the interrenal primordium, prox1 morphants exhibit a slightly smaller 
interrenal organ with a marked reduction in 3β-Hsd activity (Liu et al. 2003b).  
Midline signaling is important for the proper positioning of different organs along 
the trunk and midline. The development of the interrenal gland located close to the 
notochord, is also affected by midline signaling mutations. The morphogenetic 
movements of the interrenal primordium is perturbed in midline signaling mutants such 
as one-eyed pinhead (oepm134), squint (sqtc235) and no tail (ntltc41)  where the convergence 
of the bilateral clusters of interrenal primordia were disrupted (Chai et al. 2003). 
However, the expression of ff1b and its downstream steroidogenic enzyme targets, 
Cyp11a and 3β-hsd remained unperturbed. This indicated that initial specification and 
functional differentiation of the interrenal cells were independent from the 
morphogenetic development of the interrenal gland. The morphogenetic movement of 
the interrenal gland was also not affected in sonic hedgehog signaling mutants such as 
syutp39c and smub577 (Hsu et al. 2003). This indicated that only selective midline signals 
are important for interrenal development. 
Understanding the organization and regulation of the adrenal gland and its teleost 
equivalent, the interrenal helps us understand the developmental mechanisms that have 
been conserved through evolution and zebrafish, with its transparent embryo, provides a 
promising model to study the complex interplay between genes. The seemingly 
uncomplicated organization of the zebrafish interrenal might allow us to unravel the yet 
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unidentified molecular cues guiding the interrenal differentiation and possibly, even the 
regulation of the earliest known molecular marker of the interrenal primordium, Ff1b.  
1.6. Aims of this study 
 The main focus of our study is to unravel the molecular mechanisms underlying 
the spatial control of Ff1b in zebrafish. The transgenic line Tg(ff1bEx2:GFP) generated 
in our lab by earlier studies (Quek 2009), has proven to be very advantageous towards 
achieving our quest. Firstly, the BAC clone (pBACFf1bEx2EGFP) that contains the 
entire genomic locus of the ff1b gene, used to generate the transgenic line, indicated that 
all the elements required to induce EGFP expression in the endogenous domains were 
present within the construct. This provided us with an effective starting clone that could 
be manipulated with various genetic engineering methods to identify the location of the 
tissue specific enhancers on the ff1b gene. The second advantage of using the transgenic 
line is that it provided an excellent basis for comparison of expression domains and the 
EGFP fluorescence could also be used as a background to test the specificity of the 
enhancers. 
Studies that have attempted to understand the tissue specific regulation of the 
mouse Sf-1 were successful in identifying the putative enhancers in the intronic segments. 
However, they were not able to define the specific TFs that play a role in regulating the 
expression of SF-1 in the adult adrenal and VMH. In our study, we have used zebrafish 
as the in-vitro model since it offers a lot of advantages over the mouse model such as – 
easy observation and maintenance, the possibility of live imaging owing to its 
transparency, rapid development and generation time and easy amenability to both 
forward and reverse genetics approaches. Moreover, the endocrine system of the 
zebrafish shares most of the basic features of the mammalian endocrine system 
(McGonnell 2006) and thus could be justifiably used as a suitable model to study the 
regulation of the ff1b gene, an essential TF of the HPS axis.  
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In this research project, we have followed three major lines of research with the 
aim to understand the specific TFs involved in the tissue specific regulation of ff1b. 
Studies carried out previously in our lab have, by means of single intron deletion, 
indicated the presence of the interrenal and VMH specific enhancers of ff1b in Intron IV 
and Intron V/VII respectively. We aim to corroborate these findings by performing 
multiple intron deletions on the BAC construct. Subsequently, in order to identify the 
specific TFs, we would be dissecting the ff1b Intron IV, the location of interrenal specific 
enhancers, by series of fragmentation and sub-fragmentation in order to identify the 
shortest nucleotide sequence that would recapitulate reporter expression in the zebrafish 
interrenal gland. We also aim to analyze the intronic sequence in-silico by means of 
sequence comparison and computationally identify the binding sites for potential TFs 
that could be involved in the regulation of ff1b in the interrenal gland.  
Our second objective is to establish a stable transgenic line that would trace only 
the interrenal cells in the developing zebrafish embryo by using an interrenal specific 
enhancer. The transgenic line Tg(ff1bEx2:GFP) being maintained by our lab (Quek 
2009) traces all the endogenous Ff1b expression domains in the zebrafish. Apart from 
the VMH, interrenal gland and the gonads, expression was also observed in unexpected 
domains such as the muscles, otic vesicle and cardiac vein. Hence, attempts to isolate a 
pure population of interrenal cells proved to be very difficult owing to the close proximity 
of the EGFP expressing domains. By generating a transgenic line with a different reporter 
gene that traces only the Ff1b expression in the interrenal cells, future experiments 
involving isolation of the interrenal cells and subsequent transcriptome analysis would 
be easily feasible. 
Our third and final objective was to identify the specific TFs involved in 
regulating the expression of Ff1b in the zebrafish VMH. We, however, aim to do so by 
using the identified human SF-1 VMHE and dissecting it in order to locate the specific 
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TFs. This was mainly due to the length of the ff1b intronic segments (V and VII) where 
the VMH specific enhancers were located, that made the testing and molecular 
manipulations of the fragments slightly cumbersome. Moreover, with the high degree of 
compatibility between the expression domains and functions of SF-1 and Ff1b in 
mammal and zebrafish, the regulatory mechanisms between the two species are also 















CHAPTER 2  
MATERIALS AND METHODS 
2.1. Plasmid isolation from bacterial structure 
Small scale isolation of the various plasmid DNA (< 20 kb) used in this study 
were isolated from DH10B E.coli bacterial strains using 2 – 5 ml of bacterial culture, 
grown overnight at 37°C with suitable antibiotics. The miniprep was performed using the 
Wizard® Plus SV Minipreps DNA Purification System (Promega), that uses silica 
membrane based Wizard® SV Minicolumns. The plasmid DNA was purified by the 
SDS-alkaline denaturation method and the cleared lysate was allowed to pass through 
the silica column. The DNA bound to the silica membrane, due to the presence of high 
concentration of chaotropic salts, was then washed and eluted using 50 – 100 μl of Milli-
Q water. 
Large scale purification of the plasmids (< 20 kb) intended to be used for 
microinjection purposes were performed using the QIAGEN Plasmid Maxi Kit. 400 ml 
of the Luria Bertani (LB) medium, with appropriate antibiotics, was inoculated with the 
bacterial culture and was grown overnight at 37°C. The plasmid DNA was then extracted 
using the SDS-alkaline lysis method and purified using the QIAGEN-tip 500. The elution 
buffer was heated to 65°C before allowing to pass through the column for eluting the 
DNA.  
The large scale purification of bacterial artificial chromosomal (BAC) plasmids 
for microinjection experiments were carried out with at least 500 ml of starter culture, 
grown at 37°C with vigorous shaking. The BAC plasmids were purified using the 
QIAGEN Large Construct Kit that largely followed the same protocol as the QIAGEN 
Plasmid Maxi Kit, with modifications to include an ATP-Dependent Exonuclease 
digestion step that enables the removal of genomic DNA, nicked and damaged BAC 
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constructs. Elution of the BAC plasmids from the QIAGEN-tip 500 was done using 
elution buffer heated to 65°C and the DNA pellet finally obtained was dissolved 
overnight in TE buffer at 4°C. To ensure the stability of the BAC constructs, they were 
stored at 4°C.  
2.2. Molecular cloning techniques 
The protocols for the various cloning techniques were followed as described in 
Sambrook and Russel (2000) and the manufacturer’s manual of the corresponding 
reagents. All the polymerase chain reactions (PCR) for the generation of clone fragments 
were performed using the KAPA HiFi PCR kit (KAPA Biosystems). The restriction 
enzymes used for the various DNA manipulation purposes were purchased from New 
England Biolabs Inc (MA, USA) and Promega Corp. (WI, USA). The DNA fragments 
following PCR reactions and restriction enzyme digestions were purified using the 
QIAquick PCR purification Kit (QIAGEN) and gel extracted using the QIAquick Gel 
Extraction Kit (QIAGEN). The T4 DNA ligase was purchased from Life Technologies 
(Invitrogen).  
2.3. Site-directed mutagenesis 
Site-directed mutagenesis was performed on a plasmid template using primers 
that bind to either side of the fragment to be deleted and oriented in the reverse direction, 
to amplify the region of interest, whilst deleting the intended fragment. The primers 
intended for Inverse PCR mutagenesis were specifically designed with the 5’ end 
phosphorylated. The PCR reaction was set up in final volume of 50 μl with 1U of the 
KAPA HiFi polymerase, 0.3 μM of both the forward and reverse primers, 0.3 mM dNTPs 
and 10 ng of the template DNA. Following the PCR amplification, 1μl of DpnI restriction 
enzyme (NEB) was added to the amplified product in order to digest the methylated, non-
mutated template plasmid DNA. Following the digestion of the plasmid template at 37°C, 
the reaction was purified and ~10 ng of the purified product was electroporated into 
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DH10B electrocompetent cells. The electroporated cell mixture was recovered in 250 μl 
of LB medium and grown at 37 °C for 1 hour at ~200 rpm. The entire DNA mixture was 
then plated on LB plates with appropriate antibiotics and incubated overnight at 37°C. 
Single colonies were isolated and subsequently screened by sequencing to identify the 
mutagenized clone. 
2.4. Preparation of E.coli electrocompetent cells 
The DH10B electrocompetent cell stock was first streaked on a LB plate and 
incubated at 37°C overnight. The following day a single colony was inoculated in freshly 
prepared and autoclaved 100 ml of SOB media. The inoculated culture was allowed to 
grow at 37°C overnight (~14 hours) with ~250 rpm vigorous shaking. At the end of ~14 
hours of growth, 30 ml of the overnight culture was inoculated into two separate flasks 
(2 Litre) containing 600 ml of SOB each. The culture was allowed to grow again for ~ 2 
hours following which the culture was allowed to cool down for 10 minutes. This was 
done by directly immersing the flasks into ice water, followed by constant swirling. The 
cells were then harvested by centrifuging at 3000 X g for 15 minutes at 4°C in a high 
speed centrifuge. The 1200 ml of SOB culture was harvested in six different centrifuge 
bottles, each with 200 ml of the culture. Following the harvesting of cells, the SOB 
supernatant was discarded and 200 ml of ice-cold sterile MQ water was added to each 
bottle. The cells were re-suspended in the MQ water with gentle pipetting and inversions, 
following which they were pelleted once again at 3000 X g for 15 minutes at 4°C. The 
supernatant was once again discarded and 125 ml of ice-cold 10% glycerol was added to 
each centrifuge bottle. The cells were re-suspended again by gentle swirling the bottles 
on ice. Once the cells were re-suspended in glycerol, they were pelleted by centrifugation 
at 3000 X g, 15 minutes at 4°C. The glycerol supernatant was carefully discarded taking 
care not to disturb the pellet. The cells were then re-suspended in 10 ml of ice-cold 10% 
glycerol by gentle swirling and the bacterial suspension from all the six centrifuge bottles 
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were pooled in together. They were then pelleted for the final time at 3000 X g for 15 
minutes at 4°C. The supernatant was discarded and the bacterial pellet was re-suspended 
in 2 – 4 ml of ice cold 10% glycerol. The final volume of 10% glycerol was adjusted 
based on the OD600 of the bacterial suspension and was diluted to a final concentration 
of 2 X 1010 to 3 X 1010 cells/ml (1.0 OD600 = 2.5 x 10
8 cells/ml). The cells were subjected 
to an electroporation check to ensure that all the salts were removed and there was no 
occurrence of sparking in the cuvette. The cells were finally aliquoted (50 μl) into pre-
chilled 1.5 ml tube, snap frozen in liquid nitrogen and stored at -80°C for long term 
storage. 
2.5. Transformation by electroporation 
Electroporation was the preferred method of transformation and electrocompetent 
cells were homemade and used for the purpose. The aliquoted electrocompetent cells in 
centrifuge tubes were quickly thawed and ~ 50 μl of cells were used for each 
transformation. ~10 ng of the DNA was added to electrocompetent cells and mixed well 
by gentle tapping. In the case of ligation mixes to be transformed, not more than 1μl was 
added to each aliquot of competent cells. The mixture was then transferred into chilled 
electroporation cuvettes and the cells were electroporated using the Gene Pulser (Bio-
Rad). The gene pulser was set to a capacitance of 25 μF, pulse controller of 200 ohms 
and voltage of 1.8kV. The cuvette containing the cell mixture was then pulsed in the 
electroporation chamber. A time constant reading between 4 and 5 indicates efficient 
transformation. The cells were then allowed to recover in 250 μl of LB at 37°C with 
shaking at 200 rpm for a period of 1 hour. The cells were finally plated onto LB agar 
plates with suitable antibiotics and incubated overnight at 37°C. 
2.6. Red/ET homologous recombination 
The Red/ET homologous recombination is a technique that can be very efficiently 
used for engineering BAC plasmids with ease. The recombination strategy, also known 
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as λ-mediated recombination, used the RecE/RecT or the the Redα/Redβ phage-derived 
proteins. These proteins function as 5’ – 3’ exonucleases and DNA annealing proteins. 
Interaction between these proteins is required for the homologous recombination 
reaction. The recombination proteins are synthesized by a separate vector – pRedET that 
expresses the proteins under the control of an arabinose-inducible pBAD promoter. 
2.6.1. Generation of a linear rpsl-neo cassette by PCR reaction 
The first step of the homologous recombination strategy was to generate linear 
fragments with the homologous ends. For this purpose, long primers were designed that 
consisted of 60 bp of nucleotides homologous to the specific location on the BAC DNA 
to be modified and followed by 20 bp of nucleotides homologous to the rpsl-neo 
selectable marker. Using appropriate primers, the linear DNA fragments, of ~1.4 kb in 
length, were generated by a standard PCR reaction using HiFi Polymerases and gel 
purified for electroporation.  
2.6.2. Transformation of the pRed/ET plasmid in bacteria containing the BAC 
DNA. 
Before the introduction of the linear rpsl-neo cassette with the homologous ends, 
it was first necessary to transform the pRed/ET plasmid into the DH10B cells containing 
the pBACFf1bEx2EGFPAmp. The DH10B cells containing the BAC DNA were plated 
onto LB plates containing Chloramphenicol (Cm) antibiotics (15μg/ml). An overnight 
culture at 37 °C was then set up by inoculating one or two colonies in ~ 2 – 3 ml of LB 
medium with Cm (15 μg/ml). The following day fresh microcentrifuge tubes were taken 
and 30 μl of the overnight culture was inoculated into 1.4 ml of the LB medium with Cm 
(15 μg/ml). The cells were cultured in the Eppendorf tubes at 37°C for 2 – 3 hours with 
shaking at 1000 rpm. The cells were then prepared for electroporation by pelleting the 
cells for 30 seconds at 11,000 rpm in a cooled 2°C centrifuge. The supernatant was 
discarded and the pellet was washed with 1 ml of chilled MQ water twice by re-
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suspending the cells and followed by a quick centrifugation. Finally, the cells were re-
suspended into 30 μl of MQ water and directly used for transformation to electroporate 
the pRed/ET. The same method of transformation by electroporation as described earlier 
was followed. The cells were recovered by incubating at 30°C for 70 minutes. The 
recovered cells were finally plated on LB plates with tetracycline (Tc) (3 μg/ml) and Cm 
(15 μg/ml) and incubated overnight at 30°C. The plates were specifically incubated at 
30°C, the suitable temperature for the pRed/ET. The antibiotic Tc was used to select 
specific DH10B colonies containing the pRed/ET plasmid.  
2.6.3. Truncation of specific genomic segments from pBACff1bEx2EGFPKan 
The DH10B colonies containing both the BAC DNA and the Red/ET plasmids 
were prepared for electroporation in a similar manner except for few changes when the 
Red/ET plasmids were prepared for induction by L-arabinose. The colonies were picked 
and inoculated in overnight culture of LB medium containing Tc (3μg/ml) and Cm (15 
μg/ml). The following day, 30 μl of the fresh overnight culture was inoculated in 1.4 ml 
LB medium in centrifuge tubes with the appropriate antibiotics. The tubes were incubated 
at 30°C for 2 hours with shaking at 1000 rpm. After 2 hours, 50 μl of 10% L-arabinose 
was added to the tubes in order to induce the expression of the recombination proteins. 
The tubes were then incubated at 37°C with shaking for 1 hours. The L-arabinose induces 
the pRed/ET to synthesize the recombination proteins and the temperature shift from 
30°C to 37°C also aids in this process. The cells were then prepared for electroporation 
by pelleting them for 30 seconds at 11,000 rpm in a cooled centrifuge. The supernatant 
was discarded and the pellet was washed with MQ water twice. Finally, the pellet was 
re-suspended in 30 μl of MQ water and 1 – 2 μl (100-200 ng) of the linear PCR fragment 
is added to the tubes. The linear fragment was then electroporated into the cells using the 
same method as described earlier. The cells were recovered in 250 μl of LB medium and 
incubated at 37°C for 70 minutes. The recombination process occurs during the recovery 
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period. The cells were then plated onto LB agar plates with Tc (3 μg/ml), Cm (15 μg/ml) 
and kanamycin (50 μg/ml). The kanamycin resistance is conferred by the rpsl-neo 
cassette. The plates were incubated at 37°C for ~16 hours in order to get large BAC 
colonies. The colonies were then verified for homologous recombination by BAC 
isolation, followed by sequencing. 
Table 2.1 Long primers used in the recombination strategy to replace specific 
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2.7. General maintenance and breeding of zebrafish 
The zebrafish wild type and transgenic broodstock were maintained in the 
aquarium facility at the Department of Biological Sciences, National University of 
Singapore. The embryos obtained from zebrafish spawning were cultured in egg water 
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medium at ~28°C. The egg water is prepared by diluting 1.5ml of the sea salt stock 
solution (40g/L) in 1L of autoclaved milliQ water (Westerfield 2000). The embryos 
intended for imaging purposes were treated with PTU egg water in order to inhibit 
melanin pigment formation. PTU egg water is prepared by diluting 20 ml of 50 X PTU 
stock (150mg of PTU in 100 ml of MQ water) in 1 L egg water and thus bringing the 
final concentration of PTU to 0.2 mM. The embryos were raised in the lab uptil 4 – 5 dpf 
after which they were transferred to the aquarium facility for rearing. 
2.8. Microinjection of BAC and plasmid constructs in zebrafish embryos 
The micropippettes for microinjection were prepared by fixing the borosilicate 
glass capillaries between the heating coils of micropipette puller (Model PC-10 - 
Narishige, Japan). The needles were then pulled with the following settings:  Step 1, 
Heater 1 at 72°C. The pulled capillaries were then cut manually using a sterile blade under 
a 40X magnification using a Bausch & Lomb dissection microscope at an angle of ~45° 
to produce slanted and sharp tips. The cut capillaries were then back filled with mineral 
oil (Sigma) using a 10ml syringe fitted with 18.5 gauge needle. The cut needles were 
then arranged upon tack plastic adhesive in petri dishes for storage prior to use. 
The DNA constructs to be microinjected were prepared by diluting at a 
concentration of 50 ng/μl in 1X Danieau’s buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM 
MgSO4, 0.6 mM Ca[NO3]2) and 0.25% of phenol red. The microinjection solutions were 
prepared and stored at 4°C.  
The freshly laid embryos were collected and lined up along the grooves of agar 
in a 90mm petridish containing 1.5% agarose. Excess water was removed surrounding 
the embryos leaving only a small amount enough to keep the embryos moist. The glass 
capillary was fixed onto the pistol of the Nanoliter 2000 injector and the mineral oil in 
the capillary was emptied by pushing the 'EMPTY' button until the pistol in the needle 
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reaches 1/3rd the capillary. The injection solution containing the DNA or morpholino 
was then back filled by placing the tip of the capillary into 2 μl of injection solution and 
pushing the 'FILL' button at the same time. The zebrafish embryos were microinjected 
such that the phenol red in the solution was visible inside the cells developing. For this, 
the glass needle was penetrated into the chorion till it reaches the yolk mass. Following 
this, by stepping on the pedal, the solution was injected into the embryo. The embryos 
were then cultured in 1X egg water at 28°C.  
2.9. Generation of the stable Tg(ff1bIntronIV:mCherry) zebrafish transgenic line 
For the generation of transgenic line, I-SceI meganuclease sites were added on 
either side of ff1bIntronIVtkmCherry by PCR. The purified linear fragment was then 
diluted to a final concentration of 50 ng/μl in 1X Danieau’s buffer and 1 X NEB Cut 
smart buffer with 0.25% phenol red. Immediately prior to microinjection, the I-SceI 
meganuclease enzyme was added to the microinjection solution at a concentration of 
1U/μl. The microinjection solution was prepared freshly for every injection and was 
microinjected within 45 minutes of solution preparation.  
The injected embryos were screened for the presence of mCherry fluorescence at 
the interrenal gland. The potential founders (F0) were transferred and raised to adulthood 
in the aquarium. Upon reaching sexual maturity (3 – 4 months of age), they were cross 
bred with the wild type strain to identify the potential founder. The F1 progeny was raised 
to adulthood in the aquarium and out crossed to the wild type zebrafish to produce the 
subsequent generations.  
2.10. Confocal imaging of zebrafish embryos 
The microinjected and transgenic zebrafish embryos were screened for 
fluorescence expression using a UV epifluorescent Zeiss Axiovert 25 inverted 
microscope. The final confocal images for recording purposes were captured using the 
Olympus FluoView FV1000 (Olympus, JAPAN) laser scanning confocal microscope 
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with 488 nm as the excitation wavelength for EGFP fluorescence and 543 nm for the 
mCherry fluorescence. The images were captured in the Kalman line mode. The gain and 
offset values were set at levels to induce very low levels of background fluorescence.  
The illumination source for the 488 nm and 543 nm wavelength were the 25mW Argon 
ion and 1mW HeNe Green respectively. The zebrafish embryos and larvae were 
anaesthetized in 0.001% of Tricaine (2-phenoxyethanol) before positioning them on a 
cover glass (0.15mm thickness) for imaging. In order to capture the dorsal view of the 
zebrafish embryos and larvae, they were embedded in 3% methylcellulose with the 
ventral side up. Three dimensional images of the zebrafish larvae were captured at 5 to 
10 μm intervals. The raw confocal images were finally processed using the Image J 
software (version 1.47 V) 
2.11. Bioinformatics analysis of TF binding sites 
Transcription factor binding sites (TFBS) on input genomic sequences were 
identified using the MatInspector software tool from Genomatix (www.genomatix.de). 
The software uses a library of matrix with TFBS descriptions for identifying binding sites 
and has been shown to provide far superior results than other databases (Cartharius et al. 
2005). The core similarity threshold was set to 0.8 and the matrix similarity was set to 
0.9 for all the TFBS analyses. The core similarity refers to the bases conserved within 
the core sequence of the TFBS and a core similarity of 1.0 indicated that all the bases 
within the core sequence were conserved. With the TF matches, the results were further 
filtered based on their expression tissues. In the case of ff1b Intron IV and Sf1 FAdE, the 
search filters were set for: - Endocrine system, Adrenal Gland and Embryonic structures. 
For the TFBS search on the human VMHE and ff1b Intron V and VII, the tissue 
association filters were set for: - Brain, Nervous system and Embryonic structures. The 
potential TFBS, after being corroborated with literature survey, were finally represented 
on a schematic line diagram of the genomic segment analyzed.  
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2.12. Computational tools used for sequence comparisons 
Dotplot sequence comparisons were performed using YASS 
(http://bioinfo.lifl.fr/yass/yass.php), a genomic similarity search tool (Noe et al. 2005a).  
The tool functions similar to other sequence comparison software such as BLAST by 
using seeds to detect similar sequences and subsequently using these seeds to extend the 
alignments. It, however, can also identify fuzzy repeats and has higher sensitivity for 
short sequences bearing similarity by using multiple transition constrained seeds and 
allowing the user to set custom parameters. In this study, the scoring matrix was set at 
(+5,-4,-3,-4) and the gap costs for opening and extension were set at -8 and -4 
respectively. The E-value threshold was set to 10 and the minimum window size was set 
to 10 bp.  
The ORCA tool kit (http://www.cisreg.ca/ORCAtk/), a phylogenetic footprinting 
software, was used for identifying potential regulatory regions and TFBS. In this study, 
the ORCA toolkit was used for aligning orthologous sequences to identify regions of 
significant similarity. The parameters were custom set to a window size of 30 bp with an 
increment of 1 bp. The minimum sequences to be conserved was set at 10 bp since the 
binding sites for most TFs consists of 6 – 10 bp.  
CpG island detection was performed using the software available at 
http://www.uscnorris.com/cpgislands2/cpg.aspx. The lower limits of GC % was set at 50 
with Observed CpG/Expected CpG as 0.65. The minimum length of the CpG island was 







CHAPTER 3  
Identification of 116 bp interrenal specific enhancer in 
Intron IV of the zebrafish ff1b gene 
3.1. Introduction 
The regulatory mechanisms controlling the spatial and temporal expression of 
Ff1b in the interrenal gland, VMH and the gonads of zebrafish are still unknown. Earlier 
studies have indicated that the tissue specific regulatory elements of ff1b could be situated 
at distal locations. In this chapter, the main objective was to identify the distal regulatory 
elements and the specific TFs regulating the interrenal specific expression of Ff1b. Intron 
deletion experiments conducted earlier in our lab, using the Red/ET recombination 
deletion based strategy, had shown that the deletion of Intron IV resulted in the complete 
ablation of reporter expression in the interrenal gland (Quek 2009). This suggested that 
the interrenal specific enhancers of ff1b could be located in Intron IV. We corroborated 
these experiments with further multiple intron deletions to confirm the presence of 
interrenal-specific regulatory elements in Intron IV. The enhancer activity of ff1b Intron 
IV in zebrafish was tested by cloning in a separate reporter vector led by a minimal 
promoter. The sequences of ff1b Intron IV and Sf1 Intron IV that contains the mouse fetal 
adrenal enhancer were then compared by dotplot and other flexible alignment tools to 
identify the presence of any repeats or short strands of high similarity. The results from 
the sequence comparison and the enhancer activity analysis of different truncated ff1b 
Intron IV fragments were combined. This enabled us to identify an 864 bp core segment 
within the ff1b Intron IV that could successfully recapitulate reporter expression in the 
zebrafish interrenal gland. The Intron IV core segment was then subjected to a series of 
further fragmentation that enabled us to localize the interrenal enhancer to a ~116 bp 
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intronic segment that contained the binding sites of potential TFs capable of regulating 
Ff1b expression in the interrenal gland. 
3.2. Intron Deletion Strategy Localizes Tissue Specific Enhancers of ff1b in 
zebrafish 
The Red/ET homologous recombination allows precise genetic engineering of 
DNA of any size and can be used to study a wide range of modifications with DNA at 
any chosen position including insertion, point mutation, sub cloning and deletion 
(Muyrers et al. 1999; Muyrers et al. 2000a; Muyrers et al. 2000b; Zhang et al. 2000; 
Muyrers et al. 2004). The recombination strategy was used to delete single introns 
sequentially from the BAC construct – pBACff1bEx2EGFPAmp (Quek 2009). The 
constructs generated were microinjected into zebrafish embryos and the expression 
patterns in the injected embryos were analysed  (Quek 2009).  
 In this study, we conducted further experiments to corroborate the results 
obtained earlier by performing multiple intron deletions from the BAC construct - 
pBACff1bEx2EGFPAmp. The Red/ET homologous based recombination strategy was 
used and specific long primers were designed that shared homology arms with the target 
position to be modified. The donor fragment used for recombination encompassed the 
rpsl-neo selectable marker flanked by 50 bp sequences that were directly adjacent to the 
introns to be deleted. Homologous recombination then took place when the donor 
fragment was electroporated into a DH10B bacterial host that already contained the 
construct pBACff1bEx2EGFPAmp and pRedET. 
The intron(s) deleted BAC constructs generated were microinjected into wild 
type zebrafish embryos and EGFP fluorescence was assayed at 48 hpf. Fluorescence 
could be detected in approximately 30% of the injected embryos. The level of intrinsic 
EGFP fluorescence was compared between the original BAC construct and the intron(s) 
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deleted constructs and images were captured at 48 hpf by which time both the VMH and 
the interrenal gland had been developed. 
Earlier experiments that had carried out the single intron deletion of Intron I, II 
and III had not shown any effect on the EGFP expression (Fig 3.3 B-D, G). The 
expression observed was similar to that observed in the stable transgenic line 
Tg(ff1bEx2:GFP). EGFP expression were detected as bilateral clusters at the ventral 
diencephalon with neuronal projections in some embryos, and at the interrenal gland 
ventral to the second and third somite. This suggested that the ff1b Introns I, II and III 
probably did not contain tissue specific regulatory elements.  The absence of any 
functional regulatory element within these introns was further substantiated using the 
construct pBACff1bEx2EGFPIntII-IIIDel, where the ff1b genomic segment between the 
Intron II and III were deleted. The injection of the intron deleted BAC construct also did 
not reflect any changes in the EGFP expression patterns in the zebrafish embryos (Fig 
3.3 I).  
There was, however, a marked reduction in the number of embryos with EGFP 
expression at the interrenal when Intron IV was deleted from the ff1b gene locus in 
pBACff1bEx2EGFPAmp (Fig 3.3 E). Only 1.7%, amounting to 9 embryos out of 520 
screened for expression, showed the presence of EGFP signal at the interrenal, albeit at 
a very low intensity. This indicated the presence of regulatory elements for interrenal 
expression in Intron IV. In order to colloborate this, the genomic segment between Intron 
II to Intron IV was deleted and the resulting BAC construct was microinjected into 
wildtype zebrafish embryos. The pBACff1bEx2EGFPIntII-IVDel construct also resulted 
in only 1.8% of embryos harboring EGFP expression at the interrenal, the intensity of 









Figure 3.1 Deletion of intron(s) from pBACff1bEx2EGFPAmp using Red/ET 
homologous recombination strategy. The BACff1bEx2EGFPAmp with the ff1b 
endogenous locus and the pRed/ET plasmid, that encodes for the phage-derived proteins 
(recE and recT) required for homologous recombination were transformed into DH10B 
strain of E.coli. Subsequently, the donor DNA fragment – rpsl-neo cassette (1.3kb) 
harboring homology sequences targeting the site to be deleted, is transformed into the 
bacteria with the pBACff1bEx2EGFPAmp and pRed/ET plasmids. Homologous 
recombination occurs with a temperature shift from 30°C to 37°C and L-arabinose 
induction. The resultant BAC construct has the rpsl-neo cassette inserted in place of the 









Figure 3.2 Schematic representation of Red/ET homologous recombination based 
deletion of specific intron(s) from pBACff1bEx2EGFPAmp. A. Representations of 
single intron deletions performed earlier (Quek 2009) B. Schematic representations of 
multiple introns using the Red/ET recombination technique. The deleted genomic 
segment is indicated by a broken V shaped line. The intron deleted BAC constructs were 
injected in wild type embryos and scored for the EGFP expression at 48 hpf. The 
percentage of embryos expressing EGFP in the different tissues upon injection of the 
corresponding BAC construct are shown. The expression levels of constructs that exhibit 
a significant difference from the original construct have been highlighted in yellow. 




The deletion of Intron V and Intron VII from the ff1b gene led to a decline in the 
number of embryos with EGFP expression at the VMH (Fig 3.3 F, H). The expression 
observed at the VMH, in 2.9% and 5.6% of embryos upon injection of 
pBACff1bEx2EGPIntVDel and pBACff1bEx2EGFPIntVIIDel respectively, were of 
considerably low intensity. Combined intron deletion from Intron V to Intron VII in the 
ff1b gene, also lead to a drop in EGFP expression in the VMH with only 2% of the 550 
embryos screened showing a highly reduced expression (Fig 3.3 K). This proved that the 
Intron V and Intron VII of ff1b contained enhancers that directed expression to the 
zebrafish VMH.  
A final intron deletion was performed in order to demonstrate that the regulatory 
elements required for tissue specific expression of Ff1b are present at distal locations 
from the proximal promoter. The entire genomic segment from Intron II to Intron VII 
was removed and the resulting pBACff1bEx2EGFPIntII-VIIDel construct did not show 
EGFP expression in any of the major Ff1b expressing tissues (Fig 3.3 L) thus confirming 


























Figure 3.3 Analysis of EGFP expression at 48 hpf in zebrafish embryos injected with 
intron deleted BAC constructs. The pBACff1bEx2EGFP injected embryos showed the 
endogenous ff1b expression in the VMH and interrenal (A). Expression was also 
observed in the otic vesicle and neuronal projections. Deletion of intron I, II, III, VI and 
the genomic segment from Intron II-III did not show any drastic change in expression 
domains (B-D, G, I). Deletion of Intron IV and the genomic segment from Intron II-IV 
showed a reduction in embryos expressing EGFP in the interrenal (E, J) and deletion of 
Intron V, VII and fragment from Intron V-VII resulted in reduced EGFP expression in 
the VMH (F,H,K). The BACff1b construct with the entire genomic segment from Intron 
II-VII removed showed no expression in the VMH and interrenal with only mosaic 
expression in the muscles and otic vesicle (L). Images were captured from the lateral 
view using confocal microscope. Scale - 100μm; Abbreviations: ov, otic vesicle; ir, 










3.3. ff1b Intron IV fused to a basal promoter and reporter gene recapitulates 
reporter expression in the zebrafish interrenal 
In line with the earlier observations that indicated the presence of interrenal 
specific enhancer elements within the ff1b Intron IV, it was necessary to confirm if the 
ff1b Intron IV segment alone could recapitulate expression in the interrenal gland. In 
order to do so, the ff1b Intron IV was cloned out into a separate vector, upstream of a 
minimal thymidine kinase (tk) promoter and EGFP reporter gene. A minimal thymidine 
kinase (tk) promoter was chosen for this purpose since the tk promoter has been known 
to have a high induction value and can be efficiently used to test transcriptional activity 
of enhancers and promoter efficiency (Hu et al. 2014; Zhang et al. 2014).  
The clone – pff1bIntronIVtkEGFP, was microinjected into zebrafish embryos at 
1 to 2 cell stage and these were assayed for EGFP expression from 24 hpf. More than 
25% of embryos analyzed showed that Intron IV reproduced EGFP expression in the 
zebrafish interrenal gland. EGFP expression could be detected in the microinjected 
zebrafish embryos from a very early stage. Images of embryos captured by confocal 
microscopy showed a strong level of EGFP expression from as early as 22 hpf (Fig 3.4 
A). The EGFP signal could be detected along the developing intermediate mesoderm that 
gives rise to the pronephric and interrenal primordium in zebrafish. Few embryos also 
displayed inconsistent mosaic expression along the lateral mesoderm and the anterior 
neural tube. 
By 48 hpf, most of the mosaic EGFP expression seem to disappear and the 
expression at the interrenal primordium appeared stronger and distinct (Fig 3.4 B). EGFP 
signal could be detected as a cluster of cells ventral to the second and third somite 
reminiscent of the EGFP expression in the transgenic line tracing ff1b expressing cells – 





Figure 3.4 Transient expression of EGFP in the embryos injected with the 
pff1bIntronIVtkegfp clone. The embryos microinjected with the clone were visually 
assessed for EGFP expression and images were captured using confocal microscopy at 
the corresponding stages (A-E). The images captured at 24 hpf show a highly mosaic 
EGFP pattern (A) with the white arrow heads pointing at the prospective interrenal 
primordium. As development progressed, the expression at the interrenal gland became 
more pronounced by 48 hpf and 72 hpf (B-D). The EGFP expression appeared to become 
diminished by 4 dpf (E). Injection of control vector (ptkEGFP) did not induce EGFP 
expression in the embryos (F). Images were oriented laterally for images A-C, E-F and 






EGFP signal between the injected larvae, the expression was persistent in the developing 
interrenal gland. The EGFP expression could be detected ventral to the somites 1-3 (Fig 
3.4 C-D) with a significantly higher expression at the second and third somite coinciding 
with the interrenal organ in zebrafish. Interestingly, by 4 dpf, the EGFP expression at the 
interrenal was highly reduced and could not be observed therafter. 
The analysis of the transient EGFP expression induced by Intron IV of ff1b in 
zebrafish embryos confirmed the presence of enhancers in the intronic segment. 
However, the expression observed was highly mosaic until 28 hpf and appeared more 
distinct at the interrenal only by 48 hpf. An important aspect of the chosen method to test 
for enhancer activity was that the intronic segment was taken out of the genomic context 
that could in turn result in non-specific reporter expression in the zebrafish embryos. 
Another important factor that could attribute to the presence of diverse EGFP expressing 
cells could be the transient nature of transgenesis. Hence, in order to study the EGFP 
expression induced by Intron IV of ff1b gene, it was necessary to generate a stable germ-
line transgenic zebrafish. 
 Inspite of the mosaic and transient nature of transgenesis, the EGFP expressing 
cells mirrored the spatial and temporal expression patterns of the ff1b gene in the 
interrenal of the developing embryos and thus could still be used to study the cis-
regulatory modules that control the interrenal specific Ff1b expression. 
3.4. Truncation of ff1b Intron IV in order to identify location of prospective 
interrenal enhancer 
In order to address the interrenal specific transcriptional regulation of Ff1b in 
vivo and to examine how much of Intron IV genomic segment is sufficient to drive the 
correct spatio-temporal expression of Ff1b, it is necessary to dissect the cis regulatory 
landscape of Intron IV driving EGFP expression in the zebrafish embryos. Towards this 
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end, we prepared deletion constructs and examined their enhancer activity by 
microinjecting them into zebrafish embryos (Fig 3.5). 
Intron IV deletion series was prepared by a combination of sequential 5’ PCR 
deletion and by using restriction enzyme digestion followed by re-ligation. While the 
fragments, Fragment 1 (F1) to Fragment 6 (F6) were generated by using PCR primers 
designed to progressively delete Intron IV from the 5’ end, Fragment 7 (F7) to Fragment 
11 (F11) were generated by digesting with restriction enzymes that cut Intron IV twice, 
which was then followed by re-ligation. Restriction enzymes SacI, AccI, PpuMI, BamHI 
and XhoI were used for generating F7, F8, F9, F10, and F11 respectively. The deletion 
constructs were then individually microinjected into zebrafish embryos at the 1 cell stage 
which were scored for EGFP fluorescence at 48 hpf. Images of the embryos were 
captured between 48 hpf – 54 hpf using confocal microscopy. 
When Intron IV fragments – F1, F2 and F3 were microinjected into zebrafish 
embryos, they retained EGFP fluorescence in the interrenal although the percentage of 
embryos expressing EGFP were reduced in those injected with F2 and F3. The level of 
non-specific expression also varied in F1, F2 and F3 injected embryos. Both F1 and F2 
showed a 21% and 25% of non-specific expression respectively, in the muscles and along 
the gut. However, embryos injected with F3 had a considerable reduction in non-specific 
expression with only 7.4% of embryos expressing EGFP in the muscles, gut and even in 
the rostral regions of the zebrafish brain in some embryos. While F1 encompassed the 
entire length of Intron IV, F2 and F3 lacked the upstream 1179 bp and 2146 bp of Intron 
IV respectively.  
A drastic difference in the percentage of embryos expressing EGFP in the 
interrenal was observed in those injected with F4 that had the upstream 2831 bp of Intron 





Figure 3.5 Schematic representation of pff1bIntronIVtkegfp deletion series and the 
effects of deletion on enhancer activity in zebrafish embryos. The ff1b Intron IV was 
progressively deleted from the 5’ end by PCR (F1-F6) and was also subjected to 
restriction digestion by enzymes that cut twice in the Intron IV segment followed by self-
ligation (F7-F11). The number of embryos expressing EGFP at the interrenal 
corresponding to the truncated Intron IV fragment injected are summarized. The analysis 
of enhancer activity in the interrenal indicated the presence of interrenal specific 
enhancers in the segment between ~1100 bp to ~2800 bp of Intron IV segment. However, 
F8, F9 and F10  were able to reproduce EGFP expression in the interrenal suggesting the 
presence of overlapping TFBS on Intron IV that could rescue the tissue specific reporter 




the second and third somite. However, the level of non-specific expression remained 
unchanged with 12.7% of embryos harboring expression in areas other than the 
prospective interrenal. The last of the 5’ sequential deletion fragments, F5 and F6, did 
not induce any EGFP expression in the microinjected embryos. While F5 contained 
approximately 600 bp of the 3’ end of Intron IV, F6 was used as a negative control and 
included only the tk promoter fused to the EGFP reporter gene. The sequential 5’ deletion 
indicated that most of the elements required for expression in the interrenal were present 
in F1, F2 and F3. While F4 still induced expression in the interrenal, it was highly 
reduced. The 5’ sequential deletion has thus tentatively concluded the presence of 
interrenal specific enhancers to lie approximately between 2140 bp to 2800 bp of Intron 
IV. 
In order to more comprehensively study the cis-regulatory elements present in 
Intron IV, the sequential 5’ deletion of Intron IV was followed by further deletion using 
restriction enzymes. F7, generated by deletion using SacI that had the upstream 2400 bp 
of Intron IV deleted, resulted in 38.4% of embryos with EGFP expression in the 
interrenal gland. The percentage of embryos with non-specific expression in the muscles 
was also high at 34.7%. This result, coupled with the 5’ deletion series’ results, points to 
the region between 2406 bp and 2832 bp of Intron IV to harbor interrenal specific 
regulatory elements. 
However, the fragment F8, generated using the restriction enzyme AccI that 
deleted the Intron IV genomic segment between 314 bp and 3242 bp, also induced EGFP 
expression at the interrenal in 31.5% of the embryos analyzed. This result contradicted 
the earlier observation which showed that the regulatory elements for interrenal specific 
expression of Ff1b lies between 2406 bp and 2832 bp of Intron IV. Similarly, deletion 






















Figure 3.6 Analysis of transient expression patterns generated by injecting the 
truncated Intron IV fragments into zebrafish embryos. The microinjected zebrafish 
embryos were scored for EGFP expression and confocal images of the embryos were 
taken between 48 hpf –         54 hpf. Embryos injected with F1, F2, F3, F7, F8, F9 and 
F10 showed the presence of EGFP expression at the interrenal. F4 also resulted in EGFP 
expression at the interrenal; however, the number of embryos expressing EGFP is 
considerably lesser. F5, F6 and F11 did not induce any EGFP signal in the embryos 
indicating the fragments did not contain any cis-regulatory elements required for 











reproduced EGFP expression in the interrenal. While F9 had Intron IV sequence from 
701 bp to 2553 bp deleted, F10 had the entire Intron IV sequence beyond 1544 bp to be 
excluded. Both F9 and F10 reproduced a considerable number of embryos with EGFP 
expression at the interrenal. The last of the Intron IV deletion series, F11, generated using 
restriction enzyme XhoI, induced very faint EGFP expression at the interrenal in only 
3% of the embryos screened. 
Finally, to summarize, the fragment F3, that lacked the upstream portions of 
Intron IV, have indicated the presence of elements required for interrenal specific 
expression of Ff1b in the region between 2140 bp and 2800 bp. F3, that included Intron 
IV segment downstream of 2147 bp, induced expression in the interrenal and while F4 
that contained Intron IV segment downstream of 2832 bp was not successful in inducing 
EGFP expression in the interrenal. This suggested that the interrenal specific enhancer in 
Intron IV could be present between 2147 bp and 2832 bp.  However, F8, F9 and F10, 
that contained the upstream portions of Intron IV and lacked the Intron IV segment that 
was suggested to be essential by F3, also drove EGFP expression to the interrenal.  While 
it would be ideal for the enhancers required for the tissue specific expression of a gene 
to be placed in close contact spanning only a few hundred base pairs, that it not the case 
in many genes. The Intron IV truncation experiment has indicated the presence of 
repetitive TF binding sites on Intron IV required for interrenal specific expression. This 
could result in a compensatory effect as seen in embryos injected with F8, F9 and F10. 
In spite of the intermediate region of Intron IV deleted in different combinations in all 
the three fragments, they still drove EGFP expression to the interrenal since it also 
possessed the essential TF binding sites. Thus, it becomes necessary to study in detail the 
TF binding sites on Intron IV that act as response elements for TFs that drive interrenal 
specific expression of Ff1b by binding to enhancers on Intron IV. 
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3.5. Computational Analyses of Transcription Factor Binding Sites 
In order to identify potential TF binding sites, the MatInspector software from 
Genomatix (www.genomatix.de) was used. By using MatDefine for automatic definition 
and construction of weight matrices from TF binding sites, a large library of matrix 
descriptions of TF binding sites based on position weight matrices was designed (Quandt 
et al. 1995; Cartharius et al. 2005). MatInspector then uses the information obtained from 
the matrix library known as Matbase to scan the input nucleotide sequences and identify 
matching patterns.  
MatInspector was thus used to survey the potential TF binding sites on Intron IV 
sequence of ff1b. The parameters set for the core similarity was 0.75 and the matrix 
similarity was set at 0.8. While a core similarity of 1.0 refers to a match where the core 
sequence of the matrix exactly matches that of the sequence, a matrix similarity reaches 
1.0 only if all the nucleotides in the sequence matches the most conserved nucleotide at 
each position of the matrix. A matrix similarity score of >0.80 is regarded as a 
considerably ‘good’ match.        
The MatInspector analysis of Intron IV for cis-regulatory elements yielded in 
1214 binding sites of different TFs. By filtering the search to certain tissues – Embryonic 
structures, Endocrine system and Adrenal gland, the search was limited to TFs that could 
overlap the tissues where ff1b begins to be expressed in a developing embryo. This 
reduced the number of MatInspector matches to 756. The resulting matches were further 
screened for those observed in the intermediate mesoderm of the developing zebrafish 
embryo. The search was supplemented with literature survey on TFs regulating the 
development of the adrenal gland, pronephros and the endothelial cells in both teleosts 
and mammals. This is because both the endothelial cells and pronephros have been 
shown to develop in parallel to the interrenal gland (Serluca et al. 2002; Hsu et al. 2003; 
Liu et al. 2006). The final set of TFs that have the potential to regulate ff1b transcription  
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Table 3.1 TFs binding to Intron IV that could potentially regulate ff1b expression in the zebrafish interrenal. 

















Egr1, Early growth response 1    
(Honkaniemi et al. 2000; Kobayashi et al. 
2010) 
Elk1, ETS domain protein    
(Sharrocks et al. 1997; Oikawa et al. 2003; 
Buchwalter et al. 2004) 
Erg, v-ets avian erythroblastosis 
virus E26 oncogene 
    (Liu et al. 2008; Ellett et al. 2009) 
Ets2, v-ets avian erythroblastosis 
virus E26 oncogene 2 
    (Bartel et al. 2000; Pham et al. 2007) 
Gata1a, GATA binding protein 1 a    
(Galloway et al. 2005; Heicklen-Klein et al. 
2005; Belele et al. 2009) 
Hmga2, High mobility group AT-
hook 2 
    (Lam et al. 2014) 
Hoxa9, Homeobox A9     (Lawrence et al. 1997; Lawrence et al. 2005) 
Irx, Iroquois homeobox genes     (Wingert et al. 2011) 
Lef1/Tcf7, Lymphoid enhancer-
binding factor 1/Transcription 
factor 7 
   
(Tissier et al. 2005; Doghman et al. 2008; Kim 
et al. 2008) 
Lhx1a/b, LIM homeobox 1 a/b     (Mudumana et al. 2008; O'Brien et al. 2011) 
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Mafb, v-maf avian 
musculaoponeurotic fibrosarcoma 
oncogene homolog B 
    (Moriguchi et al. 2006; Kataoka 2007) 
Meis1a, Meis homeobox 1 a     (Minehata et al. 2008; Cvejic et al. 2011) 
Nr3c1, NR subfamily 3, group C, 
member 1 (glucocorticoid 
receptor) 
   
(Paust et al. 2006; Tacon et al. 2009; 
Briassoulis et al. 2011) 
Nr5a1a, NR subfamily 5, group A, 
member 1 a (ff1b) 
    (Patel et al. 2001; Hsu et al. 2003) 
Osr1, Odd-skipped related 
transcription factor 1 
   
(James et al. 2006; Tena et al. 2007; 
Mudumana et al. 2008) 
Pax2a, Paired box 2a    
(Pfeffer et al. 1998; Majumdar et al. 2000; 
Bouchard et al. 2002; Narlis et al. 2007) 
Pax8, Paired box 8    
(Pfeffer et al. 1998; Bouchard et al. 2002; 
Narlis et al. 2007) 
Pbx, Pre-B-cell leukemia 
homeobox 1a 
   
(Schnabel et al. 2003; Zubair et al. 2006; 
Lichtenauer et al. 2007) 
Runx1, Runt-related transcription 
factor 1 
   
(Kalev-Zylinska et al. 2002; Lam et al. 2010; 
Jin et al. 2012) 
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Sall1a, Spalt-like transcription 
factor 1a 
   
(Kohlhase et al. 1998; Nishinakamura et al. 
2006; Sweetman et al. 2006) 
Six genes, SIX homeobox genes     (Self et al. 2006; Weber et al. 2008) 
Spi1a, Spi-1 proto-oncogene a     (Ward et al. 2003; Bukrinsky et al. 2009) 
Tal1, T-cell acute lymphocytic 
leukemia 1 
    (Davidson et al. 2004; Kassouf et al. 2010) 
Wt1a, Wilms tumor 1a    
(Yang et al. 1999; Majumdar et al. 2000; Hsu 









Figure 3.7 Distribution of TFs binding sites on ff1b Intron IV. The TFs involved in the development of the interrenal (adrenal gland) are colored in 




in the zebrafish interrenal are shown in Table 3.1. The schematic representation of the 
TF binding to Intron IV are shown in Fig 3.7. 
MatInspector is a superior tool used for identification of TF binding sites on 
Intron IV. However, it only identifies regions that bear the potential for TF binding. In 
order to differentiate a functional binding site with the likelihood that it could regulate 
ff1b transcription from a physical binding site, it is necessary to complement the 
computational analysis of TF binding sites with wet-lab experiments.  
3.6. Sequence comparison between ff1b Intron IV and mammalian Sf1 Intron IV 
Sequence alignment of genes across different species has been used in various 
studies to identify conserved regulatory elements with the rationale being that functional 
enhancer elements bear a higher degree of conservation than the non-functional neutrally 
evolving genomic segments (Boffelli et al. 2004; Haeussler et al. 2011). However, the 
large evolutionary distance between teleost and mammals (approximately 400 million 
years) has also increased the changes within the nucleotide sequences of the enhancer, 
thus making it harder to identify conserved regions by simple sequence alignment such 
as Clustal or Blast. In spite of having functional significance, enhancers have been known 
to be subject to enhancer turnover during evolution (Domene et al. 2013) where the 
enhancer fragments are subject to reshuffling of the TF binding sites, deletion or insertion 
of genomic segments. However, the dot plot technique of sequence alignment 
overcomes, to some extent, the problems faced with relocation of genomic segments, 
repetitions, deletions and insertions and thus is a better tool for comparing orthologous 
genes separated by a large evolutionary distance. 
 We used the YASS, a flexible local alignment tool available at 
http://bioinfo.lifl.fr/yass/yass.php, to identify conserved motifs between ff1b Intron IV 
and the Sf1 Intron IV sequences by using dotplots (Noe et al. 2005b). The gap parameters 
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for opening and extension were set at -8 and -4 and the other parameters were set at 
default. The resulting dotplot showed the presence of homologous motifs between 2150 
bp and 2850 bp on Intron IV of ff1b. An in depth analysis of the motifs revealed that they 
also overlapped with the binding sites of potential TFs.  The dotplot representing the 
comparison of ff1b Intron IV and Sf1 Intron IV sequence along with the overlapping TF 
binding sites are shown in Fig 3.8.  
Studies on the regulation of the Sf1 gene in mice have demonstrated that the 
intronic enhancers are methylated in a tissue specific manner. The FadE, VMHE and the 
PGE of Sf1 were hypomethylated in tissues that they were active and were 
hypermethylated in the inactive tissues (Hoivik et al. 2011; Hoivik et al. 2013). Based on 
the assumption that the intronic enhancers of ff1b could also be affected by their 
methylation status, Intron IV was analysed in-silico for the presence of CpG islands 
(CGI) using the software available at http://www.cpgislands.com (Takai et al. 2002). The 
criteria for the CGI were set to a length of more than 400 bp, GC content higher than 
50% and the observed CpG to expected CpG ratio to be higher than 0.6. The parameters 
used for CGI detection were less stringent than those used for the identification of 
bonafide CGI with transcriptional role (Illingworth et al. 2009). However, the search 
parameters were similar to those used for the identification of CGI in the Sf1 intronic 
enhancers (Hoivik et al. 2011). The results showed the presence of the CGI on Intron IV 
between 2287 bp and 2780 bp that contained a high frequency of CpG dinucleotides (Fig 
3.9 A).  The 494 bp CGI on Intron IV had a GC content of 50.4% and Observed CpG to 
Expected CpG ratio of 0.613. The presence of the CGI strongly suggested the presence 




Figure 3.8 Dot plot comparison of zebrafish ff1b Intron IV versus mouse Sf1 Intron 
IV. The zebrafish ff1b is on the horizontal axis and mouse Sf1 on the vertical axis. The 
dotplot showed a higher concentration of conserved sub-regions between 2150 bp and 
2850 bp of Intron IV. A more detailed look at the aligned sequences revealed that they 
overlapped with the TF binding sites of important TFs that have been proven to have a 






Figure 3.9 CpG island and phylogenetic similarity analysis between ff1b Intron IV 
and Sf1 Intron IV. A. The CGI analysis identified a potential CGI between 2287 bp and 
2780 bp of Intron IV B. ORCAtk used for sequence comparison between ff1b Intron IV 
and Sf1 Intron IV showed the presence of homologous regions between 1 – 500 bp and 
2000 – 2800bp. C. The ORCAtk was also used for comparing the ff1b Intron IV and the 
FAdE that showed the presence of homologous regions between 1800 – 2800 bp of ff1b 





Following the analysis of CGIs in Intron IV, the ORCA toolkit (ORCAtk) was 
used to find putative regulatory elements within Intron IV through phylogenetic foot-
printing by aligning ff1b Intron IV with Sf1 Intron IV and FadE (Portales-Casamar et al. 
2009). ORCAtk utilizes local alignment to identify short blocks of very high similarity 
that are in turn used to anchor the alignment followed by global alignment between the 
anchored regions. The core algorithm used by ORCAtk features an extension of the 
Needleman-Wunsch algorithm and hence isn’t novel. However, ORCAtk allows for 
custom parameters to be defined and hence allows for a more relaxed sequence 
comparison and identification of homologous regions that could not be identified using 
other alignment tools such as Blast and Clustal. 
By setting the scoring window size as 30 bp and the minimum top percentile of conserved 
region as 20 %, the ORCAtk identified various conserved regions on Intron IV. However, 
the Intron IV segment between 1-500 bp and 2000-2800 bp showed a higher 
concentration of segments bearing similarity to Sf1 Intron IV (Fig 3.9 B). Interestingly, 
the pairwise comparison of the entire ff1b Intron IV with the 630 bp mouse FAdE present 
in Sf1 Intron IV also indicated the presence of a homologous region between 1800 bp – 
2800 bp of Intron IV (Fig 3.9 C).  
Thus to summarize, the in-silico analysis performed on Intron IV identified 
regions that could have a potential role in regulating the tissue specific expression of 
Ff1b in zebrafish. The dotplot sequence comparison of ff1b Intron IV with Sf1 Intron IV 
pointed to the region between 2150 bp to 2850 bp to bear segments of significant 
homology. The ORCAtk that functions as a more linear comparison and sequence 
alignment tool also showed that the region between 1800 bp to 2800 bp of Intron IV bore 
a considerable level of similarity to the Sf1 Intron IV.  The CGI prediction further 
augmented the results obtained and suggests that the segment of ff1b Intron IV could 
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indeed contain the sites of potential enhancers for tissue specific expression of Ff1b in 
zebrafish.  
3.7. 864 bp Intron IV fragment recapitulates expression in the zebrafish interrenal 
The truncation experiments performed on ff1b Intron IV indicated that the 
segment between ~2100 bp and ~2850 bp had a significant role in guiding reporter 
expression to the interrenal. Moreover the computational analysis on Intron IV also 
showed that the region between 1800 bp and 2800 bp had short stretches of homologous 
regions when compared with the Sf1 Intron IV and the mouse FAdE. Hence, in order to 
test the functionality of the enhancer fragment, Intron IV segment from 2084 bp to 2948 
bp was cloned upstream of the tk promoter and mCherry reporter gene (Fig 3.10 A).  
The construct pff1bIntronIV864tkmCherry was microinjected into wildtype 
zebrafish embryos at the 1 to 2 cell stage. Following microinjection, the embryos were 
analysed for mCherry expression using the Zeiss Axiovert 25 inverted microscope. The 
mCherry expression in the injected embryos could be easily observed from 24 hpf and 
images of embryos were captured for record using confocal microcopy (Fig 3.10 B-G). 
Until 72 hpf, considerable level of mosaic expression was observed in tissues apart from 
the developing interrenal in the embryo. Despite the mosaic expression in various tissues, 
the mCherry expression observed in the developing interrenal primordium was more 
intense and consistent. 
mCherry expression could be detected in the microinjected embryos from as early 
as 24 hpf. However, the expression signal at the second and third somite of the 
developing embryo that corresponds to the site of interrenal primordium was 
considerably weaker while the mosaic expression observed in the muscles seemed 
stronger (Fig 3.10 B). As development progressed, the mCherry expression at the 





Figure 3.10 Analysis of transient mCherry expression driven by the 864 bp of ff1b 
Intron IV in zebrafish embryos. The Intron IV fragment between 2084-2948 bp was 
cloned upstream of the tk promoter and mCherry reporter gene. The construct was 
microinjected into wildtype zebrafish embryos and images were captured by confocal 
microscopy at the corresponding stages of development. mCherry expressing cells were 
observed at the developing interrenal from 24 hpf and the expression persisted even at 7 
dpf (A-F). Mosaic expression in the muscles remained till 72 hpf (A-C). Expression was 
also observed at the neuromasts (D) at 5 dpf. mCherry signal was seen at the pronephric 
tubule at 6 dpf and 7 dpf (E-F). All images were taken laterally except for F where the 
larvae was oriented dorso-laterally. Scale - 100μm; Abbreviations: ir, interrenal; nm, 





C). The mCherry expression driven by the 864 bp of Intron IV fragment remained mosaic 
and random even at 72 hpf. However, the signal observed at the interrenal persisted (Fig 
3.10 D). At 5 dpf, the mCherry expressing cells at the interrenal became more evident 
and they continued to be observed in images taken on the 6dpf and 7dpf as bi-lobed 
cluster of cells at the third somite and on either side of the midline (Fig 3.10 E-G). 
A number of non-specific expression domains were observed at all stages of the 
developing embryo. While a cluster of mCherry expressing cells were present at the 
presumptive interrenal, expression was also observed more rostrally in the regions of the 
intermediate mesoderm lateral to the first somite at 48 hpf (Fig 3.10 C). Faint expression 
was also observed near the otic vesicle and in the diencephalon of some embryos. 
However, this expression was considered as an injection artifact since it wasn’t observed 
consistently in all the embryos. 
By 5 dpf, expression was observed in the neuromasts of the posterior lateral line 
of some embryos that could be classified as mosaic and non-specific. A cluster of 
mCherry expressing cells was also observed along the pronephros and intestinal bulb 
(Fig 3.10 E). At 6 dpf, expression was observed more distinctly at the interrenal and 
around a disk shaped cells that resembled the pronephric tubule located below the third 
somite and caudal to the pectoral fin (Fig 3.10 F). The expression at the pronephros 
continued to be observed at 7 dpf (Fig 3.10 G) and it would be interesting to determine 
if this expression was genuinely driven by the 864 bp of ff1b Intron IV.  
The microinjection of the construct pff1bIntronIV864tkmCherry into wildtype 
zebrafish embryos appeared to drive reporter expression to the interrenal gland apart 
from the neighboring pronephros. There was also a considerable level of mosaic 
expression observed in all the embryos. In order to confirm that mCherry expressing cells 
























Figure 3.11 Comparison of mCherry expression induced by 864 bp fragment of ff1b 
Intron IV and the endogenous EGFP expression in Tg(ff1bEx2:EGFP)embryos. The 
pff1bIntronIV864tkmCherry construct was injected into transgenic embryos 
Tg(ff1bEx2:GFP) and images were captured using confocal microscopy at the 
corresponding developmental stages. Images were taken from 48 hpf onwards when both 
mCherry and EGFP signals at the interrenal (ir) could be observed easily. Expression 
levels of mCherry at 48 hpf and its overlap with EGFP varied between embryos (A, B 
and C, D).  Overlap of mCherry and EGFP expression at the interrenal (ir) was observed 
at 72 hpf (E). By 4 dpf, an additional mCherry expression domain at the pronephric tubule 
(pt) was also observed. The expression at the pronephric tubule (pt) was also observed at 
6 dpf with the interrenal continuing to express both EGFP and mCherry. Scale - 100μm; 
Abbreviations: ir, interrenal; ov, otic vesicle; vmh, ventromedial hypothalamus; ccv, 











from the transgenic line Tg(ff1bEx2:GFP) (Quek 2009). By co-localizing the ff1b driven 
EGFP expression and the 864 bp Intron IV driven mCherry expression, the identity of 
the cells expressing mCherry could be ascertained. The microinjected transgenic 
embryos were assayed for mCherry expression and images were captured by confocal 
microscopy (Fig 3.11). 
The mCherry expression pattern driven by the 864 bp Intron IV fragment in the 
Tg(ff1bEx2:GFP) transgenic embryos was largely similar to that observed in the 
wildtype embryos. The expressions of both mCherry and EGFP were very weak at 24 
hpf and hence images were captured from 48 hpf when the signals became stronger. By 
48 hpf, the EGFP expressing cells at the interrenal were clearly discernible lateral to the 
third somite and the mCherry expressing cells were observed to localize with the EGFP 
expressing cells (Fig 3.11 A-C). However, the mCherry expression was more widespread 
and not localized only to the developing interrenal. Apart from the non-specific muscle 
expression observed, the mCherry signal was also observed at a slightly more rostral 
location lateral to somite one. The level of mCherry signal overlapping with the EGFP 
expression at the interrenal appeared to vary between the injected embryos (Fig 3.11 A-
B). Nevertheless, it was clear that the 864 bp of Intron IV induced mCherry expression 
in the interrenal cells. As development progressed, the interrenal cells were observed to 
co-express EGFP and mCherry as evidently observed in images taken from 72 hpf till 6 
dpf (Fig 3.11 D-H). 
Interestingly, the transgenic embryos at 72 hpf also expressed mCherry in the 
developing pronephric primordium that could be easily demarcated from the interrenal. 
The mCherry expressing cells at the pronephric primordium appeared ventral to the third 
somite and as development progressed, the mCherry expressing cells took the shape of 
the neck like pronephric tubule.  
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While the 864 bp ff1b Intron IV drove mCherry expression to the interrenal in the 
zebrafish, as observed by the co-localization of the EGFP and mCherry expression, there 
was a significant amount of ectopic expression in the pronephros. This led to additional 
questions if the TFs binding to Intron IV also induced expression in the pronephros that 
led to the ectopic expression of mCherry. A closer look at the TFBS on the 864 bp of 
Intron IV revealed a concentration of binding sites for TFs such as Pax2, Pax8, Wt1a and 
Six2 that have been proven to play a very important role in the specification and further 
differentiation of the pronephric primordium. However, the role of these TFs in the 
development of the interrenal gland in zebrafish is yet to be investigated. The presence 
of such a large number of pronephric specific TFs on ff1b Intron IV coupled with the fact 
that both the pronpehros and interrenal arise from the same pool of progenitor cells raises 
an interesting question if the pronephros and the interrenal are more closely linked in 
their initital specification and differentiation than suggested by earlier studies.  
3.8. Sub-fragmentation of the 864 bp Intron IV core segment to identify specific 
transcription factors involved in interrenal specific regulation of ff1b. 
The 864 bp ff1b Intron IV segment between 2084 bp and 2948 bp showed that it 
contained the necessary elements required to reproduce reporter expression in the 
interrenal gland. However, it also resulted in mCherry expression in unexpected domains. 
Hence, in order to identify a shorter nucleotide fragment with fewer TF binding sites that 
could reproduce expression specifically at the interrenal with lesser non-specific 
expression, further fragmentation of the 864 bp fragment was done. The fragments were 
cloned upstream of a tk promoter and mCherry reporter gene with flanking I-SceI 
meganuclease sites. Intron IV-Core 2 (C2) contained the ff1b Intron IV segment between 
2084 and 2948 bp and was used as a control. However, with the presence of binding sites 
of candidate TF complexes such as Pbx/Meis1a and Lef1/Tcf7 upstream of the chosen 
fragment, the intronic segment between 1975 bp and 2948 bp was also tested for enhancer 
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activity and the clone generated was named as Core 1 (C1). Intron IV-Core clones 3, 4 
and 5 (C3, C4 C5) had the core segment progressively deleted by ~200 bp from the 5’ 
end.  Further clones were generated that were deleted from the 3’ end of Intron IV-core 
segment and were numbered as C6, C7, C8, C9 and C10.  
The ff1b Intron IV-Core constructs generated were microinjected into wildtype 
zebrafish embryos at the 1 – 2 cell stage and examined by fluorescence microscopy at 48 
hpf for their enhancer activity (Fig 3.13). The schematic diagrams of the constructs 
generated with the percentage of embryos resulting in expression in the interrenal gland 
at 48 hpf are shown in Fig 3.12. The microinjection of the fragments C1 and C2 didn’t 
change the expression pattern, with both the fragments resulting in 38.9% and 36.5 % of 
the embryos with mCherry expression in the interrenal gland at 48 hpf (Fig 3.13 C1-C2). 
However, the injection of fragment C3 resulted in a complete ablation of mCherry signal 
from the embryo indicating that the essential elements required for inducing reporter 
expression at the interrenal are present between 1975 bp and 2201 bp of the ff1b Intron 
IV segment (Fig 3.13 C3). The fragment C4 that contained the ff1b Intron IV segment 
between 2450 bp and 2948 bp, on the other hand, showed the presence of random 
mCherry expression that wasn’t selective (Fig 3.13 C4). The random expression 
observed suggested the presence of repressor elements in C3, between the intronic 
segment 2201 bp and 2450 bp, that when deleted turned on non-specific mCherry 
expression. The final Intron IV-Core fragment deleted from the 5’end, C5, also did not 
result in any expression in the interrenal gland (Fig 3.13 C5). 
Following the observation from the 5’ progressive deletion of the ff1b Intron IV-
Core that indicated the presence of interrenal specific enhancers between 2084 bp and 
2201 bp of Intron IV, constructs were generated that subjected the Intron IV-core 
segment to 3’ end deletion. The Intron IV-Core fragments, C6, that contained the Intron 




Figure 3.12 Schematic representation of the sub-fragmented clones of the ff1b Intron IV-Core segment and the results obtained upon 
microinjection into zebrafish embryos. As shown in the tabular column, injection of fragments C1, C2, C6, C8, C10 continued to result in mCherry 




Figure 3.13 Transient assays of enhancer activity of Intron IV-Core sub fragments. 
The 864 bp ff1b Intron IV fragment was sub-fragmented and the clones generated were 
microinjected into wildtype zebrafish embryos. The embryos were analysed for mCherry 
expression and images taken by confocal microscopy at 48 hpf. The 5’ serial deleted 
fragments - C1 and C2 showed expression at the interrenal. Embryos injected with C3, 
C4 and C5 did not reproduce any expression at the interrenal. The 3’ end deleted 
fragments – C6, C8 and C9 were all able to successfully recapitulate expression at the 
interrenal. Images of the embryos injected with the fragment C8 at 5 dpf also clearly 
showed the presence of mCherry expression at the interrenal. However, both C7 and C9 
were also not able induce expression at the interrenal. The white arrows point to the 




mCherry signal at the interrenal, albeit at lower intensities than C1 and C2 (Fig 3.13 C6). 
The Intron IV-Core constructs C8 and C10 also resulted in 31.4 % and 42.3% of the 
embryos with mCherry expression at the interrenal (Fig 3.13 C8, C10). The embryos 
injected with Intron IV-Core C10 appeared to recapitulate more specific mCherry 
expression to the interrenal and the continued examination of the embryos injected with 
C10 showed the presence of mCherry expression in the interrenal gland even at 5 dpf. 
However, Intron IV-Core fragments C7 and C9, that retained the intronic segment 
between 2084 bp and 2201 bp and had different upstream and downstream portions 
deleted, could not recapitulate mCherry expression at the interrenal.  
The transient enhancer assays of the sub-fragmented ff1b Intron IV core segment 
demonstrated that the essential elements required to reproduce reporter expression in the 
interrenal gland were present in a 116 bp segment, between 2084 bp and 2200 bp of the 
intronic segment. However, the regulation was still a complex process as seen in the lack 
of mCherry expression induced by both C7 and C9. The intronic segment was analysed 
in detail for the presence of binding sites using the information obtained from Genomatix 
and the JASPAR database (Fig 3.14). The results obtained from the JASPAR database 
were similar to those obtained from Genomatix, except that it showed the presence of 
binding sites of an additional TF – the forkhead gene, Foxc1a. However, further 
experiments with site directed mutagenesis of the specific TF binding sites would have 






Figure 3.14 Detailed analysis of the TF binding sites on the ff1b Intron IV core segment. The region boxed by the red dotted line corresponds to the 
ff1b Intron IV fragment between 2084 bp and 2201 bp that was shown to contain the interrenal specific enhancer elements. The presence of binding sites 






By utilizing the Red/ET homologous recombination based strategy, intron(s) 
were deleted from the BAC clone pBACff1bEx2EGFPAmp in order to localize the tissue 
specific enhancers of ff1b. The results indicated that the VMH specific enhancers were 
located in the Intron V and Intron VII, and the interrenal specific enhancer is located 
within Intron IV of ff1b. Following this, Intron IV of ff1b, cloned upstream of a minimal 
tk promoter and EGFP reporter gene, was shown to successfully reproduce reporter 
expression in the interrenal gland. ff1b Intron IV was then subjected to 5’ progressive 
deletion using PCR and internal truncations using restriction enzyme and the fragments 
generated were analyzed for enhancer activity by microinjection into wildtype embyros. 
The results indicated the interrenal specific enhancer could be present in two stretches of 
the Intron IV fragment: 1-1500 bp and 2100-2800 bp. Computational analyses of TFBS 
using MatInspector helped identify the potential cis-elements required for regulating ff1b 
expression in the interrenal gland. Further, dotplot comparison between the ff1b Intron 
IV and Sf1 Intron IV indicated a cluster of short stretches of similar sequences within 
2000 bp – 2800 bp of ff1b Intron IV. CpG island detection also showed the presence of 
a CpG island within the same fragment of Intron IV. By combining these results, an 864 
bp fragment of the ff1b Intron IV was used to successfully recapitulate reporter 
expression in the interrenal gland. Further sub-fragmentation of the 864 bp Intron IV-
Core segment and testing for enhancer activity, reduced the nucleotide sequence required 




CHAPTER 4  
Differences in the enhancer expression patterns between 
zebrafish and mammals 
4.1. Introduction 
Having identified that the ff1b Intron IV possesses binding sites for potential TFs 
that could regulate the interrenal specific expression of Ff1b, the plasmid construct 
ff1bIntronIVtkegfp was microinjected into zebrafish embryos in order to analyze the 
expression patterns induced by Intron IV. However, the nature of transgenesis was 
transient and the expression patterns were highly mosaic. The EGFP expression was 
distinctly observed in the developing interrenal primordia, but the expression could not 
be observed after 72 hpf. Hence, it was necessary to generate a stable transgenic line in 
order to analyze the stable expression patterns induced by the ff1b Intron IV. In this study, 
we managed to generate a transgenic line with the ff1b Intron IV inducing mCherry 
expression in the interrenal, led by a minimal tk promoter. The stable transgenic line 
generated revealed the presence of an additional mCherry expression domain in the 
pronephric tubule apart from the interrenal. Interestingly, the 864 bp of the ff1b Intron 
IV that could successfully recapitulate mCherry expression in the interrenal (Section 
3.8), also showed expression in the pronephric tubule.  
In order to compare the expression patterns induced by the ff1b Intron IV and the 
mouse FAdE in the zebrafish embryos, we tested to check if the mouse FAdE that 
induced lacZ expression in the fetal adrenal gland of the developing mice was able to 
direct mCherry expression to the zebrafish interrenal. The ability of the mouse FAdE to 
induce mCherry expression in the interrenal showed that despite the extensive reshuffling 
and mutations to the enhancer segment through evolution, they nevertheless, possess the 
same transcriptional activity. We have further compared the TF binding sites on Intron 
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IV of ff1b with that on the FAdE in order to identify the specific TFs common between 
the two fragments that could offer more insights into the TFs involved in interrenal 
specific expression of Ff1b.  
4.2. Analysis of transient transgenesis expression patterns generated by 
SceIIntronIVtkmCherrySceI in zebrafish embryos 
In order to generate a stable transgenic line, I-SceI meganuclease restriction sites 
were cloned on either side of the ff1bIntronIVtkmCherry construct (Fig 4.1 A). The 
meganuclease I-SceI has been shown to overcome the limitations presented by the 
transient expression of transgenes by increasing the germline transmission rate (Thermes 
et al. 2002; Grabher et al. 2004). The construct generated was co-injected with the I-SceI 
meganuclease enzyme into the wildtype embryos at the 1 to 2-cell stage. The expression 
patterns observed in the microinjected embryos were less mosaic than that observed 
earlier when the pff1bIntronIVtkegfp construct was microinjected into the wildtype 
embryos (Section 3.4) presumably due to the presence of the I-SceI meganuclease 
overhangs. The microinjected embryos were scored for the presence of mCherry 
expression under a UV fluorescence microscope and expression was observed in ~46% 
of the embryos. Images were finally captured using by confocal microscopy at different 
stages of development.  
The mCherry expression in the microinjected embryos were observed as early as 
24 hpf. The expression signal, in spite of being very weak, could be observed at the level 
of second and third somite of the developing embryo (Fig 4.1 B). Expression was also 
observed at more anterior locations near the otic vesicle. As development progressed, the 
mCherry expressing cells could be observed as a cluster at the site of the expected 
















Figure 4.1 Transient mCherry expression patterns induced by 
ff1bIntronIVtkmCherry in the zebrafish embryos. A. Schematic representation of the 
construct with the I-SceI meganuclease restriction sites used to induce mCherry 
expression at the interrenal. The microinjected embryos were tracked for mCherry 
expression at different stages and images were captured using confocal microscopy (B-
G). The expression at the prospective interrenal could be observed by 24 hpf (B) and at 
48 hpf, the mCherry expression could be clearly observed at the interrenal (C-D). The 
mCherry signal reduced by 72 hpf (E) and by 5 dpf, completely disappeared. mCherry 
expression could, however, be observed at the proximal convoluted tubule of the 
developing pronephros by 5 dpf (F-G). Injection of the SceIIntronIVtkmCherrySceI into 
the transgenic line Tg(ff1bEx2:GFP) embryos showed a strong overlap of mCherry 
expression with that of EGFP at 48 hpf. Scale bar - 100μm. Abbreviations: ir, interrenal; 











The expression at the otic vesicle, though very faint, persisted even at 48 hpf. The 
intensity of the mCherry expression, however, appeared to vary among the microinjected 
embryos. By 72 hpf, the mCherry signal lateral to the second and third somite of the 
developing embryo appeared very faint (Fig 4.1 E) and by 5 dpf, the expression at the 
interrenal disappeared altogether. While this was expected of the transient transgenesis, 
the mCherry expression at the pronephric tubule at 5 dpf was totally unexpected (Fig 4.1 
F). The dorsal view of the injected embryos also clearly showed the proximal convoluted 
tubule expressing mCherry (Fig 4.1 G).   
This raised doubts as to if the ff1b Intron IV actually drove reporter expression to 
the interrenal. However, injection of the ff1bIntronIVtkmCherry construct into the 
embryos obtained from the transgenic line Tg(ff1bEx2:GFP) (Quek 2009) clearly 
showed the overlap of the mCherry expression with the EGFP in the Ff1b expressing 
cells at 48 hpf (Fig 4.1 H-J). The inability to observe any mCherry expression at the 
interrenal after 72 hpf could either be due to the mosaic and transient nature of 
transgenesis or probably due to the inability of the ff1b Intron IV to drive reporter 
expression after 72 hpf. The fetal adrenal enhancer of Sf1 identified in mouse studies was 
also able to recapitulate lacZ expression only in the fetal adrenal and could not be tracked 
in the more developed adrenal cortex (Zubair et al. 2006). The only way to confirm the 
enhancer ability of the ff1b Intron IV was to generate a stable transgenic line in which 
the mCherry expression would be more reliable and could also be tracked longer at later 
stages of development. 
4.3. Recapitulation of mCherry expression in the zebrafish interrenal by stable 
transgenesis 
In order to generate a stable transgenic line, the construct ff1bIntronIVtkmCherry 
with I-SceI meganuclease restriction site overhangs were microinjected into the wiltype 
zebrafish embryos. The zebrafish embryos were screened for mCherry expression at 48 
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hpf and those showing a strong mCherry expression at the interrenal were selected and 
raised to adulthood. Of the 30 fishes that were screened for stable transgenesis, 7 positive 
founders (F0) were identified (transgenesis efficiency = 23.3%) and the resulting 
transgenic line was named Tg(ff1bIntronIV:mCherry). The efficiency of transgenesis was 
still slightly lower than the 30.5% obtained by earlier studies that used I-SceI 
meganuclease to generate stable transgenic lines (Thermes et al. 2002). The transgenic 
founders were allowed to mate with wildtype fish in order to generate heterozygous 
embryos and judging from the number of F1 progeny that showed mCherry fluorescence, 
one of the transgenic founder was chosen to establish the stable transgenic line (line 18). 
The germline transmission rate observed was ~45-50% and they followed the Mendelian 
inheritance ratio.  
The mCherry expression in the transgenic embryos was considerably weak and 
not easily discernible at the earlier stages of development. At 48 hpf, the mCherry signal, 
in spite of being very weak, could be observed at the third somite. However, by 72 hpf, 
the mCherry expression at the interrenal could no longer be observed. In place of the 
interrenal, the proximal convoluted tubules of the pronephros were expressing mCherry. 
Interestingly, similar observation was also made in the transient transgenesis. The 
transgenic larvae continued to be monitored for mCherry expression and confocal images 
of the larvae taken after 7 dpf showed a cluster of cells at the expected interrenal. The 
pronephric tubules, however, were no longer expressing mCherry. As development 
progressed, the mCherry expressing cells at the interrenal continued to proliferate and 
could be distinctly observed by 10 dpf. The dorsal images of the transgenic embryos 
clearly showed the presence of bilobed cluster of mCherry expressing cells. The 























Figure 4.2 mCherry transgene expression patterns in the Tg(ff1bIntronIV:mCherry) 
transgenic zebrafish embryos. The mCherry expression in the transgenic embryos were 
tracked at different developmental stagesand images were captured by confocal 
microscopy. The mCherry expression at 24 hpf and 48 hpf were considerably weak. By 
72 hpf, the expression at the interrenal could not be observed but was replaced with the 
proximal convoluted tubules that were strongly expressing mCherry. By 7dpf, clusters 
of cells faintly expressing mCherry could be observed and as development progressed, 
the mCherry signal became stronger. Images were taken up till 12 dpf when the bilobed 
cluster of cells at the interrenal could be distinctly observed. The white arrows indicate 
the interrenal cells expressing mCherry. Images taken at 24 hpf and 48 hpf were of the 
lateral view and the rest of the images were taken dorsally. Scale bar: 100μm. 










could not be observed after 72 hpf that coincided with the timeline for the migration of 
the interrenal cells towards the central midline. 
While the position of mCherry expressing cells coincided with the expected 
location of the interrenal cells, in order to confirm the identity of the cells, the transgenic 
founders of this line were outcrossed with the zebrafish of another transgenic line 
Tg(ff1bEx2:GFP). By comparing the expression profile of the mCherry and EGFP 
expression and a strong overlap of both the signals, we confirmed that the mCherry 
expressing cells were indeed the interrenal cells. The embryos obtained were monitored 
for both mCherry and EGFP fluorescence and images were captured at different 
developmental stages using confocal microscopy.  
The EGFP expression in the embryos, apart from the expression in the otic vesicle 
and muscles, followed the expression profile of Ff1b in zebrafish and by 48 hpf, both the 
VMH and the interrenal expressed EGFP. Dorsal images of the larvae taken at 72 hpf 
clearly showed that the interrenal cells at the midline expressed EGFP. However, 
mCherry signal could not be observed at 72 hpf. Instead, the proximal convoluted tubule 
with its typical brush like border could be observed. The expression remained largely 
unchanged at 4 dpf with the pronephric tubules continuing to express mCherry, while no 
significant mCherry signal was observed in the interrenal cells located at the midline. By 
6 dpf, the EGFP expressing interrenal cells could be observed on either side of the 
midline indicating the interrenal cells had moved to their final position in their 
development. The mCherry signal, though very weak, could be observed at 6 dpf itself. 
As development progressed, the mCherry signal became stronger and was observed to 
overlap the interrenal cells expressing EGFP. The expression was monitored until 12 dpf 

























Figure 4.3 EGFP and mCherry expression in the interrenal by outcrossing the 
Tg(ff1bIntronIV:mCherry) transgenic line with the Tg(ff1bEx2:GFP) transgenic 
line. The ff1bIntronIVtkmCherry transgenic line was outcrossed with the 
Tg(ff1bEx2:GFP) transgenic line in order to confirm the identity of the mCherry 
expressing cells. The mCherry expression at 48 hpf was very weak and by 72 hpf, could 
only be observed at the pronephric tubules. By 6 dpf, the mCherry expressing pronephric 
tubules could not be observed and was replaced with faint mCherry signal that seemed 
to overlap with the EGFP expressing cells at the interrenal. The overlap of mCherry and 
EGFP continued to grow and became stronger as development progressed. Scale bar – 
100μm. Abbreviations: ir, interrenal; pct, proximal convoluted tubule; ov, otic vesicle; 













The transgenic line, thus generated, showed the presence of mCherry expression 
in the interrenal only at the earliest and the later stages of development. The fusion of the 
interrenal cluster of cells at the midline, unfortunately, could not be tracked. This might 
suggest that the ff1b Intron IV did not possess TF binding sites to track all the stages of 
interrenal development. It could thus imply that different TFs are required to direct Ff1b 
expression at different stages of interrenal development. However, it could also imply 
that the expression was weak enough to be tracked at earlier stages of the interrenal 
development. The transgenic line generated, in spite of the discontinuous expression 
patterns from the endogenous ff1b, offers an interesting tool for lineage tracing the 
regulatory factors involved in interrenal specific expression of Ff1b. 
4.4. Mammalian fetal adrenal enhancer drives mCherry expression in the 
zebrafish interrenal. 
The mammalian fetal adrenal enhancer (FAdE) has been shown to induce lacZ 
reporter expression in the mouse fetal adrenal (Zubair et al. 2006). Comparing the 
expression patterns induced by FAdE in zebrafish embryos and the TF binding sites on 
FAdE, the essential TFs driving Sf-1 and Ff1b expression in the adrenal cortex and 
interrenal of mice and zebrafish respectively can be determined. Hence, the mouse FAdE 
was cloned upstream of a minimal tk promoter and mCherry reporter gene (Fig 4.4 A) 
and microinjected into zebrafish wild type embryos and later into the transgenic embryos 
Tg(ff1bEx2:GFP) at the 1-2 cell stage. The microinjected embryos were screened for 
fluorescence using UV epifluorescence microscopy following which the expression 






















Figure 4.4 Transient expression patterns induced by the mammalian fetal adrenal 
enhancer in zebrafish embryos. A. The schematic representation of the fetal adrenal 
enhancer cloned upstream of the mCherry reporter gene and minimal tk promoter is 
shown. The FAdEtkmCherry construct was microinjected into zebrafish embryos and the 
expression was observed at different developmental stages (B-G).  The mCherry 
expression at both 24 hpf and 48 hpf was widespread, but mCherry signal could be clearly 
observed at the expected interrenal by 48 hpf (B-C). Apart from the interrenal, the 
pronephric duct was also expressing Cherry (D). By 72 hpf, much of the non-specific 
expression reduced and mCherry signal could be distinctly observed from the interrenal 
(E-F). Images taken at 5 dpf also show the presence of mCherry signal at the interrenal. 
But it was accompanied by a strong expression in the pronephric tubule. Images were 
captured using confocal microscopy. Images from B-E,G were taken from the lateral 
view; F was taken from the dorsal view. Scale bar – 100μm. Abbreviations: ir, interrenal; 










The microinjection of the FAdE into the zebrafish wildtype embryos resulted in 
embryos with mCherry expression beginning as early as 24 hpf (Fig 4.4 B). However, 
the expression was markedly mosaic. There were non-specific expression patterns 
observed in the muscles with increased mCherry expression along the somites. A cluster 
of cells expressing mCherry was also observed at the level of second and third somite. 
However, it was hard to determine if this was induced by the injected FAdE or the result 
of non-specific expression observed in various tissues.  
The level of non-specific expression, however, decreased considerably by 48 hpf 
and was seen to be concentrated at the presumptive interrenal primordium, lateral to the 
second and third somite (Fig 4.4 C). mCherry expressing cells were also observed in the 
zebrafish diencephalon and at the level of the first somite but were assumed to be non-
specific since similar expression patterns in the zebrafish brain were not observed later 
at 72 hpf (Fig 4.4 E). mCherry expressing cells were also observed along the pronephric 
duct (Fig 4.4 D). At 72 hpf, the mCherry expression was observed as a cluster of cells at 
the third somite close to the central midline (Fig 4.4 E-F). Interestingly, there was also 
mCherry expression observed along the lateral edges on either sides of the midline at the 
level of somite two and three. As development progressed, by 5 dpf, the mCherry 
expressing cells at the interrenal became more distinct. However, expression was also 
observed in the pronephric tubule that could be easily seen as the neck shaped cells 
directly below somite two and three.  
While microinjection of the mouse FAdE into the zebrafish wildtype embryos 
revealed that the mouse enhancer also drove mCherry expression to the zebrafish 
interrenal, it was still necessary to confirm that the mCherry expressing cells were indeed 
the interrenal cells. In line with that objective, the mouse FAdE was microinjected into 


















Figure 4.5 Co-localization of mCherry expression driven by the FadE with EGFP 
expression in Tg(ff1bEx2:GFP) embryos. pFAdEtkmCherry was microinjected into 
the transgenic embryos and images were taken by confocal microscopy at different 
developmental stages. mCherry expression could be observed as early as 20 hpf (A). By 
24 hpf, EGFP expression at the VMH could be observed. But, the EGFP expression at 
the interrenal could not be observed until 48 hpf (C-D). mCherry expression was also 
observed at the interrenal at 48 hpf. The mCherry expression was more widespread and 
could be observed at more anterior locations (D). Overlap of mCherry and EGFP 
expressing cells at the interrenal continued to be observed at 72 hpf and at 4 dpf (E-G). 
At 4 dpf, an additional mCherry expression domain was observed at the pronephric 
tubule (F-G). Scale bar: 100μm. Abbreviations: vh, ventromedial hypothalamus; ov, otic 











microinjected into 1 – 2 cell stage embryos which were examined for both EGFP and 
mCherry expression patterns in the developing embryo. 
The confocal images captured at 20 hpf and 24 hpf (Fig 4.5 A – B) revealed that 
while mCherry expression began early in development, the EGFP signal from the 
interrenal was weak. As observed earlier in the wildtype embryos injection, mCherry 
signal was observed at the site of the interrenal primordium. There was also a 
considerable level of overlap in the posterior muscles between the EGFP and mCherry 
expressing cells. 
As development progressed, by 48 hpf, the EGFP expressing VMH and interrenal 
cells proliferated and could be observed more clearly (Fig 4.5 C – D). The mCherry 
expressing cells were seen to overlap with the EGFP expressing interrenal. However, a 
close up on the image taken at 48 hpf (Fig 4.5 D) clearly show that the mCherry 
expression domain was more widespread and not limited to the interrenal. mCherry 
signal was also observed at more rostral locations closer to somite one. At 72 hpf, co-
localization of the both EGFP and mCherry signals at the interrenal continued to be 
observed (Fig 4.5 E). Interestingly, there was also a low level of co-localization of the 
two signals at the otic vesicle. Images of the microinjected embryos taken at 4 dpf (Fig 
4.5 F – G) also show the presence of both EGFP and mCherry expression at the interrenal. 
Another interesting observation was the presence of the mCherry expression in the 
pronephric tubule similar to the earlier injection of the same construct in wildtype 
embryos.  
Thus, to summarize, the mouse fetal adrenal enhancer was microinjected into 
zebrafish embryos and was shown to induce expression in the zebrafish interrenal. 
However, it also resulted in mCherry expression being observed at the pronephric tubule. 
This unexpected expression at the developing pronephros, however, was not observed in 
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the mouse studies. This indicates a differential use of enhancers regulating transcription 
and the eventual specification and differentiation of cells during development between 
mammals and zebrafish.  
4.5. Comparison of transcription factor binding sites on the ff1b Intron IV and the 
mouse fetal adrenal enhancer (FAdE). 
Both the zebrafish ff1b Intron IV and mouse Sf1 FAdE reproduced mCherry 
reporter expression in the zebrafish interrenal. The fragments also induced expression in 
the pronephros. Comparing the TFs that bind to both the fragments could give us an idea 
of the TFs that are responsible for inducing the expression in the interrenal and the 
pronephros. Hence, the mouse Sf1 FAdE was subjected to a MatInspector analysis and 
the TFs that were common between the two fragments were analysed.  
MatInspector analysis of the FAdE resulted in 126 unique TFs with a matrix 
similarity greater than 0.8 that could bind to the FAdE. The ff1b Intron IV, on the other 
hand, had 302 unique TFs with multiple binding sites distributed over the 3.8 kb long 
intron. Both the ff1b Intron IV and FAdE had 54 common TFs between them which were 
analysed and the essential TFs were mapped onto the FAdE (Fig 4.6). Binding sites for 
TFs such as Hox/Pbx, Hmga2, Tcf/Lef-1, Sf-1 and Gr were found in both fragments. 
These TFs have already been shown to be essential for the development of the adrenal 
gland (Nandi 1962; Ashar et al. 1996; Bourdeau et al. 2003; Schnabel et al. 2003; Tissier 
et al. 2005; Kim et al. 2008; Briassoulis et al. 2011).  
While the presence of the aforementioned common TFBS might explain the 
observation of mCherry expression in the interrenal, the observation of mCherry 
expression in the pronephric tubule was still unexpected. The only common TF that has 
a role in the development of the pronephros and is observed to be common between the 
ff1b Intron IV and FAdE is the Mafb response element (Mare). The binding sites for TFs 
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such as Pax2a and Pax8 that were identified on the ff1b Intron IV were not present on 
FAdE. However, binding sites for the hepatic nuclear factor 4 a (Hnf4a) was noted to be 
present on FAdE. The hnf genes are predominantly expressed in the liver and pronephros 
and the hnf mutants have been shown to result in renal cysts and defects in the 
development of the kidney (Bingham et al. 2004; Harries et al. 2004; Hiesberger et al. 
2005). The presence of response element of TFs that are observed in the pronephros 
might explain the mCherry expression in the pronephros. 
The TFs with important regulatory role identified by (Zubair et al. 2006) were 
also mapped out for effective comparison. The MatInspector software was able to 
recognize two SF-1 sites that corresponded to Ad4 site 1 and Ad4 site 3 in the mouse 
study. However, the Ad4 site 2 and the Ad4 site 4 were not recognized. The Hox/Pbx 
site recognized by the MatInspector software also did not coincide with the same 
nucleotide sequences. Instead, it was mapped adjacent to the Hox/Pbx site identified by 
the mouse study. The software also did not recognize a Pbx/Prep site that was considered 
to be important for early specification of the adrenal primordium in the fetal mouse 







Figure 4.6 Comparison of TFBS between Sf1 Intron IV and ff1b Intron IV and 
schematic representation of binding sites on the FAdE. A. Venn diagram representing 
the common TFs between ff1b Intron IV and Sf1 FAdE. 54 TFs were common between 
the two fragments. B. Putative TFs that were common to both the fragments were mapped 
onto the FAdE. The TFs colored in green represent factors involved in vascularization, 
colored in blue represent factors involved in adrenal development and those colored in 
red represent factors involved in the development of the pronephros. The binding sites 
for Hnf4a (colored in yellow) were identified on the FAdE. The TFs (Pbx/Prep, Hox/Pbx, 
Ad4BP sites) identified to be of regulatory importance in Sf1 expression in the fetal 







In this study, we generated a stable transgenic line with the ff1b Intron IV 
inducing mCherry expression in the zebrafish interrenal gland. The developing interrenal 
gland had mCherry expression uptil 48 hpf, after which mCherry expression could not 
be observed. However, by 6 – 7 dpf, the interrenal cells began expressing mCherry again. 
The intermittent mCherry expression pattern observed in the transgenic line indicates 
that the ff1b Intron IV induces mCherry expression at different stages of the developing 
interrenal gland. The transgenic line generated also had mCherry expression at the 
proximal convoluted tubule. While the expression at the pronephros in the transgenic line 
was unexpected, similar expression patterns were observed in zebrafish embryos 
microinjected with the mouse FAdE. The pFAdEtkmCherry construct successfully 
recapitulated mCherry expression at the zebrafish interrenal. However, it also resulted in 
expression in the pronephric tubule. The comparison of TFBS between the ff1b Intron IV 
and mouse FAdE revealed several TFs involved in the development of the interrenal 
gland to be common. However, TFs that are well known for their role in pronephric 
development did not bind to the FAdE. The expression patterns offer an interesting 
platform to study the differences in enhancer usage between zebrafish and mouse. 
Studying the TFs involved in the tissue specific expression of the ff1b Intron IV and Sf1 







CHAPTER 5  
Mammalian VMH enhancer recapitulates expression in the 
zebrafish brain 
5.1. Introduction 
The ventromedial hypothalamus (VMH), located in the medial region of the 
hypothalamus adjacent to the third ventricle and dorsal to the median eminence (ME) 
and pituitary gland, plays a key role in regulating energy homeostasis and behavioral 
responses, such as food intake, female sexual behavior, initiating fear response and 
locomotion (Hetherington et al. 1983; Choi et al. 1998; Flier et al. 1998; Choi et al. 1999; 
Elmquist et al. 1999). Although the molecular mechanisms underlying the development 
of the VMH is still unclear, studies have established the importance of NR5A1 in the 
development and function of the VMH (Ikeda et al. 1995; Shinoda et al. 1995; Dellovade 
et al. 2000; Zhao et al. 2008). SF-1 is crucial for the terminal differentiation of the VMH 
neurons and mediates the circuitry between the hypothalamus and telencephalon (Tran 
et al. 2003). SF-1 gene disrupted mice, rescued with corticosteroid injections and adrenal 
transplantation showed induction of late-onset obesity as a result of decreased activity 
indicating the involvement of SF-1 in regulating appetite and body weight (Majdic et al. 
2002). Given the importance of SF-1 in the VMH, it is very important to elucidate the 
mechanisms regulating the tissue specific expression of SF-1 in the VMH. 
Studies in mice have localized a VMH-specific enhancer to the intron VI of the 
Sf-1 gene (Shima et al. 2005). The 503 bp enhancer was able to drive VMH-specific 
expression of the lacZ reporter gene with the basal promoter of Sf-1. The same expression 
pattern was also reproduced with the hps68 basal promoter indicating that VMHE was 
primarily responsible for regulating the expression in the VMH. By fragmenting the 
VMHE and testing for enhancer activity in mice, potential nucleotide sequences 
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responsible for VMH-specific expression in the mice were identified. However, the TFs 
responsible for regulating the tissue specific expression by binding to the VMHE are yet 
to be recognized. 
As explained in chapter 3, using a Red/ET mediated homologous recombination 
strategy we have established the presence of potential enhancers in the Intron V and VII 
of ff1b for regulating Ff1b expression in the VMH. Deletion of the introns V and VII 
have led to a drastic reduction in the expression of EGFP in the zebrafish VMH. 
However, homology searches between the nucleotide sequences of intron 6 of 
mammalian Sf-1 and intron V and VII of zebrafish ff1b have failed to identify any 
conserved regions due to the large evolutionary distance between the two species.  
Nevertheless, the NR5A1 NR has been highly conserved in its function and expression 
domains in mammals and zebrafish. This raises the possibility that the TFs regulating the 
tissue specific expression of Sf-1 in mammals could also be responsible for Ff1b 
regulation. Studies comparing the cis-regulatory elements between the mammals and 
zebrafish have shown that the functionally relevant regulatory regions may still be 
conserved in spite of the lack of sequence conservation (Muller et al. 2002). Towards 
that end, we have tested the ability of the human VMHE to drive expression of the 
reporter gene in zebrafish. Having shown that the VMHE was indeed able to recapitulate 
expression in the zebrafish brain, by dissecting the VMHE and using transient 
transgenesis we have been able to identify the specific nucleotide sequences that are 
required for tissue specific expression of Ff1b in the zebrafish VMH. We have also 
compared the TFBS between the human VMHE and ff1b Intron V and VII in order to 
identify regulatory fragments in the zebrafish introns that could regulate VMH specific 
expression of Ff1b in zebrafish. 
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5.2. Human VMH enhancer recapitulates expression in the zebrafish brain 
In order to test if the VMHE was able to drive expression in the zebrafish, the 
513 bp SF-1 VMHE, obtained from the human genomic DNA, was cloned between the 
restriction enzyme sites SacI amd BamHI and directly upstream of a minimal tk promoter 
and mCherry reporter gene. The resulting construct - phVMHEtkmCherry was 
microinjected into wildtype embryos at 1 to 2 cells stage. The embryos were screened 
for intrinsic fluorescence and analyzed for the spatial expression patterns that the VMHE 
could reproduce in the zebrafish. About 30% – 40% of the embryos screened for 
fluorescence showed different levels of mCherry expression mostly localized in the 
brain. Despite the mosaic expression and transient nature of fluorescence, the VMHE 
was able to direct mCherry expression to the zebrafish VMH with neuronal like 
projections extending towards the midbrain. 
The mCherry expression could be detected at very low levels under a 
fluorescence microscope as early as 13 hpf. However, images were taken only from 24 
hpf onwards when the expression levels increased and could be easily captured by 
confocal microscopy. Images were captured until 4 dpf after which there were no 
significant changes in the mCherry expression domains brought about by the VMHE.   
 
Figure 5.1 Schematic representation of phVMHetkmCherry. The 513 bp VMHE was 
cloned between a BamHI and SacI restriction site immediately upstream of a minimal tk 
promoter and mCherry reporter gene. 
Extremely low levels of mCherry expression were detected in the embryos as 
early as 13 hpf that coincided with the process of neurogenesis in the developing embryo. 
However, the level of expression was too weak to be captured. By about 24 hpf, 
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mCherry-positive cells appeared as bilateral clusters near the anterior tip of the neural 
tube (Fig 5.2 A, B). Mosaic mCherry expression was also observed in many embryos 
along the spinal cord (Fig 5.2 A, B). As development progressed, the number of mCherry 
expressing cells increased and by 48 hpf, they appeared to be more widespread and could 
be seen as a band of cells between the eyes extending all the way from the pre-optic area 
to the ventromedial nuclei of the hypothalamus (Fig 5.2 C, D). Despite the widespread 
expression in the forebrain, by 3 dpf the fluorescent cells were higher in number in the 
ventral diencephalon with neuronal projections and neuronal cell body like structures 
extending both rostrally and caudally towards the midbrain tegmentum and the hindbrain 
(Fig 5.2 F). By 4 dpf, the mCherry expression was more restricted and localized to a 
distinct region within the ventral hypothalamus (Fig 5.2 G, H). Low levels of expression 
were also observed in the tectum in some of the embryos screened.  
Collectively, these fluorescence images show that the human VMHE directs 
mCherry expression to the ventral diencephalon. However, the expression is not 
restricted only to the VMH. Computational analysis of the TFs binding to the VMHE 
indicate that most of the TFs are expressed in different regions of the brain which could 
explain the more diverse mCherry expression. The deletional analysis of the VMHE can 





















Figure 5.2 The human VMHE in combination with basal tk promoter targets 
mCherry expression to the zebrafish VMH. The expression domains of mCherry in 
the zebrafish brain at different developmental stages were captured by confocal (A-E; G-
H) and epifluorescence microscopes (F). The mCherry expression was more widespread 
till 48 hpf. However by 3dpf, the expression was mostly restricted to the VMH and 
neuronal projections extending from the VMH caudally towards the midbrain could be 
detected at higher magnifications. Images A-D were captured from the lateral view, F-G 
from dorsal view and E from a dorso-lateral view. Images of the whole mount live 
embryos were taken with confocal microscopy at the corresponding developmental 










5.3. Localization of VMHE directed mCherry expression with EGFP in 
Tg(ff1bEx2:GFP) transgenic embryos 
The mCherry expression directed by the VMHE was observed in a widespread 
location in the diencephalon. In order to ascertain if the expression was actually present 
in the zebrafish VMH, the phVMHEtkmCherry construct was microinjected into 
transgenic embryos obtained from the transgenic line Tg(ff1bEx2:GFP). The identity of 
the mCherry expressing cells could be confirmed by checking for the co-localization of 
the VMHE induced mCherry and the BACFf1b driven EGFP expression in the transgenic 
line.  
The EGFP expression in the transgenic embryos recapitulated the endogenous 
expression of ff1b in the VMH and the interrenal (Chai et al. 2000; Quek). By about 20 
hpf, weak EGFP signals were visible in the VMH. Additional EGFP expression in the 
otic vesicle and muscles were also observed. Images were captured after 24hpf when the 
EGFP signal from the VMH intensified and appeared as bilateral clusters close to the 
anterior tip of the neural tube. The mCherry expression was also discernible by 24 hpf 
and was seen to be overlapping the endogenous ff1b led EGFP expression in the VMH 
(Fig 5.3 A).  
As development progressed, the number of both EGFP and mCherry expressing 
cells increased steadily. By 48 hpf, the EGFP expressing cells in the VMH were clearly 
seen to be colocalizing with the mCherry expressing cells (Fig 5.3 B, C). Few embryos 
showed mCherry expression in the otic vesicle that were seen to be overlapping with the 
EGFP expression. The co-localization of the VMHE directed mCherry expression with 





Figure 5.3 Colocalization of VMHE directed mCherry expression with EGFP 
expression in Tg(ff1bEx2:GFP) embryos. The colocalization of mCherry and EGFP 
expression showed that VMHE directs expression to the zebrafish VMH. The mCherry 
expression also appeared to be more widespread and not restricted only to the VMH. 
Images were captured at different developmental stages using confocal microscope (A-
C) and using epifluorescence microscope (D-E). Images A-C, E were captured from the 
lateral view. Image D was captured from the dorsal view. Scale bar – 200μm. 







As expected of the Tg(ff1bEx2:GFP) transgenic line, EGFP expressing cells were 
observed in the interrenal that appeared only as a small cluster of cells at 24 hpf and 
developed into a discrete structure ventral to the third somite by 48 hpf. The VMHE did 
not drive mCherry elsewhere, including the interrenal, and the co-localization of the 
EGFP and mCherry expressing cells show that most of the mCherry expression was 
restricted to the brain and spinal cord and did not seem to be present elsewhere.  
These experiments show that despite the widespread expression in the brain, the 
human VMHE was also able to recapitulate reporter gene expression in the zebrafish 
VMH. With the large evolutionary distance between zebrafish and mammals, the 
differences in the enhancer activity could be due to changes in the endogenous gene 
expression patterns that could in turn alter the cellular TF environment. Studies 
examining the efficacy of human conserved non-coding elements (CNEs) to be able to 
drive expression in zebrafish have shown that about 83% of the tested CNEs showed a 
hugely different expression pattern in zebrafish (Ariza-Cosano et al. 2012). The VMHE 
also harbors a concentrated presence of neural TFs involved in the development of the 
brain and the nervous system. These factors could explain the extensive mCherry 
expression in the brain. Despite these drawbacks, the VMHE provides a short enhancer 
fragment that could be used as a basis in order to identify TFs that regulate VMH-specific 
ff1b expression in zebrafish.  
5.4. Computational analyses of TFBS on the VMHE 
Having proven that the human VMHE reproduces mCherry expression in the 
zebrafish VMH among its other expression domains, it was now necessary to study the 
TFBS on the enhancer segment that could help us identify the specific TFs required for 
tissue specific expression of Ff1b in the zebrafish VMH.  
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As described earlier in Section 3.5, the MatInspector software (Cartharius et al. 
2005) from Genomatix (www.genomatix.de) was used to computationally identify 
putative TF binding sites on the 525 bp human VMHE. By setting the matrix similarity 
score to an upper limit of 0.8 and core similarity score to 0.75, the VMHE was surveyed 
for the presence of TF binding sites. Among the 185 potential TF binding sites identified 
on the VMHE, several TFs were discovered that had important regulatory roles in the 
initial specification and differentiation of several neuronal cell types found in the central 
nervous system. The potential TFs were further short-listed based on their domains of 
expression and all the TFs expressed in the diencephalon and the presumptive 
diencephalon during development of the zebrafish embryo were selected (zebrafish 
database used: www.zfin.org). This narrowed down the search to 34 putative cis-
elements on the VMHE. A number of these binding sites were overlapping and 
represented essentially the same TF on both the sense and anti-sense strand. The final 22 
cis-elements are schematically represented on VMHE (Fig 5.4).  
A quick look at the TF binding sites on VMHE revealed the presence of clusters 
of binding sites that could be easily divided into four distinct islands. They were labelled 
as Region I, II, III and IV. Each region contained nucleotide fragments that had the 
potential to bind multiple TFs and were characterized by adjacent and closely spaced 
consensus sequences. Region III and IV, were demarcated by the fact the TFs binding to 
region III, namely POU6F1 (Pouc) and Pax6a did not have overlapping nucleotide 
sequences with any TF from the neighbouring region IV.  Many TFs were found to be 
commonly binding to both region I and region IV. The TFs – Cart1, Dlx genes, Pou3f 
genes and Nkx1.2Ia were found in both region I and IV of the VMHE. The TFs binding 








Figure 5.4 Mapping of potential TFBS on the human VMHE. The potential TFs that 
could bind to the VMHE were mined using the Matinspector software and the selection 
of candidate TFs was based predominantly on their expression patterns and the stages 
they were observed in the developing zebrafish embryo. The final 22 chosen cis-elements 
appeared to be concentrated in specific clusters based on which they were divided into 
four regions for easy downstream molecular manipulations. The different TFs in each 
region had overlapping binding sites with some TFs binding to both the sense and anti-
sense strand in the same region. While region I and IV had a number of common TFs 





5.5. Progressive deletion of VMHE in order to identify enhancer regions regulating 
expression in the zebrafish VMH 
The in-silico analysis of regulatory regions involved in the tissue specific 
expression of Ff1b in the zebrafish VMH, using the MatInspector software, revealed the 
presence of aggregated TF binding sites on Intron IV. However, identification of TF 
binding sites on VMHE using computational methods does not guarantee that the TF 
would definitely have a role in inducing mCherry expression in the zebrafish VMH.  In 
order to identify specific regulatory modules within the VMHE, it was necessary to 
dissect the VMHE and analyse the enhancer activity of the truncated VMHE fragments. 
In line with this, the VMHE was divided into four regions that were subjected to 
sequential 5’ deletion using different forward PCR primers while keeping the reverse 
primer constant. The schematic representation of the 5’ truncations of VMHE are shown 
in Fig 5.5. Fragment 1 was essentially the entire VMHE and was used as a positive 
control. Fragment 2, in spite of the upstream 111 bp of VMHE being deleted, 
encompassed all the enhancer regions identified. Fragment 3, 4 and 5 had the enhancer 
regions sequentially deleted from the 5’ direction. Fragment 6 was used as a negative 
control since it consisted of only the tk promoter fused to the mCherry reporter gene and 
did not have any VMHE fragment. 
The linear fragments generated were purified and individually microinjected into 
the zebrafish wildtype embryos at the 1 – 2 cell stage. The resulting mCherry expression 
patterns caused by the deletion of the VMHE were analysed by UV epifluorescence 
microscopy. Images of the injected larvae were finally captured at 48 hpf using confocal 








Figure 5.5 Sequential 5’ deletion of hVMHetkmCherry. The VMHE was sequentially 
deleted from the 5’ end using PCR in order to test for the presence of potential TFBS.  
Each fragment generated had a progressive deletion of enhancer region.  Fragment 1 
constituted the entire length of VMHE and was used as a positive control. Fragment 2, 
3, 4 and 5 had progressive deletion of enhancer regions. Fragment 6 was used as a 
negative control. The linear fragments were purified and microinjected into zebrafish 






Figure 5.6 Transient expression assays of 5’ truncated enhancer fragments. The 
VMHE was progressively deleted from the 5’ end using PCR and the linear fragments 
were microinjected into wildtype embryos. The injected embryos of the corresponding 
fragments were imaged by confocal microscopy at 48 hpf. While fragment 1 and 
fragment 2 reproduced mCherry expression in the VMH, there was ablation of expression 
in the embryos injected with the other fragments. Fragment 1 contained the entire length 
of VMHE and while fragment 2 carried all the four enhancer regions identified, it didn’t 
include the upstream 112 bp of VMHE that didn’t possess binding sites of any significant 
TFs. The observation of mCherry expression only in embryos injected with fragment 1 
and fragment 2 indicated that deletion of enhancer region 1 caused the ablation of 




The zebrafish embryos injected with fragment 1 and fragment 2 recapitulated 
mCherry expression in the zebrafish VMH (Fig 5.6 A-B). In spite of the mCherry signal 
being mosaic in the injected embryos, mCherry expressing cells were still observed at 
the VMH of the injected embryos. This suggested that all the elements required to direct 
reporter expression to the VMH were present in both fragment 1 and fragment 2.   
However, the embryos injected with fragment 3, 4 and 5 did not show any 
mCherry expression in the zebrafish embryos. Fragment 3 included enhancer region II, 
III and IV and only had region I deleted. This suggested that deletion of enhancer region 
I caused the ablation of mCherry expression in the zebrafish embryos. The truncation 
experiments on the human VMHE were thus able to identify the necessity of enhancer 
region I to recapitulate mCherry expression in the zebrafish VMH. 
5.6. Internal deletion of human VMHE to test importance of enhancer Region I to 
induce mCherry expression in the zebrafish brain 
The linear sequential deletion of VMHE demonstrated that the removal of 
enhancer region I resulted in the complete loss of mCherry expression in the zebrafish 
VMH. However, this does not definitely prove that the TFs binding to only region I 
would be essential for driving reporter expression to the VMH. TFs have been known to 
work in combination and it was possible that the TFs on region I worked in consort with 
the TFs binding to the other enhancer region(s) to drive reporter expression. Hence, in 
order to check if the region I alone could drive reporter expression to the VMH, Apa I 
restriction enzyme was used to remove the enhancer regions downstream of region I. 
This resulted in the generation of a construct (Fragment 7) which had only the VMHE 


















Figure 5.7 Analysis of enhancer activity in deletion mutants by retaining Region I 
of TFs and deleting downstream TF binding regions. A. Schematic representation of 
deletion mutagenesis of VMHE. Clones were generated by keeping the Region I of TF 
binding sites and deleting downstream regions in different combinations. Fragment 7 
contained only enhancer region I and while fragment 8 contained all the enhancer 
regions, the nucleotide sequence between region II and III were deleted. Fragment 9 had 
the segment between region I and III removed. B – G. Images taken of the corresponding 
deletion clone injected embryos at 24 hpf and at 48 hpf. mCherry expression was 
observed in the VMH in embryos injected with Fragment 8 that had all the enhancer 
regions (D-E). While ectopic mCherry expression was observed in the embryos 
microinjected with the Fragment 7 and 9, none of them had the expression at the VMH 












Further, two more constructs were generated by means of inverse PCR and the schematic 
representations of the deletion constructs are depicted in Fig 5.7 A. Fragment 8 had ~200 
bp of nucleotide sequence between the enhancer region II and III deleted that did not 
contain any essential TF binding site. Fragment 9 had the entire fragment between region 
I and III deleted and essentially, did not contain enhancer region II. The three fragments 
were linearized and purified before being microinjected into wildtype zebrafish embryos 
at 1 – 2 cell stage. 
The microinjected embryos were scored for mCherry expression both at 24 hpf 
and 48 hpf and their images were captured by confocal microscopy (Fig 5.7 B-G). The 
zebrafish embryos injected with all the deletion fragments appeared to have mCherry 
expression at the anterior end of the neural tube at 24 hpf (Fig 5.7 B, D, F). The embryos 
injected with Fragment 9 in particular displayed ectopic expression with extensive 
expression in the brain and muscles (Fig 5.7 F). However, as development progressed, it 
became clear that the embryos injected with Fragment 7 and Fragment 9 did not harbor 
mCherry expression at the VMH. Ectopic expression was observed at the otic vesicle and 
neuromasts in the embryos injected with the Fragment 7 and 9, but no expression was 
observed in the VMH. Fragment 8, however, induced expression at the VMH and this 
could be clearly observed as bilateral clusters at the site of the prospective VMH (Fig 5.7 
E). 
All the deletion mutant fragments were also microinjected into the transgenic 
embryos obtained from the transgenic line Tg(ff1bEx2:GFP) (Quek 2009) in order to 
analyze the co-localization of the ff1b induced EGFP expression in the VMH and the 
VMHE deletion mutant fragment induced mCherry expression. The deletion fragments 
were injected into the embryos at 1-2 cell stage and the embryos were scored for mCherry 





Figure 5.8 Colocalization of the mCherry induced by the VMHE deletion mutants 
with EGFP expression driven by ff1b in the transgenic embryos Tg(ff1bEx2:GFP). 
The transgenic embryos were injected with the deletion fragments and were analysed for 
mCherry and EGFP expression at 48 hpf. The embryos injected with Fragment 8 
demonstrated that the mCherry signal co-localized with that of the EGFP (B). However, 
embryos injected with Fragment 7 and 9 did not harbor mCherry expression at the VMH 
(A, C). Scale bar: 100μm Abbreviation: vh, ventromedial hypothalamus 
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The microinjection into the transgenic embryos also clearly showed that while 
Fragment 8 was able to induce mCherry expression in the zebrafish VMH (Fig 5.8 B), 
neither Fragment 7 nor Fragment 9 were able to drive reporter expression to the VMH 
(Fig 5.8 A,C). Due to the transient nature of transgenesis, the intensity of mCherry 
expression appeared to vary between the embryos injected with Fragment 8. However, 
~35.6% of the embryos screened for mCherry expression following injection of 
Fragment 8 showed a cluster of mCherry expressing cells at the VMH. 
The ability of Fragment 8 to drive reporter expression to the VMH while 
Fragment 7 and 9 could not, clearly showed that enhancer region I worked in cooperation 
with the enhancer region II to induce mCherry expression at the zebrafish VMH. This 
theory is also supported by results of the 5’ truncation series of human VMHE performed 
earlier that showed the inability of the construct to induce mCherry expression in the 
VMH when the enhancer region I was deleted. Further study of the TFs binding to region 
I and II would help us understand the regulatory mechanisms involved in regulating ff1b 
expression in the VMH. 
5.7. Analysis of core sequence of transcription factor binding motif 
Having shown that the nucleotide sequences in Region I and II are essential in 
inducing mCherry expression in the zebrafish VMH, an in-depth analysis was done on 
the TF binding sites on the human VMHE. The TFs were further shortlisted and were 
selected based on the information available on the Zebrafish Model Organism Database 
(ZFIN) (www.zfin.org) and also from the available research (Table 5.1). While some TFs 
have already been shown to be involved in the specification and differentiation of VMH 
neurons in zebrafish and mammals (highlighted in green in table 5.1), other TFs are 
known to be expressed in the VMH but their role in its development have not yet been 
defined (highlighted in pink in Table 5.1).  
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Among the list of candidate TFs are the basic helix-loop-helix (bHLH) 
neurogenin (Neurog) genes that have been involved in the early stages of neural 
differentiation and are expressed in the neural progenitors. While Neurog1 has a broad 
expression patterns with its expression beginning as early as 8 hpf at the end of 
gastrulation (Korzh et al. 1998), the expression of Neurog3 begins only by 24 hpf and is 
expressed only in the zebrafish hypothalamus (Wang et al. 2001a). Neurogenin 3 
(Neurog 3), in particular, has been shown to be expressed in the neuronal progenitors and 
involved in the specification of arcuate and ventromedial hypothalamic regions in the 
mouse embryos. Studies have shown a drastic reduction of about 30% in the number of 
SF1 neurons in the VMH of Neurog3 mutant mice (Pelling et al. 2011). Embryonic 
inactivation of Neurog3 in mice has also shown to result in hyperphagia with reduced 
energy expenditure that resulted in early onset of obesity, indicating the defective 
development of the VMH and hypothalamic neurons (Anthwal et al. 2013).  
Members of the LIM homeodomain protein family that are implicated in 
determining neuronal identity during development have also been found to have binding 
sites on the human VMHE. Islet-1 (Isl-1), first identified as a transcriptional regulator of 
the insulin gene in the pancreas, was found to be expressed in the primary nervous system 
indicating that Isl-1 has an early developmental regulatory role (Korzh et al. 1993). 
Studies in mice have later reported the localization of the Isl-1 protein to the VMH and 
ARC (Davis et al. 2004e). In adult mice, Isl-1 is expressed in and around the VMH with 
Isl1 localizing with some of the SF-1 expressing cells. However, loss of SF-1 in KO 
mice, apart from altering the distribution of the VMH neurons, also revealed dispersed 
expression patterns of Isl-1 (Davis et al. 2004a). While this does not necessarily indicate 
that Isl-1 is required for the regulation of Ff1b and SF-1, its expression in the VMH 
strongly suggests that it could be involved in the neuronal specification of target genes 
and possibly NR5A1 in both zebrafish and mammals. Another member of the LIM-
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homeodomain TF family, Lmx1b, also has been chosen as a candidate TF for the 
regulation of Ff1b expression in the VMH. Both LMX1A and LMX1B play important 
roles in the development of the nervous system and particularly in the neural tube 
regionalization. In zebrafish, both the Lmx1b orthologs - Lmx1ba and Lmx1bb are 
expressed in the diencephalic domains by 24 hpf and as development progressed, their 
expression is restricted to the ventral diencephalon by 48 hpf (Burzynski et al. 2013). 
Studies that were focused on dopaminergic (DA) neurons showed that knockdown of 
lmx1b in zebrafish resulted in reduction in the number of DA neurons in the ventral 
diencephalon. Although the study focused on the role of Lmx1b in the development of 
diencephalic dopaminergic precursors, Lmx1b could still be involved in the development 
of other neurons in the diencephalon (Filippi et al. 2007). 
The POU family of homeodomain proteins have been known to play very 
important roles in the establishment and maintenance of the identity of cells along the 
CNS. In zebrafish, the POU III class of homeodomain proteins are first expressed within 
the primordia cells of the ventral diencephalon and later in the ventral forebrain and 
hypothalamus as development progresses (Hauptmann et al. 1996; Spaniol et al. 1996). 
Sox 2, a major regulator of neural primordia, is in turn regulated by Pou5f1 and Pou3f 
genes and thus indicating the role of the Pou3f genes in determining various neural cell 
fates (Iwafuchi-Doi et al. 2011). The binding site of another member of the POU domain 
family, Pou6f1, was also present in the enhancer region III and IV. Early expression 
studies revealed that in spite of low homology to the other POU proteins, the Pou6f1 can 
still bind to the octamer sequence characteristic of the Pou domain and is expressed along 
the neural tube and in the brain in studies carried out in zebrafish (Johansen et al. 1993) 
and mice (Okamoto et al. 1993). The studies carried out with Pou3f and Pou6f1 genes do 
not show a concrete link to the development of the VMH neurons in either zebrafish or 
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mammals. However, they represent an important class of proteins with regulatory role in 
the development of the CNS and hence were classified as a candidate TF.  
The distal-less (DII) (Dlx) genes are another class of homeodomain TFs whose 
binding sites are present in the enhancer region I and IV. Dlx genes are involved in the 
development of the telencephalon and diencephalon with distinct spatial and temporal 
expression patterns (MacDonald et al. 2010). Studies have shown the role of dlx genes 
in the development of γ-amino butyric acid (GABA) neurons in the ARC and VMH, in 
zebrafish and mice studies (Yee et al. 2009; MacDonald et al. 2013). With its regulatory 
role in the VMH of both zebrafish and mammals, it is highly likely that the Dlx genes 
could also be involved in the regulation of Ff1b (SF-1) and thus the development of the 
Ff1b (SF-1) neurons in the VMH.  
Genetic screen homeobox 1 (Gsx1) was also shown to have binding sites on the 
human VMHE. In zebrafish, gsx1 expression begins very early and by 18 hpf, gsx1-
positive cells were observed in the ventral diencephalon. In sonic-hedgehog mutants 
lacking hypothalamus markers, the expression of gsx1 is also reduced indicating that 
Gsx1 is expressed in the zebrafish hypothalamus (Cheesman et al. 2004). Mouse studies 
have shown the Gsx1 mutant mice display defects in pituitary development characterized 
by smaller pituitary size and reduced number of prolactin and growth hormone producing 
cells (Li et al. 1996). No direct link between Gsx1 and Ff1b (or SF-1) have been described 
to date. However, with its expression in the VMH and its role in regulating the 




Figure 5.9 In depth analysis of the core sequences at the enhancer regions on the human VMHE. 
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Stage observed from References 
Brn-2, POU-III protein class Pou3f genes 
Gastrula:Bud (10.0h-10.33h) to Larval:Day 
5 (120.0h-144.0h, 3.9mm, 6 teeth) 
(Hauptmann et al. 1996; Sampath et al. 
1996; Spaniol et al. 1996; Iwafuchi-Doi et al. 
2011) 
Brn-5, POU-VI protein class 
(also known as emb and CNS-
1) POU6F1  
(Johansen et al. 1993; Okamoto et al. 1993) 
DLX-1, -2, and -5 binding 
sites 
Dlx1a, Dlx2a, 
Dlx2b, Dlx5a As early as cleavage (0.75h) to adult 
(MacDonald et al. 2013) (Yee et al. 2009; 
MacDonald et al. 2010) 
Homeo domain factor Pbx-1 Pbx1a 
Zygote:1-cell (0.0h-0.75h) to Adult (90d-
730d, breeding adult) 
(Teoh et al. 2010; Schulte et al. 2014) 
Homeobox transcription 
factor Gsh-1 Gsx1 
Zygote:1-cell (0.0h-0.75h) to Hatching:Pec-
fin (60.0h-72.0h) 





Gastrula:90%-epiboly (9.0h-10.0h) to Adult 
(90d-730d, breeding adult) 
(Filippi et al. 2007; Burzynski et al. 2013) 
Neurogenin 1 and 3 
(Neurog1/3) binding sites Neurog1/3 
Gastrula:50%-epiboly (5.25h-
5.66h) to Adult (90d-730d, breeding adult) 
(Wang et al. 2001a; Orozco-Solis et al. 2010; 
Pelling et al. 2011; Anthwal et al. 2013) 
Pancreatic and intestinal lim-
homeodomain factor Isl1 
Gastrula:Bud (10.0h-10.33h) to Adult (90d-
730d, breeding adult) 
(Davis et al. 2004a; Davis et al. 2004e; Lee 
et al. 2006) 
Retinoid-related orphan 
receptor alpha2 Rorab 
Segmentation:1-4 somites (10.33h-
11.66h) to Larval:Day 5 (120.0h-144.0h, 
3.9mm, 6 teeth); roraa - expressed only after 
30hpf 
(Flores et al. 2007; Jetten 2009) 
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The pre-B cell leukemia transcription factor 1 (Pbx1a) encodes a TF belonging 
to the three amino acid loop extension (TALE) family of homeodomain proteins. The 
role of Pbx1a in regulating the development of the VMH or the ff1b (Sf-1) neurons is not 
proven. However, given the widespread expression of pbx1a in different brain vesicles 
and its role in the maintenance of the midbrain-hindbrain boundary and the diencephalic-
mesencephalic boundary in zebrafish (Erickson et al. 2007; Sgado et al. 2012), the 
plausible role of Pbx1a in imparting segmental identity to the VMH and regulating the 
expression of ff1b could not be ignored. While the Pbx proteins generally function as 
HOX co-factors, recent studies have shown that TALE class of homeodomain proteins 
also contribute to the early development of the brain independent of Hox activity (Schulte 
et al. 2014). 
A binding site for retinoid-related orphan receptor (ROR) was also found on the 
human VMHE in the enhancer region II with the consensus sequence AGGTCA found 
on the anti-sense strand. In zebrafish, rora and rorb expression was detected in the optic 
primordia by 12 hpf and in the presumptive diencephalon by 14 hpf (Flores et al. 2007). 
Expression in the developing diencephalon continued till 3 dpf after which the expression 
of both rora and rorb could not be detected. The presence of ROR genes in the 
diencephalon and its role in the regulation of energy homeostasis and other metabolic 
pathways suggests that it could also be involved in the regulating the expression of ff1b 
(or Sf-1) (Jetten 2009).  
The binding sites of the TFs on the human VMHE have been shown in detail in 
Fig 5.9. Except for Neurog1/3, Isl-1 and the Pou3f genes, there is no evidence that the 
other chosen TFs could be involved in the regulation of ff1b in the zebrafish VMH. 
However, taking into account its expression in the diencephalon and the stages of 
expression in the developing zebrafish embryo, the possibility that the other TFs could 
have a role in ff1b regulation could not be ignored. 
138 
 
5.8. Presence of similar candidate transcription factor binding sites on the ff1b 
Intron V and Intron VII 
The earlier experiments identified that the TFs in enhancer regions I and II work 
in cooperation to regulate the expression of Ff1b in the zebrafish VMH. The TFs binding 
to enhancer region I were – Neurog 1, Lmx1b, Dlx factors, and a Pou3f class of protein 
and the TFs that bind to the enhancer region II are  - Isl1, Rorab and Pbx1a. The BACFf1b 
intron deletion experiments performed in Section 3.2 identified the presence of VMH 
specific enhancers of the ff1b gene in the Intron V and VII. Hence, the ff1b Intron V and 
VII were analyzed for TFBS using MatInspector for the presence of binding sites similar 
to the human VMHE. The TFs were then mapped onto the Introns V and VII and color 
coded, the TFs belonging to VMHE region I were coded in purple and those belonging 
to the VMHE region II were coded in blue. The TF Pou6f1 belonged to the enhancer 
region III and IV was also mapped out on the ff1b Intron V and VII and was colored in 
green. The in-silico analysis revealed the presence of clusters of candidate TFs on both 
Intron V and VII and these clusters bore high degrees of similarities to the binding sites 
on the human VMHE (Fig 5.10 and 5.11).  
Analysis of the ff1b Intron V showed the presence of a number of TFBS of the 
candidate TFs. Three regions of the ff1b Intron V stood out in the analysis as they showed 
a cluster of the candidate TFs (Fig 5.10), of which the panels A and B were strikingly 
similar to the VMHE in the positioning of the TFBS. While the presence of TFs 
belonging to the enhancer region II differed, all the three TF binding clusters identified 
on ff1b Intron V had binding sites for TFs on enhancer region I - Lmx1b, Pou3f2, Dlx 





Figure 5.10 Distribution of candidate TFs on ff1b Intron V. The TFs identified by 
MatInspector analysis were mapped onto the ff1b Intron V. The TFs appear to be 
concentrated at specific locations and the distribution of TFs mapped out on A and C 




Figure 5.11 Distribution of candidate TFs on ff1b Intron VII. The TFs were identified 
by MatInspector and mapped onto the Intron VII.  Binding sites of all the TFs belonging 
to enhancer region I from the VMHE were identified on the Intron VII, including Neurog 
1 in (A). The spatial positioning of the TF binding sites on the Intron VII were also highly 




Interestingly, binding sites for Neurog 1 was not identified on the ff1b Intron V. 
However, the ff1b Intron VII had the binding site for Neurog 1 and the other TFs 
belonging to the enhancer region I and II (Fig 5.11 A). With the exception of Isl1 and 
Pbx1a, all the other TFs were present on ff1b Intron VII Panel A within a span of 300 bp. 
Two other TF binding clusters were also identified on ff1b Intron VII that matched the 
TF binding profile on the human VMHE.  
Sequence homology comparisons between the zebrafish ff1b Introns V and VII 
and the SF-1 VMHE did not reveal the presence of any conserved regulatory element. 
However, the presence of candidate TF binding sites on the ff1b Introns V and VII 
indicated that the introns could have a potential role in regulating the VMH specific 














The human VMHE was cloned in a mCherry expression vector with a minimal 
tk promoter and microinjected into zebrafish embryos to analyze their expression 
patterns. The mammalian SF-1 VMHE was successful in recapitulating mCherry 
expression in the zebrafish VMH. However, expression wasn’t restricted to the zebrafish 
VMH and observed to be more widely dispersed. In order to identify specific TFs 
required for VMH specific expression in the zebrafish, the VMHE was sequentially 
fragmented from the 5’ end using PCR and the fragments were tested for enhancer 
activity. The 5’ series truncated fragments indicated the importance of enhancer region I 
to be required for mCherry expression in the VMH. Subsequently, the region I of the 
VMHE was retained and other enhancer regions were deleted. The internal deletion 
experiments showed that the Region I worked in concert with the nucleotide sequences 
in Region II to induce mCherry expression in the zebrafish VMH. Finally, the ff1b Introns 
V and VII were analyzed for the presence of similar TFBS. The analysis revealed the 
presence of arrays of TF binding sites on both the introns that shared similar spatial 
distribution profile as the SF-1 VMHE. Hence, in spite of the fact that no homologous 
regions were detected between the human SF-1 VMHE and the ff1b Introns V and VII, 
the presence of similar candidate TFs on the Introns V and VII suggested the presence of 







CHAPTER 6  
DISCUSSION 
6.1. Regulation of interrenal specific expression of ff1b by an ancestral Intron IV 
6.1.1.  Genomic organization of ff1b and the presence of ancient Intron IV in the 
zebrafish ff1b gene 
The evolution of introns in eukaryotes has been explained by two contradicting 
theories (Roy et al. 2006; Rogozin et al. 2012). The “introns-early” or the “introns first” 
theory holds that the protein coding segments of ancestral eukaryotic and prokaryotic 
genes were interrupted by numerous introns that played an important role in the 
recombination of protein coding sequences through ‘exon shuffling’. This theory 
suggests that the introns are ancient and are subsequently lost in different lineages during 
evolution. The “introns late” concept suggest that introns are a novelty in the eukaryotic 
genome and are not present in the prokaryotes. There is still no evidence supporting either 
the “intron first” or “intron late” theory but the fact remains that introns have evolved 
concomitantly with the eukaryotic. The zebrafish ff1b gene characterized by the presence 
of an additional intron that interrupts the exon coding for the hinge domain, provides an 
excellent example to study the same.  
In the last decade, the NR5A1 receptor has been characterized in many species 
including the teleosts. Comparative analysis of the exon-intron boundaries between 
orthologous Ftz-F1 genes from mammals and ray-finned fishes have revealed that Intron 
IV interrupting the hinge domain coding exon 4 in the zebrafish ff1b gene is indeed 
exclusive to zebrafish and is not observed in other vertebrates (Fig 6.1). The extra Intron 
IV is also not observed in the other zebrafish paralogues of ff1b. Interestingly, however, 
the Ftz-F1 gene in D. melanogaster and cnhr genes in C.elegans indicate the presence of 
an intron in an equivalent position comparable to Intron IV in zebrafish ff1b. This 
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conforms to the intron early concept since the Ftz-F1 genes in early eukaryotes are 
characterized by the presence of numerous introns that are subsequently lost during 
evolution. This theory suggests that the ff1b Intron IV represents an ancestral intron that 
has been retained only in the Danio rerio lineage.  
Alternatively, several studies have shown the gain of introns lineage specifically 
in actinopterygian (ray-finned) fishes (Venkatesh et al. 1999; Kumar et al. 2011). While 
it is more common for loss of introns during evolution, spliceosomal intron gains are 
very uncommon and rare and if they do occur, are usually accompanied by a major 
evolutionary transition. Studies have shown that the possibility of creation of a functional 
intron by segmental genomic duplication resulting in paralogues with and without the 
intron (Hellsten et al. 2011). Parsimonious analysis of gene structure in paralogous gene 
families in evolutionary diverged species have also indicated a higher number of  intron 
gains than losses in lineage specific expansion of a gene based on the assumption that 
genome duplication events could also be accompanied by accelerated intron loss or gain 
events (Babenko et al. 2004). Thus, presence of an extra intron only in ff1b and not in 
ff1d suggests Intron IV could also be gained during the genome duplication event of the 
NR5A1 receptors in zebrafish. 
Interestingly, the proline rich hinge domain, has also been attributed for the high 
degree of divergence between the SF-1 proteins of eutherian and marsupial mammals 
(Whitworth et al. 2001). Studies have demonstrated its reaction with c-Jun and 
Transcription Factor IIB component of the transcription initiation complex and is 
involved in the transcriptional activation of SF-1 (Li et al. 1999). Thus, the presence of 
an extra intron in the hinge domain of the zebrafish ff1b gene raises the possibility that 
Intron IV, apart from being ancestral and unique to zebrafish among vertebrates, could 




Figure 6.1 Genomic organization of NR5A1 receptors and comparison with 
zebrafish ff1b. The exon and intron organization along with the corresponding protein 
domains are shown in different colors. The gene strucutre of the zebrafish ff1b gene is 
compared with that of different representative species that indicates the presence of 
ancestral Intron IV exclusively in zebrafish ff1b. 
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6.1.2. Localization of interrenal specific enhancer in the ancestral Intron IV of the 
zebrafish ff1b gene 
Studies that used Sf1 promoter fragments of different lengths failed to direct 
expression to all the SF1 expression domains (Stallings et al. 2002; Wilhelm et al. 2002). 
These experiments suggested the presence of distally located cis-regulatory elements 
responsible for regulating Sf1 expression. This was further corroborated by studies that 
showed the presence of intronic enhancers on Sf1 capable of recapitulating reporter 
expression specifically to the fetal adrenal, VMH and pituitary and fetal testis in mice 
(Shima et al. 2005; Zubair et al. 2006; Shima et al. 2008; Shima et al. 2012).  
Hence, there was reasonable grounds for an assumption that the cis-regulatory 
elements for ff1b could also be situated in the introns. The intron deletion experiment 
carried out using Red/ET homologous recombination technique was able to localize 
interrenal specific enhancers to Intron IV and VMH specific enhancers to Intron V and 
Intron VII of ff1b (Fig 3.2-3.3). A small percentage of embryos showed EGFP expression 
in the interrenal and VMH when injected with Intron IV and Intron V, VII deletion 
constructs respectively. However, it is to be noted that the intensity of EGFP expression 
was drastically less when compared to the control. This could be explained by the fact 
that inspite of the removal of cis-regulatory elements present in the introns, the ff1b 
promoter was still functional in directing the reduced reporter expression to the specific 
tissues. However, the promoter alone was not sufficient in driving the reporter 
expression, as was also observed in earlier studies (Stallings et al. 2002; Wilhelm et al. 
2002).  
Interestingly, in the mouse studies, the fetal adrenal enhancer of Sf1 mouse 
studies was also localized to Intron IV of Sf1. However, as shown in Figure 6.1, Sf1 
Intron IV does not coincide with ff1b Intron IV. Intriguingly, in zebrafish, Intron IV that 
contained the interrenal specific enhancer was also identified to be the extra intron in the 
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ff1b gene that was not observed in the other orthologous vertebrate Ftz-F1 genes. 
Studying the interrenal specific enhancer of ff1b in zebrafish could thus, not only help us 
in understanding the regulation of ff1b, but also offer insights into their evolution. 
6.1.3. ff1b Intron IV enhancer validation using transient transgenesis 
Since the late 1980s, different experimental approaches have been developed to 
study the ability of conserved sequences to influence the expression of tissue specific 
genes. By cloning the enhancer fragment upstream of a minimal promoter driving a 
fluorescent reporter, the activity of a putative enhancer can be easily tested in vivo. 
Studies carried out by Woolfe and his colleagues used this rapid in vivo assay system in 
zebrafish to test approximately 1400 non-coding sequences that were found to be highly 
conserved between humans and pufferfish (Woolfe et al. 2005).  
We have also used the transient transgenesis strategy and have shown that the 
clone, pff1bIntronIVtkEGFP recapitulated EGFP expression in the developing interrenal 
gland (Fig 3.4). The mosaic expression observed at the earlier stages in the injected 
embryos could be attributed to the transient nature of transgenesis (Stuart et al. 1988; 
Westerfield et al. 1992; Iyengar et al. 1996). Considerable level of EGFP expression was 
also observed in the yolk syncytial layer (YSL) of the zebrafish embryos. The 
observation of transgene expression in the YSL, and not the yolk cell itself, is considered 
non-specific and is not likely due to the activity of the enhancer (Muller et al. 1993; 
Iyengar et al. 1996; Muller et al. 1999). During the development of the zebrafish embryo, 
the marginal blastomeres at the 1000 cell stage fuse with the yolk cell to form the YSL. 
The YSL contains large number of giant nuclei and the polyploidisation of the YSL 
enhances the transcription of the injected DNA causing a difference in the replication 
rates between the syncytium and the other embryonic tissues (Williams et al. 1996). 
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Despite the mosaic nature of EGFP expression, the specificity of the regulatory 
sequence was still maintained and thus served the purpose of analyzing the enhancer 
activity of ff1b Intron IV. Interestingly, at 72 hpf, the expression domain appeared to 
extend to the first somite and wasn’t just restricted to the prospective interrenal. This 
could either be a non-specific expression or a true expression induced by the ff1b Intron 
IV. The inability to track EGFP expression in the embryos after 4 dpf could be due to the 
degradation of the injected DNA leading to the inability to observe fluorescence. 
However, it could also indicate the inability of the ff1b Intron IV in directing reporter 
expression in the mature interrenal.  
In spite of the ease of use and reduced time consuming strategy, transient studies 
of enhancer activity have certain limitations. The injected DNA persists 
extrachromosomally in the injected embryos and is less likely to be influenced by 
‘position effects’ of stable transgenesis. However, factors such as variation in 
microinjection volume and copy number of DNA injected are inadvertently introduced. 
Segregation and compartmentalization of the injected DNA during cleavage complicates 
the analysis of expression pattern. While concatemerisation of injected DNA increases 
its stability, the chances of non-specific expression are also increased. In this regard, 
using a large construct such as bacterial artificial chromosome (BAC) that contains all 
the regulatory elements driven by the endogenous promoter can be more effective. The 
large BAC constructs are also less likely to cause positional changes and thus reflect the 
transgene expression faithfully. Hence, the ideal method to study the enhancer activity 
of Intron IV of ff1b would have been to use the BACff1bEx2EGFP (Quek 2009) 
construct with all the intronic segments removed while retaining Intron IV. This would 
enable us to test the ability of Intron IV to drive reporter expression driven by the 
endogenous promoter while keeping all the cis-elements in context.   
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6.1.4.  Dissection of ff1b Intron IV led to contradictory expression analysis 
The ff1b Intron IV was 3.8 kb in length and in order to identify a smaller fragment 
that could contain all the TF binding sites required for interrenal specific expression of 
ff1b, Intron IV was dissected further and the fragments analysed by transient transgenesis 
(Fig 3.5-3.6). The 5’ progressively deleted fragments, upon microinjection into wildtype 
zebrafish embryos indicated that the prospective interrenal specific enhancer to be 
located between ~2140 bp to ~2800 bp. However, fragments generated by retaining the 
upstream region of Intron IV while deleting the Intron IV segment deemed important by 
the 5’ truncation experiment, also resulted in considerable percentage of embryos with 
EGFP expression at the interrenal. The contradictory expression could be explained due 
to the presence of essential TF binding sites on both the upstream and downstream 
regions of Intron IV.  
Further analysis on the specific TFs that could bind to Intron IV using the 
MatInspector software (as detailed in Section 3.5) revealed an duplicated pattern of TF 
binding sites. Binding sites for TFs such as: 1. Lef1/Tcf7 2. Meis1a/b 3. Gata1a 5. Pbx1a 
5. Ets family of TFs were observed in the Intron IV segment between 2100 bp and 2800 
bp and in the upstream Intron IV segment from 1 to 1500 bp. While this indicated that 
the reason for the contradictory fragments expressing EGFP at the interrenal could be 
due to the presence of binding sites for similar TFs, it also indicated that these TFs could 
be involved in the interrenal specific expression of ff1b.  
The enhancer activity of the different truncated Intron IV fragments were 
analysed by transient transgenesis. This method of checking for enhancer activity was 
quick and easy. However, it was also error prone since it could introduce mosaic 
expression due to position effects. While it would be ideal to compare the enhancer 
activity of the different fragments by generating a stable transgenic line with each 
construct, it was also very time consuming. Hence, the transient method of transgenesis 
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offered an easier and faster method to pin point the location of the prospective interrenal 
enhancer.  
6.1.5. Using MatInspector to predict transcription factor binding sites 
In order to study the transcriptional regulatory mechanism of ff1b, the 
MatInspector search derived TFs from three different pathways were studied: 1. TFs 
involved in the organogenesis of the interrenal (mammalian adrenal cortex) 2. TFs 
involved in the development of the pronephros 3. TFs involved in angiogenesis and 
vascularization of both the interrenal and pronephros. The TFs divided into these three 
categories were mapped on to the zebrafish ff1b Intron IV as shown in Figure 3.7 and 
their roles in various developmental processes were tabulated in Table 3.1.  
By combining a comprehensive literature survey and the information available 
on the genes involved in the development of the adrenal gland and the interrenal from 
Gene Ontology, seven candidate TFs with binding sites on the ff1b Intron IV, were 
classified as those involved in the organogenesis of the interrenal. The chosen TFs were 
– Ff1b, Glucocorticoid receptor, Nr3c1; Spalt-like transcription factor 1a, Sall1a; Pre-B-
cell leukemia homeobox 1a, Pbx1a; Lymphoid enhancer-binding factor 1/Transcription 
factor 7, Lef1/Tcf7; High mobility group of protein, Hmga2; and Early growth response 
protein, Egr-1; 
The transcription of Sf1 has been shown to be controlled by an auto regulatory 
loop by binding to the Ftz-F1 response elements (FRE) in the 5’ upstream region of Sf1 
(Nomura et al. 1996). Similar FREs were also observed in Intron IV of ff1b. Moving on 
to the next TF, binding sites of Nr3c1 are not just present on the hypothalamus and 
pituitary, but also on the adrenal cortex (Paust et al. 2006; Briassoulis et al. 2011) and 
are shown to be involved in the development of the adrenal cortex. Studies have shown 
that Nr3c1 mutants results in defects in the development of the adrenal cortex leading to 
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adrenocortical tumors (Bourdeau et al. 2003; Tacon et al. 2009). Another TF identified 
to be required for interrenal gland development with a binding site on Intron IV is Sall1a. 
Mutations involving SALL1 in humans results in a rare autosomal-dominant 
malformation known as the Townes-Brocks syndrome that results in anal, renal, limb 
and ear anomalies (Kohlhase et al. 1998). The TF, Hmga2 has also been identified to be 
required for the development of the adrenal gland (Ashar et al. 1996). Binding sites of 
Egr-1 have also been identified on the ff1b Intron IV that interacts with SF-1 and plays 
an important role in the regulation of the luteinizing hormone-β in the pituitary (Kaiser 
et al. 2000). While it is not certain that Egr-1 could have a role in the transcription of 
either Sf-1 or ff1b, the expression of Egr-1 begins at a very early stage in the zebrafish 
embryos and the possibility that it could regulate the transcription of ff1b in the interrenal 
cannot be discounted. 
The Wnt and the β-catenin signaling pathway has already been proven to be 
involved in the development and maintenance of the adrenal cortical tissue (Tissier et al. 
2005; Kim et al. 2008). The accumulation of β-catenin, activated by Wnt signaling, 
induces the Lef/Tcf family of TFs to regulate the expression of downstream target genes 
(Amerongen et al. 2009). The last candidate TF involved in the development of the 
adrenal gland is Pbx1a that belongs to the three amino acid loop extension (TALE) class 
of homeodomain proteins. PBX1 forms complexes with HOX to regulate the 
transcription of target genes and its activity is enhanced by the interactions with PREP 
or MEIS (Jacobs et al. 1999; Ferretti et al. 2000). Studies have also established the role 
of PBX1 in the development of the adrenal glands and gonads (Schnabel et al. 2003; 
Lichtenauer et al. 2007). The presence of Hox/Pbx and Pbx/Meis binding sites on the 
fetal adrenal enhancer of mouse Sf1 and their role in inducing reporter expression in the 
fetal adrenal (Zubair et al. 2006) further increased the possibility of Pbx1a in zebrafish 
to also regulate the expression of ff1b in the interrenal.  
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Since both the interrenal gland and the pronephros remained in close proximity 
to each other throughout development, the TFs that have been proven to be indispensable 
for the formation of the pronephros have also been considered - Wilms’ tumor suppressor 
gene, Wt1; Paired domain containing homeobox proteins, Pax2a and Pax8; Odd-
skipped related transcription factor, Osr2; Lim homeodomain TF, Lhx1; sine oculis 
homeobox family, Six2a; Maf family of TFs, Mafa and Mafb; Iroquois family of TFs, 
Irx3 and Irx5. All the above TFs have been shown to be essential for the organogenesis 
of different segments of the pronephros (Yang et al. 1999; Majumdar et al. 2000; 
Bouchard et al. 2002; Tena et al. 2007; Weber et al. 2008; Swanhart et al. 2010; Wingert 
et al. 2011).  
Both the interrenal and the pronephros require extensive signaling from the 
endothelium all throughout their development (Liu et al. 2006; Chou et al. 2010; Chou 
et al. 2013). The TFs with binding sites found on the ff1b Intron IV and involved in 
regulating endothelium development are:- Ets family of TFs, runt-related transcription 
factor 1, Runx1; GATA binding protein 1a, Gata1a; myeloid ectopic viral insertion site 
1, Meis1; homeobox gene, Hoxa9; and T-cell acute lymphocytic leukemia 1, TAL1  
The MatInspector software from Genomatix was used to identify potential TFs 
that could have a role in the transcription of interrenal specific expression of ff1b. The 
TFs with the most relevance to the development of the interrenal gland were chosen as 
candidates. However, all the computationally derived regulatory segments are not 
functionally relevant until they are confirmed by further experiments. 
6.1.6.  Computational comparison of zebrafish ff1b Intron IV sequence with other 
orthologous genes 
An essential tool in the quest for identification of functional coding and non-
coding sequence in the vertebrate genome is comparative genomics. The basic 
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understanding is that the sequences involved in the regulation of developmentally 
important genes would remain conserved through evolution. The common technique 
used for this purpose is phylogenetic footprinting that searches for homologous 
sequences that could be shared between evolutionarily distant species. Cross species 
comparison between human and mouse has helped in the identification of numerous 
conserved non-coding elements that are involved in the regulation of various genes. 
However, due to the slow rate of divergence between mammals and the relatively small 
evolutionary distance between mouse and humans (approximately 60 million years), 
human-mouse comparisons have resulted in extensive sequence similarity, even in the 
non-coding sequences and thereby complicating the search of bona fide conserved 
sequences with a regulatory role. The neutrally evolving regions diverge at a rate of 0.1 
to 0.5% per million years among vertebrates (Tautz 2000). The zebrafish genome can 
help overcome the drawbacks since the common ancestor between teleost and mammals 
existed approximately 430 million years ago (Muller et al. 2002). Hence, the similarities 
between neutrally evolving segments are lesser leaving only the truly functional 
sequences to remain conserved between the species. 
However, a comparison of the NR5A1 receptors using the AVID global 
alignment software (Bray et al. 2003) failed to detect any conserved sequences in Intron 
IV of zebrafish ff1b (Fig 6.2). Apart from the distinct conserved islands that corresponded 
to the exonic regions, few non-coding elements were detected in the Intron III and Intron 
V of ff1b. Intron IV, however, did not have any homologous segments even when 
compared with ftz-f1 from Drosophila melanogaster and nhr-25 from Caenorhabditis 
elegans, both of which indicated the presence of introns interrupting their hinge domain 
in their genomic organization (Fig 6.1). The inability to detect any conserved regulatory 
elements computationally is further compounded by the whole genome duplication in the 
teleosts (Amores et al. 1998; Postlethwait et al. 1998). The paralogue of ff1b in zebrafish, 
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ff1d, is found to be more homologous to the mammalian Sf1 in terms of their genomic 
organization, in spite of the fact that Ff1b is the functional ortholog of mammalian Sf1 
in zebrafish. 
While the presence of conserved regulatory elements across a wide evolutionary 
range implies conserved function across the species, there are cases where conservation 
of function is observed without significant sequence conservation. Studies involving the 
non-coding elements of HOXA2 showed the presence of well conserved elements among 
all vertebrates, including teleosts (Westerfield et al. 1992). However, the 1kb segment 
upstream of GAP43 failed to detect any conserved element in teleosts, in spite of the 
presence of highly conserved elements among mammals (Pashos et al. 2008). The 
enhancers are also expected to undergo evolution, thus making it difficult to be identified 
by the current algorithms. As summarized by a study (Domene et al. 2013), the regulatory 
sequences could be subjected to three different cases: (i) reshuffling and turnover causing 
the sequence similarity to decrease, while maintaining the ancestral transcriptional 
activity. In other words, in spite of the sequences evolving, the TFs recognizing the 
binding site on the regulatory element would still be conserved (ii) the enhancer turnover 
causing both qualitative and quantitative changes in the expression patterns induced by 
the gene (iii) in rare cases, the enhancer turnover could also result in the birth of novel 
regulatory patterns in different lineages. 
In our study, Intron IV has been clearly proven to be involved in regulating the 
interrenal specific expression of ff1b in zebrafish. The absence of significant stretches of 
homologous sequence in Intron IV could be due to the great evolutionary distance 
between zebrafish and mammals. Besides, Intron IV has also been shown to be ancestral 
and unique to zebrafish. Moreover, the essential element required for regulating tissue 
specific expression are the short TFBS (6-12 bp). Hence, identifying short stretches of 
conserved elements would help us in revealing the essential TFBS on Intron IV.   
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While general local alignment tools are confounded by genomic rearrangements 
present in genomic sequences, local alignments tools such as dot plots are better suited 
for detecting short stretches of nucleotide sequence matches. They are also capable of 
detecting DNA reshuffling and segmental duplications. The dot plot analysis performed 
between both the segments shown to carry interrenal and adrenal specific enhancer in 
zebrafish and mouse respectively, the ff1b Intron IV and Sf1 Intron IV, indicated a 
number of short similarities between the two segments (Fig 3.8). The ff1b Intron IV 
segment between ~2000 to ~2864 bp was identified to contain a higher concentration of 
short stretches of similar sequences that also coincided with the binding sites of candidate 
TFs that were identified by MatInspector.  
Apart from the dotplot, the CpG island analysis of Intron IV also indicated the 
presence of a concentration of CpG dinucleotides between 2287 bp and 2780 bp of Intron 
IV (Fig 3.9 A). Studies have demonstrated the presence of CpG islands in the promoter 
and intergenic regions of genes and are usually subjected to tissue-specific differential 
methylation (Song et al. 2005; Song et al. 2009). Similar CpG islands were also detected 
in the VMHE, PGE and the FAdE and were found to be hypomethylated in the tissues 
where they were active and hypermethylated in the inactive tissues (Hoivik et al. 2011).  
Thus to summarize, in spite of the lack of significant homologous sequences 
between the ff1b Intron IV and other orthologous sequences, Intron IV segment between 
2000 bp – 2900 bp was shown to harbor very short stretches of conserved sequences. 






Figure 6.2 AVID VISTA comparison of N5A1 receptors between different species 
with zebrafish ff1b as the base sequence. The ff1b genomic sequence is subjected to a 
global alignment with the NR5A1 receptors of the corresponding species, including the 
paralogue of ff1b in zebrafish, ff1d. The zebrafish ff1b is used as the base sequence with 
the minimum conservation identity set at 50% in a window size of 30 bp. The genomic 
organization of ff1b is also shown above with the exons indicated by the dark blue boxes. 
6.1.7. Identification of the shortest nucleotide sequence sufficient to induce reporter 
expression in the interrenal  
Based on the results obtained from the Intron IV fragmentation enhancer analysis 
and comparative analysis of ff1b Intron IV with Sf1 Intron IV, the Intron IV fragment 
between 2084 bp and 2948 bp were tested for enhancer activity. The microinjection of 
the clone pff1bIntronIV864tkmCherry in wildtype zebrafish embryos resulted in 
embryos with mCherry expression in the interrenal gland, lateral to the second and third 
somite (Fig 3.10). The mCherry expression induced by the 864 bp of ff1b Intron IV was 
confirmed by injecting into the transgenic embryos Tg(ff1bEx2:GFP) (Quek 2009) (Fig 
3.11). However, in both the wildtype and transgenic embyros injection, mCherry 
expression was also observed more anteriorly in the neck shaped cells of pronephric 
tubule that had the characteristic brush like border.  
The expression at the pronephric tubule could not be discounted for as non-
specific and mosaic since ~28% of the embryos analysed had mCherry expression at the 
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pronephric tubule. Moreover, the construct used for microinjection was cloned with I-
SceI meganuclease restriction site overhangs that has been shown to increase the 
integration efficiencies into the genome and reduce non-specific expression (Thermes et 
al. 2002; Grabher et al. 2004; Soroldoni et al. 2009). The unexpected mCherry expression 
observed at the pronephric tubule could be due to the presence of response elements or 
binding sites for TFs that are specifically expressed in the proximal segment of the 
pronephric tubule such as Pax2a and Pax8. A single binding site for the podocyte specific 
transcription factor, Wt1a was also present on the 864 bp of ff1b IntronIV. Puzzlingly, 
similar expression at the pronephros was not observed when the pBACff1bEx2EGFP 
intron deleted constructs were microinjected (Section 3.3). This could be because the 
Intron IV segment was taken out of context and the mCherry expression driven by Intron 
IV was led by a minimal tk promoter and not the endogenous ff1b promoter.  
With the confirmation that the essential regulatory elements were present within 
the 864 bp of the Intron IV-Core segment, further sub-fragmentation of the core segment 
indicated that the interrenal specific enhancers were present within an 116 bp segment. 
The fragmentation series also revealed the presence of insulators between 2201 bp and 
2450 bp of the ff1b Intron IV, that when deleted in Intron IV-Core 4 (C4), induced non-
specific expression in the developing zebrafish embryo. However, contradicting results 
were observed when the Intron IV-Core fragments C7 and C9 were not able to induce 
mCherry expression at the interrenal gland. These results indicated a very complex 
pattern of enhancer and repressor segment usage. An important point to be considered is 
that the Intron IV segment was cloned out of the genomic context and hence the other 
factors that play a very important role in transcriptional regulation such as the in vivo 
chromatin looping and other epigenetic factors have not been taken into account.  
Specifically focusing on the TFs that could be involved in regulating the 
interrenal specific expression of ff1b and with binding sites between 2084 bp and 2200 
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bp, the possible roles of Nr3c1 and Foxc1a were looked into. The single glucocorticoid 
receptor (GR) in zebrafish, is a cytosolic TF, that when activated by ligands such as 
cortisol, translocates to the nucleus and regulates the transcription of the target genes 
(Alsop et al. 2008; Schaaf et al. 2009). Studies have shown that both cortisol and GR are 
maternally transferred from the oocyte to the developing embryo and are required for 
early development in the zebrafish (Nesan et al. 2013a; Wilson et al. 2013). Knockdown 
of GR has been shown to result in disrupted mesoderm and abnormal somite formation 
in zebrafish. Transcriptome analysis of the embryos subjected to GR knockdown, 
however, indicated an upregulation of ff1d and star transcripts (Nesan et al. 2013b). 
While their effect on ff1b has not been studied, the up-regulation of other steroidogenic 
genes indicated that the GR plays an important role in suppressing the transcription of 
ff1b and the downstream steroidogenic enzmyes during early embryogenesis. However, 
the transcriptome analysis was performed on the whole embryo and hence, the organ or 
region specific effect of GR knockdown cannot be inferred. The other TF with binding 
sites in the crucial segment of Intron IV-Core is the forkhead TF, Foxc1a. Studies have 
shown that knockdown of foxc1a resulted in loss of the interrenal-pronephric primordium 
and the subsequent lack of podocytes and impaired development of the interrenal cells 
(O'Brien et al. 2011). Combined knockdown of both Foxc1a and Wt1a have shown a 
complete disappearance of both the podocytes and the interrenal gland, both of which 
develop from the intermediate mesoderm at the third somite in the developing embryo.  
Apart from enhancers, cis-regulatory elements also include insulators and 
repressors that are required for the correct expression pattern (Conte et al. 2007). In the 
zebrafish genome, these interactions would be modulated by chromatin loopings and thus 
be responsible for interrenal specific expression of ff1b. Based on the results obtained 
from the enhancer activity of the Intron IV-Core sub-fragments, analysis of the TF 
binding sites on the intronic segment between 1975 bp and 2700 bp indicated the 
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presence of such repressor and enhancer elements. The binding sites of the zinc finger 
protein, CTCF (CCCTC binding factor) was found on the core segment between 2200 
bp and 2450 bp. CTCF has been implicated in mediating multiple functions such as both 
transcriptional repression and activation, cell differentiation and apoptosis (Burcin et al. 
1997; Vostrov et al. 1997; Awad et al. 1999; Bell et al. 1999).  
6.2. Stable transgenic line with mCherry expression regulated by the ff1b Intron 
IV reveals interesting expression patterns in zebrafish 
The inability to track reporter expression after 72 hpf of microinjecting the 
construct pff1bIntronIVtkegfp into the zebrafish embryos necessitated the generation of 
a stable transgenic line. The need for a stable transgenic line was further compounded by 
the expression observed in the pronephric tubule induced by the 864 bp of ff1b Intron IV. 
Hence, a transgenic line was generated that was able to track the interrenal cells 
expressing mCherry induced only by Intron IV of the ff1b gene (Section 5.3).  
In order to increase the efficiency of transgenesis, I-SceI meganuclease restriction 
site overhangs were added to either sides of the construct – ff1bIntronIVtkmCherry. The 
I-SceI meganuclease overcomes limitations of transgenesis such as mosaic transgene 
expression, low insertion frequency and germline transmission (Stuart et al. 1988; Culp 
et al. 1991). I-SceI meganuclease mediated transgenesis reduces the extent of mosaic 
expression in the founders. Not surprisingly, the mCherry expression observed in the 
microinjected embryos appeared less mosaic and more restricted to the interrenal (Fig 
4.1). The successful integration of the transgene into the zebrafish genome was 
confirmed by the Mendelian ratio of transgene inheritance observed in the F1 generation.  
The mCherry expression patterns, both in the stable transgenic line and in the 
transient transgenesis, revealed unexpected patterns of intermittent expression. This 
could be due to several reasons. The I-SceI meganuclease enzymes has been thought to 
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promote nuclear localization of the injected transgene. However, the exact mechanism 
of how the enzyme works is currently still not clear. The expression observed in the 
developing pronephros could be due to a positional effect of transgene integration into 
the zebrafish genome. The unexpected expression could also possibly reveal an unknown 
role of ff1b Intron IV in regulating Ff1b expression in the interrrenal gland. The interrenal 
gland, in zebrafish, remains in very close proximity to the developing pronephric 
primordium as it undergoes distinct stages of development (Chai et al. 2000; Chai et al. 
2003; Hsu et al. 2003). The complete organogenesis of the interrenal gland has been 
shown to take longer than 5 dpf in zebrafish. Interestingly, the mCherry expressing cells 
in the interrenal gland also begin to appear after 5 dpf, suggesting that the ff1b Intron IV 
regulates mCherry expression in a more developed interrenal gland.  
The mCherry expression at the pronephros was initially regarded as non-specific 
in the transient transgenic experiments. However, similar expression patterns were also 
observed in the stable transgenic line raised (Fig 4.2). Intriguingly, later experiments 
showed that the mouse FAdE also induced similar expression patterns in the pronephric 
tubule and the interrenal gland (Section 4.4) suggesting that the expression observed in 
the pronephric tubule could indeed be genuine. The development of the pronephros, 
unlike that of the interrenal gland, is complete by 72 hpf. Incidentally, mCherry 
expression at the pronephros appeared between 48 – 72 hpf. Hence, in both the 
pronephros and the interrenal, the mCherry expression is observed after the initial 
organogenesis of both the pronephros and the interrenal is more or less near completion. 
The absence of mCherry expression in the pronephros beyond 5 dpf, however, is still 
unexplainable.   
 While both the interrenal and the pronephric primordia arise from the lateral 
intermediate mesoderm, the morphogenetic movements of the two organs are regulated 
differently and are controlled by different endothelial signals (Serluca et al. 2002; Hsu et 
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al. 2003; Liu et al. 2006). Hence, the presence of binding sites of different endothelium 
derived TFs on the ff1b Intron IV could also induce the mCherry expression at different 
stages in the pronephros and the interrenal gland.  
The current method of observation of mCherry expression domains were 
restricted to fluorescence by confocal microscopy. The expression domains would have 
to be confirmed by in-situ hybridisation or immunohistochemistry to check for the co-
localization of mCherry expression and the pronephric and interrenal markers.  
6.3. Differences in the expression patterns induced by the fetal adrenal enhancer 
in zebrafish and mice 
It is of general belief that the non-coding sequences of functional importance 
involved in the regulation of tissue specific expression of various genes would be 
generally conserved across evolution as compared to the surrounding sequences. 
However, this wasn’t observed in the case of interrenal specific enhancer of the ff1b gene 
in zebrafish. Homologous comparison of the zebrafish ff1b gene with the mammalian 
SF-1 gene did not identify any CNEs in the zebrafish ff1b gene. Although some studies 
have identified conserved sequences from orthologous genes driving similar expression 
patterns (Poulin et al. 2005; Shin et al. 2005; Woolfe et al. 2005; Pennacchio et al. 2006), 
increasing studies are now proving otherwise (Takahasi et al. 2011; Ariza-Cosano et al. 
2012; Gordon et al. 2012). Studies have now demonstrated that in spite of no sequence 
conservation between regulatory elements of orthologous genes, they were able to 
regulate tissue specific expression in their respective host species (Fisher et al. 2006; 
Hare et al. 2008; McGaughey et al. 2008; Chatterjee et al. 2011; Domene et al. 2013). 
Other studies have also shown that the CNE from one species may drive dramatically 
different expression patterns in another species (Wittkopp et al. 2004; Ritter et al. 2010; 
Maeso et al. 2013).    
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In order to test this in the case of tissue specific regulation of ff1b and to identify 
any cis and/or trans changes in the evolution of the NR5A1 receptor, the ideal method 
was to analyze the expression patterns induced by the FAdE of the Sf1 gene in zebrafish. 
Analysis of the mCherry expression patterns revealed that the FAdE, apart from the 
interrenal gland, was also able to induce mCherry expression in the pronephric tubule of 
the zebrafish. The expression in the pronephros could not be disregarded as mosaic non-
specific expression since it was observed in ~40% of the injected zebrafish embryos.  
The difference in the expression patterns induced by the same enhancer fragment 
in zebrafish and mouse studies could be due to several experimental reasons. Firstly, in 
the mouse studies, an upstream basal promoter of the Sf1 gene was used to direct the 
FAdE expression (Zubair et al. 2006). In our studies, we have used a minimal tk promoter 
to direct mCherry expression induced by the FAdE in the developing zebrafish embryos.  
The tk promoter does not drive expression on its own in the zebrafish embryos, but is 
capable of directing expression when cloned downstream of an active enhancer 
(Dickmeis et al. 2004). Apart from the different promoters used, the reporter gene used 
in the mouse study was LacZ as compared to the fluorescent mCherry reporter gene in 
our study. However, the use of a different reporter gene was less likely to be the reason 
for different expression patterns. The use of the lacZ cassette as a reporter gene and the 
subsequent enzymatic dependent detection might help in amplifying the reporter signal 
and thus compensate for the opacity of the mouse embryo. The zebrafish embryos, on 
the contrary, being transparent might be better suited for direct visualization of 
fluorescence. While stable transgenic mouse lines were generated in the earlier study 
(Zubair et al. 2006), our study was only based on transient transgenesis. It would be more 
efficient to confirm the FAdE induced mCherry expression patterns in zebrafish by using 
the Tol2 transposon or the I-SceI meganuclease mediated transgenesis that would enable 
the integration of a single to few copies of the reporter construct.   
163 
 
Apart from the experimental errors, the anatomical differences in expression 
patterns indicated the possibility of cis and trans evolution of the tissue specific 
regulation. Regulation of tissue specific gene expression is controlled by arrays of cis-
regulatory elements that are recognized by TFs which in turn are expressed differentially 
and at particular developmental stages. The combination of cis-elements and trans-
factors control gene expression patterns. The evolution of both the cis-elements (cis 
changes) and the TFs with respect to their activity and specificity (trans changes) can in 
turn lead to the evolution of gene expression regulation between species. 
A study in 2010 analyzed 41 CNEs sequences across humans, mouse and 
zebrafish to determine the influence of lineage specific accelerated sequence evolution 
that in turn leads to differences in the TFBS (Ritter et al. 2010). Comparison of enhancer 
activities by testing zebrafish CNEs in zebrafish (ZZ) and orthologous human CNEs in 
mouse showed that 22% of the CNEs revealed differences in expression patterns between 
zebrafish and mouse. The activity of the same conserved sequence in different hosts 
inducing different expression patterns indicated that the differences are mainly due to 
trans-changes. The activity of orthologous CNEs in the same hosts inducing different 
expression patterns indicated underlying cis-changes. The study also showed that trans-
changes in the CNEs were not present without corresponding cis-changes. While this 
study (Ritter et al. 2010) underplayed the effect of trans-changes on the CNEs, more 
recent studies have showed that trans-changes also have a potential role in the evolution 
of gene expression. 47 human CNEs tested in zebrafish and mouse embyros showed that 
83% of the sequences resulted in differences in the expression patterns (Ariza-Cosano et 
al. 2012). While many studies researching orthologous CNEs have reported cis-changes 
in the CNEs (de la Calle-Mustienes et al. 2005; Navratilova et al. 2009; Navratilova et 
al. 2010), disparate expression patterns caused by changes in the trans environment were 
also observed in other studies (Wittkopp et al. 2004; Maeso et al. 2013).  
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A similar case of disparate expression patterns were observed in our study. Strong 
mCherry expression was observed in the pronephric tubule of the zebrafish that wasn’t 
observed in the developing mouse embryos of the earlier studies. The observation of 
differences in expression patterns induced by the Sf1 FAdE in zebrafish and mouse 
strongly indicated the probability of a change in the trans environment between zebrafish 
and mouse. Concordant with earlier studies that trans changes were not observed in the 
absence of cis changes, the search for homologous conserved regulatory elements in the 
ff1b gene was not successful. The ff1b Intron IV segment that carried the zebrafish 
interrenal specific enhancer did not contain any conserved element when compared to 
the mammalian SF-1 gene. This indicated cis changes in the interrenal specific regulatory 
element during the evolution of the ff1b/SF-1 gene. Interestingly, trans changes may be 
indirectly correlated with cis changes i.e. the sequences to which the trans factors bind. 
Cis changes leading to the loss of the binding site of a particular enhancer might in turn 
allay the selective pressure required to continually keep a particular TF being expressed 
in the corresponding tissue. On the other hand, the loss of a particular TF from an 
expression domain could in turn lead to the loss of the necessity to preserve the binding 
site of the corresponding TF. This suggests that concerted cis and trans evolution is 
required to regulate the tissue specific expression of a gene.  
6.4. Comparison of transcription factor binding sites on Intron IV of ff1b, ff1d and 
Sf1.  
In spite of the lack of sequence conservation between the tissue specific 
enhancers of ff1b and its orthologous genes, the main regulatory unit of the enhancers 
were the TFs. Hence, by comparing the TFBS on the ff1b Intron IV and the mammalian 
Sf1 adrenal enhancers, more insight into the specific TFs required for tissue specific 
expression of Ff1b in the interrenal could be revealed.  
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The comparison of TFs that have the potential to bind to the FAdE and the ff1b 
Intron IV provided a number of TFs that could have a role in regulating Ff1b expression 
in the zebrafish interrenal gland (Fig 4.6). Among the TFs that were similar between our 
analysis using MatInspector and the earlier mouse study (Zubair et al. 2006) were – 
Hox/Pbx and the SF-1 binding sites. However, the MatInspector study did not identify 
the presence of any Pbx/Prep binding site. Our analysis of the FAdE using MatInspector 
also identified the presence of binding sites of the TFs – Hmga2, Nr5a1a, Tcf/Lef1, 
Nr3c1 and Mare that have been shown to have roles in the development of the interrenal 
gland in zebrafish and its mammalian equivalent, the adrenal gland. Binding sites of TFs 
involved in the vascularization of the interrenal gland and the pronephros were also 
identified on the FAdE – Gata1a and Tal1. 
The MatInspector transcription factor binding site analysis was restricted to the 
~580 bp FAdE located within Sf1 Intron IV. However, this fragment was only capable of 
inducing reporter expression in the fetal adrenal and the expression was observed to fade 
away as the X zone regressed during the adrenal cortex development in mice. On the 
other hand, our study utilized the entire Intron IV segment of the ff1b gene and was 
observed to induce expression at a later developmental stage of the interrenal. It was 
possible that the ff1b Intron IV also contained a smaller fragment capable of inducing 
expression only in the earlier stages of the interrenal primordia, in spite of the lack of 
clear evidence that such a fetal zone exists in the zebrafish interrenal. By using the whole 
Intron IV segment, the binding sites of TFs required to induce expression in the early 
interrenal could have been masked by insulators. The other caveat in our study is that the 
ff1b Intron IV has been taken out of context and hence does not follow the organization 





Figure 6.3 Comparison of TFs with binding sites on the Sf1 Intron IV and ff1b 
Intron IV. The TFs with binding potential on the Sf1 Intron IV were analysed using 
MatInspector and the TFs common between Sf1 Intron IV and ff1b Intron IV were 
mapped on the Sf1 Intron IV. TFs involved in pronephric development are colored in red, 
those involved in the development of the interrenal (adrenal) gland are colored in blue 
and those involved in vascularization are colored in green. The segment of the Sf1 Intron 
IV corresponding to the FAdE has been boxed by a red box.  
Hence, in order to identify other common TFs that could have been missed, we 
have also compared the TFBS on the entire stretch of the Sf1 Intron IV and the ff1b Intron 
IV. This revealed the presence of 193 common TFs and the candidate TFs that could 
have a role in the development of the adrenal gland were mapped onto the 5.8kb Sf1 
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Intron IV (Fig 6.3). Not surprisingly, many TFs that were deemed as candidate TFs on 
the ff1b Intron IV were also noticed to have binding sites on the Sf1 Intron IV. However, 
the binding sites of TFs that are involved in the development of the pronephric kidney 
were considerably lesser in number on the Sf1 Intron IV as compared to the ff1b Intron 
IV. By combining an additional 700 bp of the Sf1 Intron IV downstream of the identified 
FAdE, most of the TFs identified to have binding sites on the 864 bp of ff1b Intron IV 
would be included. It would be interesting to compare the expression patterns induced 
by these fragments in the developing zebrafish embryo.  
6.5. Analysis of regulatory activity of the human VMHE in the zebrafish brain 
6.5.1.  Widespread expression patterns induced by the human VMHE in the 
zebrafish brain 
Apart from the interrenal, Ff1b is also expressed in the VMH. The intron deletion 
experiment on the BACFf1b indicated that the enhancers required for the VMH specific 
expression of Ff1b could be located within the Introns V and VII. The ff1b Intron V and 
VII being 6.6 kb and 2.2 kb long respectively, made the process of further deletion 
analysis by fragmentation highly tedious and cumbersome. Hence, we decided to identify 
the TFs involved in the VMH specific expression of Ff1b by first testing the enhancer 
activity of the mammalian SF-1 VMHE in the zebrafish.  
The microinjection of the human VMHE into the zebrafish embryos successfully 
recapitulated reporter expression in the zebrafish VMH. The phVMHEtkmCherry 
construct injected into the transgenic embryos Tg(ff1bEx2:GFP) also clearly showed that 
the mCherry expressing cells overlapped with the EGFP expressing ff1b cells. However, 
the expression wasn’t restricted to the VMH and was more widespread. mCherry 
fluorescence was also observed in rostral regions of the diencephalon and the anterior 
hypothalamus. The expression domains of mCherry in the larvae would be better 
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discerned by sectioning the larve and further staining by either in-situ hybridization or 
immunohistochemistry since it would help us to histologically delineate the specific 
clusters of cells expressing mCherry.  
In order to identify specific TFs responsible for VMH specific expression of the 
human VMHE, an in-silico analysis of the TFBS was performed using MatInspector. The 
analysis revealed binding sites for a number of TFs that are not restricted only to the 
VMH, but are also expressed in other domains of the zebrafish diencephalon. An 
interesting pattern observed in the TFBS was that they occurred as clusters on the human 
VMHE and that the binding sites for many TFs appeared to overlap each other.  
The zebrafish hypothalamus, in spite of the evolutionary distance, does not differ 
from its mammalian counterpart in the basic organization and the neuronal populations 
(Machluf et al. 2011). The hypothalamus consists of several nuclei, each of which is 
composed of different neuronal cell types. The ventromedial hypothalamic nuclei, a 
bilateral cluster of cells, is found in the medial and basal region of the hypothalamus. It 
can be further characterized into the three regions, each defined by a set of neuronal cell 
types – dorsomedial, central and ventrolateral. Studies on the mouse hypothalamus have 
shown that Sf1 is expressed in the medial and basal regions of the VMH (Roselli et al. 
1997; Cheung et al. 2013), while estrogen receptors are exclusively found only in the 
neurons of the ventrolateral VMH (Shughrue et al. 1997; McClellan et al. 2006). Hence, 
the focus of our study was to identify TFs responsible for inducing Ff1b expression only 
in the dorsal and central subset of cells in the VMH. The presence of TFBS on the VMHE 
that are usually expressed outside of our small domain of study in the VMH could cause 
the widespread expression patterns observed. Moreover, the VMHE was taken out of its 
gene locus and cloned upstream of a minimal tk promoter. This was unlike the mouse 
study that utilized the endogenous Sf1 promoter (Shima et al. 2005) to direct the reporter 
expression. The extended expression induced by the human VMHE in zebrafish could 
169 
 
also be due to changes in the trans environment during the course of evolution. 
Differences in the expression domains was also observed when the mouse FAdE was 
microinjected into the zebrafish embryos (discussed in section 6.3).  
6.5.2.  Fragmentation of the human VMHE reveals synergistic activity of TFs 
present in two clusters to regulate reporter expression in the zebrafish VMH 
With the TFs occurring in discrete clusters on the VMHE, the enhancer could be 
easily subdivided into discrete enhancer regions (Fig 5.4). The 5’ progressive deletion 
performed on the VMHE and the subsequent analysis of the enhancer activity by 
microinjection into the zebrafish embryos showed that the deletion of region I completely 
obliterated the mCherry expression in the zebrafish VMH (Fig 5.6). The internal 
truncation experiment performed later showed that the TFs binding to region I alone 
could not recapitulate mCherry expression in the zebrafish VMH. However, the region I 
in combination with the binding sites on region II reproduced mCherry expression in the 
zebrafish VMH (Fig 5.7 – 5.8). This showed that a concerted effort of TFs binding to the 
region I and region II was required to induce reporter expression in the VMH.  
The earlier mouse study that identified the VMHE (Shima et al. 2005) 
demonstrated the presence of conserved nucleotide sequences with a typical ATTA motif 
- recognition sequences of homeodomain proteins (Fig 6.4). According to their study, 
HD2/3 and HD4/5, located within the F2 and F5 were essential to induce reporter 
expression in the mouse embryos. The deletion of either F2 or F5 did not change the 
expression patterns in the ventral diencephalon. However, combined deletion of both F2 
and F5 resulted in ablation of lacZ reporter expression in the mouse VMH. 
Electrophoretic mobility shift assays (EMSA) showed that both HD2/3 and HD4/5 bound 
to the same protein complexes and thus deletion or mutation of either HD2/3 or HD4/5 
could compensate for the other. Deletion of F1 resulted in ectopic expression in the 
ventricular zone and expression was also observed to expand dorsally. The ectopic 
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expression was later shown to be due to suppressive elements in the nucleotide cluster 




Figure 6.4 Analysis of enhancer regions on the human VMHE. The TFBS as 
identified by our study was compared to the conserved nucleotide sequences identified 
by the earlier mouse study (Shima et al. 2005). The cis-regulatory elements identified by 
the earlier study were mapped on to the human VMHE (F1-5, red boxes; C1.3, green 
triangle; HD2-5, yellow triangles). The conserved elements HD2/3 and HD4/5, located 
within the fragment 2 and 5 respectively, were identified to be essential for inducing 
reporter expression in the mouse embryos. This was in contrast to our study that showed 
that the essential nucleotide sequences could be located within the first 200 bp of the 
human VMHE.  
 
The results demonstrated by the mouse study was in contrast to our results that 
show that the deletion of enhancer region I resulted in the absence of mCherry expression 
in the zebrafish embryos. Further studies have shown that the mCherry expression was 
reproduced in the zebrafish VMH only when the microinjected nucleotide sequence 
contained both the enhancer regions I and II. The enhancer region II and the 
corresponding TF binding sites (Isl1, Rorab and Pbx1a) identified by our study coincided 
with HD2/3. While HD4/5 corresponded to the TFBS in the enhancer region IV, the 
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binding sites for candidate TFs in the enhancer region I also coincided with the conserved 
nucleotide clusters as identified by the earlier study. However, the enhancer region I, 
deemed as unimportant in the mouse study, was shown to be essential for inducing 
mCherry expression in the zebrafish embryos. Hence, apart from the nucleotide 
sequences in enhancer region II that were shown to be essential by both mouse and 
zebrafish studies, the results of our study did not correspond to the mouse study.  
The differences in expression patterns and the essential nucleotide sequences 
required for inducing reporter expression in the zebrafish and mouse embryos strongly 
suggested the role of trans changes in the cellular environment between zebrafish and 
mouse. An important point to be noted is that the mouse Sf1 VMHE was analysed in the 
earlier study (Shima et al. 2005). On the other hand, in our study, we have analysed the 
enhancer activity of the corresponding human SF-1 VMHE. Although the sequence 
conservation between the human and mouse SF-1 VMHE was more than 90% and the 
essential TFBS were conserved between the two species, the use of the enhancer 
sequence from different species might account for certain changes in the enhancer 
expression patterns in zebrafish. However, with similar trans changes observed in the 
expression patterns induced by the Sf1 FAdE in zebrafish embryos, the role of trans 
changes between the two species could be implied in the case of the VMHE too.  
6.5.3.  Identification of candidate TF arrays on the ff1b Intron V and VII indicates 
conservation in regulatory activity. 
Many studies have used genomic sequence comparison based approaches to 
identify cis-regulatory modules (CRMs). However, recent studies have shown that CRMs 
of many genes may be functional without sequence conservation across different species. 
With the functionality of the CRMs being within the specific TFBS, studies have 
identified cis-regulatory elements of many genes by searching for these specific TFBS 
(Schmidt et al. 2010; He et al. 2011; Schmidt et al. 2011; Taher et al. 2011). With the 
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binding sites being only 6-10 bp long, the large evolutionary distance between certain 
species makes it difficult for the CRM to be identified by traditional sequence 
conservation methods.  
Based on the binding events on the SF-1 VMHE, a search for similar TFBS on 
the ff1b Intron V and VII revealed cluster of TFBS that had the same consistent binding 
spacing as the VMHE (Fig 5.10 -5.11). The presence of such similarity in the prediction 
of binding events indicated that the ff1b Intron V and VII could possess the enhancers 
required for directing VMH specific Ff1b expression in the zebrafish.  
6.6. Conclusion 
Major tissue-specific genes with multiple roles in development and patterning 
require extensive spatial and temporal regulation in their gene expression. In this study, 
we have focused on the regulatory mechanisms controlling the expression of Ff1b in the 
zebrafish interrenal and the VMH. By using a Red/ET homologous recombination based 
deletion approach, we have localized the presence of interrenal specific enhancers within 
Intron IV and VMH specific enhancers to Intron V and VII.  
Experiments were performed to show that the ff1b Intron IV, cloned out of the 
genomic context, reproduced reporter expression in the zebrafish interrenal gland. In 
order to identify specific TFs that are involved in the interrenal specific expression of 
Ff1b, the 3.8 kb long ff1b Intron IV was subjected to a series of fragmentation and in-
silico sequence comparisons to determine an 116 bp fragment that reproduced reporter 
expression in the interrenal gland. In spite of intermittent and unexplainable expression 
patterns, we have generated a stable transgenic line with the ff1b Intron IV inducing 
mCherry expression in the zebrafish interrenal. We have also tested the expression 
patterns induced by the mouse Sf1 FAdE in zebrafish embryos. The difference in 
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expression patterns observed when the same enhancer fragment was tested in zebrafish 
and mouse suggests an evolution in the trans environment between zebrafish and mouse.  
In order to identify the TFs involved in the VMH specific expression of Ff1b, we 
have tested the human VMHE and analysed the expression patterns induced by it in the 
zebrafish embryos. The SF-1 VMHE reproduced mCherry expression in the zebrafish 
VMH. The VMHE was fragmented in order to identify nucleotide sequences that are 
involved in the induction of mCherry expression in the zebrafish VMH. This approach 
identified two enhancer regions that work together in order to induce mCherry expression 
in the zebrafish VMH. Similar enhancer regions with TFBS of specific TFs were 
identified on the ff1b Introns V/VII that could potentially regulate Ff1b expression in the 
zebrafish VMH.  
6.7. Future perspectives 
The Red/ET homologous recombination based deletion approach on the 
pBACFf1bEx2EGFPAmp firmly established that the interrenal and VMH specific 
enhancers of the ff1b gene are located within Intron IV and Intron V/VII respectively. 
Further analysis on the capability of ff1b Intron IV to induce reporter expression in the 
zebrafish interrenal, coupled with enhancer fragmentation and in-silico comparative 
analysis, we were able to trim the enhancer segment involved in interrenal specific 
expression from the original 3.8 kb long Intron IV to a 116 bp stretch of ff1b Intron IV. 
The analysis of the enhancer activity of the Intron IV-Core fragment were based on 
transient transgeneis. The expression patterns observed in the injected larvae could be 
further substantiated by generating a stable transgenic line. A better idea on the tissues 
expressing mCherry could also be obtained by studying the histological sections of the 
injected larvae and performing either in-situ hybridizations or immunohistochemistry 
staining on them. Subsequent site-directed mutagenesis on specific binding sites of 
candidate TFs would further help us define the cis-regulatory elements required for 
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interrenal specific expression of Ff1b. This would open up further avenues where we 
could study in detail the mechanism of enhancer-protein interaction and the identification 
of other crucial players that facilitate the transcription of the ff1b gene (Ong et al. 2011).  
We have already established that the ff1b Intron IV indeed directs reporter 
expression to the interrenal. However, we have cloned Intron IV upstream of a minimal 
tk promoter and thus the enhancer segment taken out of its gene locus could attribute to 
the differences in gene expression patterns. In order to overcome this problem, we could 
perform an extensive deletion on the BACFf1bEx2EGFPAmp construct and retain only 
Intron IV and the upstream promoter segment by removing all the intervening regions. 
The observation of expression patterns induced by the generated BAC construct would 
help us confirm the earlier observations. An alternative strategy that could be used is to 
employ the genome editing tools available such as CRISPR and TALEN to perform an 
in vivo removal of the ff1b Intron IV segment from the zebrafish genome to confirm the 
presence of enhancers within the intronic segment. By performing the genome editing 
directly on the embryos obtained from the transgenic line Tg(ff1bEx2:GFP), the 
development of the interrenal cells could be monitored with ease by EGFP fluorescence.  
An important achievement in this study is the generation of a stable zebrafish 
transgenic line – Tg(ff1bIntronIV:mCherry) that showed the presence of mCherry 
expression in the zebrafish interrenal gland. The transgenic line provides a useful tool to 
investigate the development and organogenesis of the interrenal gland. The transgenic 
line Tg(ff1bIntronIV:mCherry) can be outbred with the established transgenic line 
Tg(ff1bEx2:GFP) and the interrenal cells can then be easily isolated by FACS. The 
transcriptome of the isolated interrenal cells can also be studied. It would also help us 
compare the transcripts observed in the zebrafish interrenal gland and the mammalian 
adrenal cortex (Nishimoto et al. 2012; Rege et al. 2014). Analyzing the difference in 
transcriptome of the interrenal gland and the adrenal cortex of the two species would also 
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help us explain the lineage specific trans effects that could cause the observed differences 
in enhancer expression patterns.  
The zebrafish provides an excellent system to study the developmental patterning 
of various organs owing to its transparent nature, short gestation period and ease of 
breeding. The transgenic line generated - Tg(ff1bIntronIV:mCherry) can be used to 
observe, in real time, the morphogenetic patterning involved in the development of the 
interrenal gland. The transgenic line can also be outbred to endothelium-free mutant lines 
such as cloche mutants to study the role of endothelium signaling in the interrenal 
organogenesis (Liu et al. 2006). With the observation of mCherry signal also at the 
pronephric tubules, outbreeding the transgenic line with cloche mutants could help us 
understand if the mCherry expression at the pronephros are genuine (Serluca et al. 2002).  
Apart from the in-vivo experiments, both the constructs – 
pff1bIntronIVtkmCherry and pff1bIntronIV-CoretkmCherry with the essential binding 
sites (C8 and C10), could be transformed into a suitable stem cell line and with the 
presence of appropriate factors, tested if they could promote the differentiation towards 
an endocrine lineage. This would open up further avenues where we could study in detail 
the morphogenesis of the interrenal gland in vitro. With the organization of the interrenal 
cells being intermingled with the chromaffin cells as compared to the layered 
organization of the adrenal gland in mammals, studying the organogenesis of the 
interrenal gland in vitro would help us determine the factors that are involved in the 
organization of the adrenal gland. 
Apart from the interrenal, Ff1b is also expressed in the zebrafish VMH. Our study 
has managed to identify a short stretch within the SF-1 VMHE that is required for 
inducing mCherry expression in the zebrafish VMH. Further analysis by site directed 
mutagenesis at the binding sites of specific TFs at enhancer region I and II would confirm 
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the role of the TFs in the development of the zebrafish VMH. Having identified the 
specific TFs with binding sites on the VMH, similar intronic segments on the ff1b Introns 
V and VII could be tested for enhancer activity in the zebrafish embyros. While lineage 
specific trans changes are observed for the interrenal specific ff1b enhancer, it would be 
interesting to examine if such changes were also observed for the VMH specific ff1b 
enhancer.  
The endocrine system and the HPS axis of teleosts and mammals share extensive 
similarity. In spite of this, we observe differences in the gene organization and enhancer 
usage in ff1b and SF-1. This provides an interesting opportunity to study the lineage 
specific cis and trans changes of the orthologous gene in distant species. The transgenic 
line Tg(ff1bIntronIV:mCherry) generated also offers an interesting platform to study the 
development of the interrenal cells and to understand the molecular basis for the 
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